TABLE OF CONTENTS

SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒
Filed by a Party other than the Registrant
Check the appropriate box:

Preliminary Proxy Statement

Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material Under Section 240.14a-12
TrueBlue, Inc.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
No fee required.
Fee paid previously with preliminary materials:
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

TABLE OF CONTENTS



TABLE OF CONTENTS

Notice of 2024 Annual
Meeting of Shareholders
and Proxy Statement
Wednesday, May 15, 2024 at 8:00 a.m., Pacific Daylight Time
Virtual Meeting Site: www.virtualshareholdermeeting.com/TBI2024

TABLE OF CONTENTS

Letter to Shareholders
Tacoma, Washington
April 4, 2024
Dear Shareholders:
On behalf of the board of directors and management of TrueBlue, Inc. (“TrueBlue,” “Company,” “we,” “us,” or “our”), it is a pleasure to invite you to TrueBlue’s 2024 Annual Meeting of Shareholders (“Meeting”). This year’s Meeting will be held in a virtual format through a live webcast at www.virtualshareholdermeeting.com/TBI2024 on Wednesday, May 15, 2024, at 8:00 a.m., Pacific Daylight Time (“PDT”). A recording of the Meeting will be available on the TrueBlue Investor Relations website after the Meeting. For further information on how to participate in the Meeting, please see the Information About the Meeting section in the proxy statement.
You may submit questions in writing during the Meeting. To submit a question during the Meeting, you must first join the Meeting with your 16-digit control number (“Control Number”). Your Control Number can be found next to the label for postal mail recipients or within the body of the email sending you the proxy statement. We intend to answer questions pertinent to Company matters as time allows at the question and answer session following the formal portion of the Meeting. Questions that are substantially similar may be grouped and answered once to avoid repetition. The Meeting webcast will begin promptly at 8:00 a.m. PDT. We encourage you to access the Meeting prior to the start time. Online check-in will begin at 7:30 a.m. PDT, and you should allow ample time for the check-in procedures. If you experience technical difficulties during the check-in process or during the Meeting, a technical assistance phone number will be made available on the Meeting’s registration page 15 minutes prior to the start time of the Meeting.
As in prior years, TrueBlue has elected to deliver our proxy materials to the majority of our shareholders over the internet. This delivery process allows us to provide shareholders with the information they need, while at the same time conserving resources and lowering the cost of delivery. On or about April 4, 2024, we mailed to our shareholders a Notice of Internet Availability of Proxy Materials (the “Proxy Notice”) containing instructions on how to access our 2024 proxy statement and 2023 Annual Report to shareholders for the fiscal year ended December 31, 2023 (the “2023 Annual Report”). The Proxy Notice also provides instructions on how to vote online, by telephone, or by requesting and returning a proxy card, and includes instructions on how to receive a paper copy of the proxy materials by mail.
The matters to be acted upon are described in the Notice of Annual Meeting of Shareholders and Proxy Statement.
YOUR VOTE IS VERY IMPORTANT. Whether or not you plan to attend, it is important that your shares be represented. Please vote online, by telephone, or by mail as soon as possible to ensure that your vote is counted. If you are a shareholder of record and attend the Meeting, you will have the right to vote your shares during the Meeting.
Very truly yours,
/s/ Jeffrey B. Sakaguchi
Jeffrey B. Sakaguchi
Board Chair
TrueBlue, Inc. 2024 Proxy Statement  P. 1

TABLE OF CONTENTS

Notice of 2024 Annual Meeting of Shareholders
TRUEBLUE, INC.
1015 A Street
Tacoma, Washington 98402
NOTICE OF 2024 ANNUAL MEETING OF SHAREHOLDERS
 
Date and Time:
May 15, 2024 at 8:00 a.m., Pacific Daylight Time
Location:
www.virtualshareholdermeeting.com/TBI2024
Record Date:
March 11, 2024
Voting:
Shareholders as of March 11, 2024, are entitled to vote. Each share of common stock is entitled to one vote for each director nominee and one vote for each of the proposals.
Voting Matters
Proposals*
Board Vote
Recommendation
Page
Reference for
More Information
1
Elect the directors named in the proxy statement
  • 8 of 9 nominees are independent
  • Diverse slate in terms of attributes, experience, and skills, including all 4 committees led by directors from underrepresented groups (by gender or race/ethnicity)
  • Robust Board oversight of Company strategy and risks
  • Proactive and evolving corporate governance practices
FOR
2
Advisory vote on our executive compensation
  • Program offers competitive total compensation opportunities to executives while aligned with shareholder interests
  • Executives are incentivized to focus on both short- and long-term Company performance
FOR
3
Approval of the Amendment and Restatement of the Company’s 2016 Omnibus Incentive Plan
  • Allows the Company to maintain a compensation policy that includes a balanced mix of cash and equity
  • Helps the Company compete more effectively for key employee talent
  • Aligns the long-term interests of employees and shareholders
FOR
4
Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 29, 2024
  • Independent firm with reasonable fees and strong geographic and subject matter expertise
  • Performance annually assessed by the Audit Committee
  • Served as independent registered public accounting firm since 2009
FOR
*Brokers cannot vote for Proposals 1, 2, or 3 without shareholders’ instructions on how to vote.
TrueBlue, Inc. 2024 Proxy Statement  P. 2

TABLE OF CONTENTS

Notice of 2024 Annual Meeting of Shareholders
Vote Right Away
Even if you plan to attend our 2024 Annual Meeting of Shareholders online, please read this proxy statement with care and vote right away using any of the methods below. In all cases, have your proxy card or voting instructions form in hand and follow the instructions.

Important notice regarding the availability of proxy materials for the Annual Meeting of Shareholders to be virtually held on May 15, 2024: Our proxy statement is attached. Financial and other information concerning TrueBlue is contained in our 2023 Annual Report. The proxy statement and our 2023 Annual Report are available on our website at investor.trueblue.com. Additionally, you may access our proxy materials and vote your shares at www.proxyvote.com.
By Order of the Board of Directors,
/s/ Todd N. Gilman
Todd N. Gilman
Corporate Secretary
Tacoma, Washington
April 4, 2024
TrueBlue, Inc. 2024 Proxy Statement  P. 3

TABLE OF CONTENTS

2023 Proxy Statement
Table of Contents
TrueBlue, Inc. 2024 Proxy Statement  P. 4

TABLE OF CONTENTS



TrueBlue, Inc. 2024 Proxy Statement  P. 5

TABLE OF CONTENTS

About TrueBlue
TrueBlue 2023 Business Highlights


Revenue
$1.9 billion
Adjusted EBITDA(1)
$29.0 million
Return of Capital
$33.9 million of common stock, 1,877,078 shares repurchased in 2023
10.1 million shares repurchased in the past five years, a 25% reduction in shares outstanding
Technology Developments
Successfully launched pilot for our new, proprietary version of JobStack, for our PeopleReady Brand.
(1)
Please see Appendix A to this proxy statement for a detailed definition and reconciliation of the non-generally accepted accounting principles (“non-GAAP”) financial measure to the most directly comparable GAAP financial measure.

TrueBlue, Inc. 2024 Proxy Statement  P. 6

TABLE OF CONTENTS

Proxy Summary
This summary highlights information contained elsewhere in this proxy statement. This summary does not contain all of the information that you should consider, and you should read the entire proxy statement carefully before voting.


TrueBlue, Inc. 2024 Proxy Statement  P. 7

TABLE OF CONTENTS

Proxy Summary


TrueBlue, Inc. 2024 Proxy Statement  P. 8

TABLE OF CONTENTS

Proxy Summary


TrueBlue, Inc. 2024 Proxy Statement  P. 9

TABLE OF CONTENTS

Proxy Summary


Risk Ranking: Low
Risk Exposure: Low
Risk Management: Average
TrueBlue, Inc. 2024 Proxy Statement  P. 10

TABLE OF CONTENTS

DIRECTORS

PROPOSAL 1.
ELECTION OF DIRECTORS
The Nominees
The board of directors (the “Board”) has nominated the following persons for election as directors: Colleen B. Brown, William C. Goings, Kim Harris Jones, R. Chris Kreidler, Sonita Lontoh, Taryn R. Owen, Paul G. Reitz, Jeffrey B. Sakaguchi, and Kristi A. Savacool. The Board recommends a vote “FOR” each of the nominees. All directors other than Ms. Owen and Mr. Reitz were elected at the 2023 Annual Meeting of Shareholders. Mr. Reitz was appointed to the Board on August 11, 2023 as a recommendation from a third-party search firm, and Ms. Owen was appointed to the Board on September 12, 2023 in connection with her appointment to the role of President and Chief Executive Officer. The biographies of each of the nominees below contain information regarding the nominees’ service on the Board, business experience, and director positions held currently or at any time during at least the last five years. Each biographic summary is followed by a brief summary of certain experiences, qualifications, attributes, or skills that led the Corporate Governance and Nominating Committee (the “Governance Committee”) and the Board to determine that each nominee should serve as a director for the Company. The summaries do not include all of the experiences, qualifications, attributes, or skills of the nominees. General information regarding the nomination process is included in the Corporate Governance section under “Nominations for Directors.”
FOR
THE CORPORATE GOVERNANCE AND NOMINATING COMMITTEE AND THE BOARD OF DIRECTORS RECOMMEND A VOTE “FOR” EACH OF THE NOMINEES NAMED ABOVE
TrueBlue, Inc. 2024 Proxy Statement  P. 11

TABLE OF CONTENTS

Director Biographies
Colleen B. Brown
Independent

Age: 65

Director since:
June 2014

Committees:
Corporate
Governance (Chair
since June 2022),
Compensation, I&T
PROFESSIONAL HIGHLIGHTS
 • Former Director, President, and Chief Executive Officer of Fisher Communications, a public multimedia and technology company
 • Former CEO of Spark Networks (LOV), the fourth largest dating company in the world
 • Former founder and Managing Director of Marca Global, an internet technology company
 • Member of National Association of Corporate Directors (“NACD”), WCD, IWF, and C200
 • Henry Crown Fellow
 • Member of the Aspen Global Leadership Network at the Aspen Institute
 • Cyber certificate from Carnegie Mellon
CURRENT DIRECTORSHIPS
 • Big 5 Sporting Goods Corporation, public
 • Port Blakely, private
 • SpringRock Ventures, private
 • Delta Dental, nonprofit
PREVIOUSLY HELD DIRECTORSHIPS
 • Fisher Communications
 • Spark Networks SE (Board Chair)
 • American Apparel (Board Chair)
 • CareerBuilder
 • Classified Ventures
COMMUNITY INVOLVEMENT
 • Previously, Washington Roundtable, a nonprofit public policy organization representing major private sector employers throughout Washington State
 • Previously, United Way of King County
DIRECTOR QUALIFICATIONS
Ms. Brown brings extensive executive experience in strategic planning, operations, finance, and technology. Her leadership as a public company Chief Executive Officer, as well as a senior officer in two large media companies, is a valuable resource to the Company. As an NACD fellow, Ms. Brown is a champion of best practices in corporate governance.
William C. Goings
Independent

Age: 66

Director since:
April 2016

Committees: Compensation (Chair
since December 2020),
Corporate Governance,
I&T
PROFESSIONAL HIGHLIGHTS
 • Former Executive Vice President of TD Bank Group and President of TD Insurance
 • Former Senior Vice President and Chief Operating Officer at TD Insurance
 • Former senior leadership roles at Genworth Financial and GE Capital
 • Member of NACD
CURRENT DIRECTORSHIPS
 • Encore Capital Group, public
 • AARP Service Inc., private
 • Penn Mutual Insurance Company, private
COMMUNITY INVOLVEMENT
 • Former Independent Director, Vice Chair, Purcell Marian IB World School
DIRECTOR QUALIFICATIONS
Mr. Goings worked for global companies as a business unit Chief Executive Officer and in functional roles in strategic planning, international business development, e-business, and corporate banking. Mr. Goings brings extensive governance and relevant work experience to the Board, currently serving in director leadership positions on several boards, and prior broad business operating experience, strategic planning, leadership development, and a problem-solving, results-oriented approach.
TrueBlue, Inc. 2024 Proxy Statement  P. 12

TABLE OF CONTENTS

Director Biographies
Kim Harris Jones
Independent

Age: 64

Director since:
May 2016

Committees:
Audit (Chair since
March 2020), Corporate
Governance, I&T
PROFESSIONAL HIGHLIGHTS
 • Former Senior Vice President and Corporate Controller of Mondelez International
 • Former Senior Vice President and Corporate Controller at Kraft Foods, Inc.
 • Number of former positions at Chrysler LLC, most notably as Senior Vice President and Corporate Controller
CURRENT DIRECTORSHIPS
 • United Rentals Inc., public
 • Fossil Group, Inc., public
 • Consortium for Graduate Study in Management, finance committee
 • Harris-Jones Charitable Gift Foundation, President and Chairman, nonprofit
PREVIOUSLY HELD DIRECTORSHIPS
 • Ethiopian North American Health Professionals Association, nonprofit
COMMUNITY INVOLVEMENT
 • Member of the Executive Leadership Council.
DIRECTOR QUALIFICATIONS
Ms. Harris Jones has extensive management, financial, and business experience at large, complex corporations undergoing significant corporate growth and change. Her significant financial and board experience are valuable resources to the Board.
R. Chris Kreidler
Independent

Age: 60

Director since:
July 2020

Committees:
Corporate Governance,
Audit, I&T
PROFESSIONAL HIGHLIGHTS
 • Senior advisor to McKinsey & Company, a strategy and management consulting firm, 2016 - current
 • C-suite coach and mentor, 2019 - current
 • Former EVP and CFO of Sysco Corporation
 • Former EVP, CFO and Chief Customer Officer, C&S Wholesale Grocers
 • Multiple former senior leadership roles at Yum! Brands, Inc.
CURRENT DIRECTORSHIPS
 • Alyasra Foods, private
 • Special Advisor to the board of directors of Soul Foods, private
PREVIOUSLY HELD DIRECTORSHIPS
 • BradyIFS, private
 • Aimia Inc. (Chairman of the Audit Committee), public
 • Wok Holdings, private
 • P.F. Chang’s China Bistro, private
COMMUNITY INVOLVEMENT
 • Member of the Board of Advisors for the Jones Graduate School of Business at Rice University
DIRECTOR QUALIFICATIONS
Mr. Kreidler’s service as a former financial executive with domestic and international experience and with deep strategic planning, operational, and transactional expertise provides a valuable resource to the Company. His extensive board experience provides the Company with insights to develop creative solutions for complex business issues and focus on delivery of desired strategic outcomes that create high shareholder, organizational, and client value.
TrueBlue, Inc. 2024 Proxy Statement  P. 13

TABLE OF CONTENTS

Director Biographies
Sonita Lontoh
Independent

Age: 48

Director since:
October 2021

Committees:
Corporate Governance,
Audit, I&T
PROFESSIONAL HIGHLIGHTS
 • CMO, Personalization, 3D Printing & Digital Manufacturing at HP Inc., a global technology company, 2018-2022
 • Former senior executive, Digital Grid at Siemens AG, a global leader in automation and digitalization solutions
 • Former senior executive in technology, innovation and marketing at Trilliant Inc., a global provider of IoT solutions
 • Various former leadership roles in strategy, innovation, and climate at PG&E, one of the largest energy providers in the United States
 • NACD directorship-certified
 • NACD Climate Governance certification
 • Digital Directors’ Networks cybersecurity-certified
 • Stanford Directors’ College certifications
 • Inducted into U.S. Asian Hall of Fame
 • Inducted into the U.S. Women in Manufacturing Hall of Fame
 • Named as one of the Top 30 AAPI Board Directors by Board Prospect
 • Named as one of the Directors to Watch by Directors & Board magazine
 • Named as the Most Influential Women in Business by San Francisco Business Times
CURRENT DIRECTORSHIPS
 • Sunrun Inc., public
 • Advisory Board of the Jacobs Institute of Design Innovation at the University of California Berkeley
 • NACD Blue Ribbon Commissioner on board culture
 • NACD/WEF/CGI Climate Advisory Council
COMMUNITY INVOLVEMENT
 • Previously, mentor for the U.S. State Department’s TechWomen program
DIRECTOR QUALIFICATIONS
Ms. Lontoh brings deep expertise in digital transformation, customer experience, global marketing, and innovation. Her leadership experience at both innovative, high-growth businesses at large, global Fortune 100 companies, and at entrepreneurial, venture-backed Silicon Valley technology companies, provides valuable insight, foresight, and perspective to the Company’s digital and growth strategies.
Taryn R. Owen
Not Independent

Age: 45

Director since:
September 2023

Committees: I&T
PROFESSIONAL HIGHLIGHTS
 • President and Chief Executive Officer and Director of the Company, September 2023 - current
 • President and Chief Operating Officer of TrueBlue September 2022 - September 2023, continuing as President of PeopleReady and PeopleScout
 • Executive Vice President of TrueBlue and President of PeopleReady and PeopleScout, October 2021 - September 2023
 • Executive Vice President and President of PeopleReady, December 2019 - October 2021
 • Executive Vice President and President of PeopleScout, 2014-2019
 • Former Senior Vice President of Global Operations and as Vice President of Client Delivery at PeopleScout
 • Former Operations Director at Randstad Sourceright Solutions, where she led global RPO engagements
PREVIOUSLY HELD DIRECTORSHIPS
 • Member of the Board of Advisors of HRO Today
 • Member of the Human Capital Industry Advisory Board for Wharton’s Center for Human Resources
DIRECTOR QUALIFICATIONS
Ms. Owen has more than 25 years of staffing and talent acquisition experience, including 14 years at the Company. She has led TrueBlue through significant periods of growth, was instrumental in its pandemic response and recovery, spearheaded its digital transformation strategies, and successfully led several acquisitions and substantial international expansion. Ms. Owen has been recognized for her industry leadership, including annual appearances on the Staffing Industry Analysts’ (SIA) Staffing 100 and Global Power 150.
TrueBlue, Inc. 2024 Proxy Statement  P. 14

TABLE OF CONTENTS

Director Biographies
Paul G. Reitz
Independent

Age: 51

Director since:
August 2023

Committees:
Corporate Governance,
Audit, I&T
PROFESSIONAL HIGHLIGHTS
 • President, CEO, and Director of Titan International, Inc., a publicly traded, global leader in off-road tires, wheels, and undercarriages serving the agriculture, construction, and earthmoving industries, January 2017 - current
 • President of Titan International Inc., January 2014 - January 2017
 • Former Chief Financial Officer of Titan International Inc.
 • Former Chief Accounting Officer at Carmike Cinemas
 • Former leadership roles at McLeodUSA Publishing, Yellow Book USA Inc., and Deloitte
CURRENT DIRECTORSHIPS
 • Titan International, Inc., public
PREVIOUSLY HELD DIRECTORSHIPS
 • Wheels India LTE, public
DIRECTOR QUALIFICATIONS
Mr. Reitz’s service as a public company Chief Executive Officer with domestic and international experience provides a valuable resource to the Company. He brings to the Board extensive public company executive experience in global strategy development and execution, operations, and finance. Mr. Reitz’s significant leadership expertise in improving global operating efficiency, performance, and financial health is a valuable resource to the Company.
Jeffrey B. Sakaguchi
Independent

Age: 62

Director since:
December 2010

Board Chair since:
June 2022

Committees:
Corporate Governance,
Audit, I&T
PROFESSIONAL HIGHLIGHTS
 • President and Chief Operating Officer of Evolution Robotics Retail, Inc.
 • Leadership roles with Accenture and McKinsey & Company, global management consulting firms
 • NACD Leadership Fellow
 • NACD directorship-certified
 • Educational Counselor for Massachusetts Institute of Technology
CURRENT DIRECTORSHIPS
 • Eccentex, Inc., a privately held early-stage software company
 • ThinkIQ, Inc., a privately held early-stage software company
PREVIOUSLY HELD DIRECTORSHIPS
 • Founding board member of ACT Holdings, Inc.
 • Advisory board member of Habla.AI
 • Chairman of the board of directors of Neah Power Systems, Inc. (renamed XNRGI, Inc.)
COMMUNITY INVOLVEMENT
 • Member and former Chairman of the Board of Directors of the Los Angeles Region American Red Cross and member and former Chairman of their National Philanthropic Board
DIRECTOR QUALIFICATIONS
Mr. Sakaguchi’s experience in several leadership roles is valuable to the Board’s efforts in overseeing the Company’s performance improvement and market share growth initiatives. His background and expertise in emerging technology, start-ups, and strategy provides valuable guidance to the Company’s strategic, innovative, and technological efforts. His experience provides a valuable resource to the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 15

TABLE OF CONTENTS

Director Biographies
Kristi A. Savacool
Independent

Age: 64

Director since:
July 2018

Committees:
I&T (Chair since
June 2022), Corporate
Governance, Compensation
PROFESSIONAL HIGHLIGHTS
 • Former Chief Executive Officer of Aon Hewitt, the global human resources solutions business of Aon plc.
 • Several former senior executive management positions at The Boeing Company in the areas of information technology (as Chief Information Officer for Commercial Airplanes), operations, and business services
CURRENT DIRECTORSHIPS
 • Ascension Inc., private
 • RxBenefits, Inc., private
 • Escuela Adelante, nonprofit
 • HealthQuest Capital’s Board of Advisors, nonprofit
PREVIOUSLY HELD DIRECTORSHIPS
 • Private Health Management, Inc., private
 • Springbuck, Inc., private
 • United Way of King County in Seattle, Washington
 • Trustee for DePaul University
 • Midtown Educational Foundation in Chicago, Illinois
 • Board of Court Appointed Special Advocates of Lake County, Illinois
COMMUNITY INVOLVEMENT
 • Former executive member of the Center for Corporate Innovation, Fortune 1000 health care CEO roundtable
DIRECTOR QUALIFICATIONS
Ms. Savacool has extensive financial, management, and business experience in professional services and large scale, global operations. Her invaluable experience as a public company business unit Chief Executive Officer in the human resource and outsourcing industry provides valuable guidance to the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 16

TABLE OF CONTENTS

CORPORATE GOVERNANCE

Leadership Structure
The board of directors (the “Board”) of TrueBlue, Inc. (“TrueBlue,” “Company,” “we,” “us,” or “our”) has divided the Company’s leadership among three directors:
Taryn R. Owen serves as Chief Executive Officer (the “CEO”);
Jeffrey B. Sakaguchi serves as Chair of the Board (the “Board Chair”); and
Colleen Brown serves as Chair of the Corporate Governance and Nominating Committee (the “Governance Committee”).
The Board has appointed different individuals to fulfill the roles of the Board Chair and the CEO for over 20 years. The Board believes that it is in the best interest of the shareholders and an efficient allocation of the time and responsibilities for Company leadership to separate these roles. The key duties and responsibilities of the Board Chair and the Chair of the Governance Committee are set forth in the tables below. When the Board Chair is not an independent director, we have appointed a lead independent director to ensure independent leadership of the Board when such independence was necessary or advisable for the Board.
Key Duties and Responsibilities
Board Chair
Plans the Board meeting calendar.
Proposes the agenda for meetings of the Board and shareholders, with input from the CEO and other directors.
Presides at meetings of the Board and the shareholders except where the Board Chair has a conflict or elects to delegate such responsibility to another director.
Maintains effective communications between the Board and the CEO
Chair of Governance Committee
Presides at meetings of the Board and the shareholders in the absence of the Board Chair.
Leads the Governance Committee in discharging such responsibilities as may be established in its charter including without limitation:
the annual evaluation processes for the CEO, the Board, and Board committees;
the identification, review, and proposal of nominees (including the nomination of existing directors) to the Board;
changes in the composition of the Board’s committees; and
the CEO succession planning process.
Identifies, communicates, and reviews existing and new governance requirements, proposals, and trends.
Undertakes such other matters as may be delegated to the Chair of the Governance Committee by the Board Chair.
TrueBlue, Inc. 2024 Proxy Statement  P. 17

TABLE OF CONTENTS

CORPORATE GOVERNANCE
Director Independence
The Board affirmatively determines the independence of each director and nominee for election as a director in accordance with criteria set forth in the Company’s Corporate Governance Guidelines (the “Guidelines”), which include all elements of independence set forth in the New York Stock Exchange (“NYSE”) listing standards and related U.S. Securities and Exchange Commission (“SEC”) Rules and Regulations. At a regularly scheduled portion of each Board meeting or as part of the Governance Committee meetings, the independent directors meet in executive session without management or any non-independent directors present. Independent directors have no material relationship with the Company, except as directors and shareholders of the Company.
As reported in last year's proxy statement, Steve Cooper served as a director in 2023, and the Board determined that he was not independent because he also served as CEO of the Company during that time.
Based on the aforementioned standards, at its meeting held on March 13, 2024, the Board made the independence determinations for each of our directors:
Name
Tenure
Independent
Colleen B. Brown
10 years
Yes
William C. Goings
8 years
Yes
Kim Harris Jones
8 years
Yes
R. Chris Kreidler
4 years
Yes
Sonita Lontoh
2 years
Yes
Taryn R. Owen
1 year
No(1)
Paul G. Reitz
1 year
Yes
Jeffrey B. Sakaguchi
13 years
Yes
Kristi A. Savacool
6 years
Yes
(1)
Based on the NYSE rules, the Board determined that Ms. Owen is not independent because she is the CEO of the Company.
By having a majority of independent directors serve on the Board, there are several key benefits to the Company which are set forth in the table below.
Key Duties and Responsibilities
Independent Directors
Bring an objective view in balancing the concerns of interested parties and ensure the Board acts in the best interests of the Company on issues such as strategy, performance, risk management, resources, key appointments, and standards of conduct.
Safeguard and balance the concerns of all stakeholders.
In situations of conflict between management and shareholders’ concerns, aim towards the solutions which are in the best interest of the Company.
Establish suitable levels of compensation for the CEO and executive vice presidents.
Chair the Audit, Compensation, and Governance Committees.
Create a process of checks and balances on management and other directors.
Create an environment for innovation.
Risk Assessment
Enterprise risk management is an integral part of our business processes and the Company has an enterprise risk management (“ERM”) program to integrate risk responsibilities within the current management structure. Specific risks are assigned to the Board’s committees and business area experts. The most significant risks are regularly discussed with the Board as part of its active oversight of risks that could affect the Company. Risks are delegated among the committees based on the expertise of each committee. Each committee and the Board discuss specific risks with management throughout the year, as appropriate. The Board believes the administration of this risk oversight function does not negatively affect the Board’s leadership structure.
The Board exercises an oversight role with respect to the most significant risks facing our Company and maintains responsibility for certain risks, while designating the Audit Committee with the primary responsibility for overseeing the Company’s ERM program and process. Management provides the Board with periodic reports on the Company’s risk and ERM program findings. The Audit Committee has responsibility to periodically review the Company’s guidelines, policies, and procedures to assess and manage risk exposure.
The individual committees also consider risk within their areas of responsibility as highlighted below. The committee chairs provide reports of their activities to the Board at each regular Board meeting including apprising the Board of any significant risks within their areas of responsibility and management’s response to those risks.
TrueBlue, Inc. 2024 Proxy Statement  P. 18

TABLE OF CONTENTS

CORPORATE GOVERNANCE
Meetings and Committees of the Board
The Board
Each director is expected to devote sufficient time, energy, and attention to ensure diligent performance of his or her duties and to attend all Board, committee, and shareholders’ meetings. The Board met eleven (11) times during 2023. All directors attended all the meetings of the Board and of the committees on which they served during the fiscal year ended December 31, 2023. Our Guidelines provide that each of our directors is expected to attend our annual meeting of shareholders and all directors participated in the 2023 Annual Meeting of Shareholders on May 11, 2023.
Committees of the Board
The Board has four standing committees to facilitate and assist the Board in the execution of its responsibilities. These committees are the Audit Committee, the Compensation Committee, the Governance Committee, and the Innovation and Technology Committee (“I&T Committee”). With the exception of the I&T Committee, of which Ms. Owen is a member, all the committees are comprised solely of non-employee, independent directors. Charters for each committee are available on the Company’s website at https://investor.trueblue.com/corporate-governance/governance-documents. The charter of each committee is also available in print to any shareholder upon request. The table below shows membership for each of the standing Board committees as of December 31, 2023, the number of times each committee met in 2023, and outlines each committee’s key responsibilities and functions.
Committees, Members as of April 4, 2024, and Number of Meetings in 2023
Key Areas of Responsibility and Risk Oversight During 2023
Full Board
Retains responsibility for oversight of major Company initiatives and risks such as:
Company Strategy;
Company competition and emerging business risks;
Mergers & Acquisitions;
Major Litigation;
Leadership and Oversight of Ethical Standards; and
11 Meetings
Enterprise Risk Management (“ERM”).
Audit Committee

Harris Jones (Chair)
Kreidler
Lontoh
Reitz
Sakaguchi
Reviews and discusses the Company’s earnings reports and financial statements with management and the independent auditors prior to the release of this information to the public.
Monitors risk relating to the Company’s financial statements, systems, reporting process, and compliance.
Oversees the adequacy of the Company’s system of internal controls and the performance of the Company’s internal audit function.
Consults with the Company's independent external auditors and management to ensure the adequacy of internal controls that could significantly affect the Company's financial statements.
Reviews compliance policies to ensure alignment with legal and regulatory requirements.
Oversees the Company's Ethics and Compliance Program, including monitoring compliance with the Company's Code of Conduct and Business Ethics.
Oversees management's process for identifying risks and setting mitigation strategies.
Reviews and discusses with management the guidelines, policies, and procedures that govern the process by which the Company assesses and manages its exposure to risk.
Monitors the process and management of the Company-wide ERM program.
Evaluates and approves or disapproves in advance all audit and non-audit services proposed to be provided by the independent auditors.
10 Meetings
The Board has determined that each member of the audit committee is financially literate and that Ms. Harris Jones and Messrs. Sakaguchi, Reitz and Kreidler each qualify as an “audit committee financial expert” under applicable SEC Rules.
TrueBlue, Inc. 2024 Proxy Statement  P. 19

TABLE OF CONTENTS

CORPORATE GOVERNANCE
Committees, Members as of April 4, 2024, and Number of Meetings in 2023
Key Areas of Responsibility and Risk Oversight During 2023
Compensation Committee

Goings (Chair)
Brown
Savacool
Approves compensation, including incentive plan awards, for the CEO and executives.
Administers incentive compensation plans.
Monitors compliance with stock ownership guidelines.
Determines compensation levels for senior executives.
Prepares required disclosures regarding compensation practices.
Manages executive compensation risk.
Oversees the Company's human capital management program.
Reviews compensation and benefits policies and practices of the Company.
7 Meetings
Establishes incentive plan performance metrics and goals.
Corporate Governance and Nominating Committee

Brown (Chair)
Goings
Harris Jones
Kreidler
Lontoh
Reitz
Sakaguchi
Savacool
Oversees corporate governance matters.
Establishes criteria for Board membership, including diversity, experience, skill set, and the ability to act effectively on behalf of shareholders.
Identifies and reviews the candidates for the Board.
Provides a forum for independent directors to meet separately from management.
Reviews and recommends to the Board any changes to the Guidelines.
Oversees the Board’s evaluation process.
Conducts the CEO evaluation and succession planning process.
Reviews and determines compensation paid to non-employee directors.
Reviews any conflicts of interest and related party transactions and relationships involving directors and executive officers.
Monitors trends and best practices in corporate governance.
Monitors the Company’s government relations activities.
6 Meetings
Leads the Company’s response on environment, social, and governance issues.
Innovation and
Technology
Committee

Savacool (Chair)
Brown
Goings
Harris Jones
Kreidler
Lontoh
Owen
Reitz
Sakaguchi
Oversees and advises management on significant Company digital policies and trends.
​Oversees Company technology initiatives and development of intellectual property.
Monitors the Company’s cybersecurity risks and related incidents.
Examines reports on the protection and privacy of client, employee, candidate, and associate data.
Oversees major business model innovation and technology programs, investments, and architecture decisions.
Monitors emerging technology trends and industry trends, and their potential impact on the Company’s strategy.
4 Meetings
Advises on leadership and talent development in the Company’s innovation and technology teams.
TrueBlue, Inc. 2024 Proxy Statement  P. 20

TABLE OF CONTENTS

CORPORATE GOVERNANCE
Audit Committee
The Audit Committee is comprised solely of non-employee directors, all of whom the Board determined are independent pursuant to the NYSE rules and the independence standards set forth in Rule 10A-3 of the Exchange Act. The Governance Committee and the Board have determined that all the members of the Audit Committee are “financially literate” pursuant to the NYSE rules. The Board has affirmatively determined that Ms. Harris Jones and Messrs. Kreidler, Reitz, and Sakaguchi are “audit committee financial experts,” as such term is defined in Item 407 of Regulation S-K. The Board has adopted a charter for the Audit Committee, which is available on the Company’s website at https://investor.trueblue.com/corporate-governance/governance-documents. The charter is also available in print to any shareholder upon request.
Compensation Committee
The Compensation Committee is comprised solely of non-employee directors, all of whom the Board determined are independent pursuant to the NYSE rules. The Compensation Committee is comprised entirely of independent directors. During 2023, none of the Company’s executive officers served as a member of a compensation committee or board of directors of any other entity that had an executive officer serving as a member of the Company’s Board. The Board has adopted a charter for the Compensation Committee, which is available on the Company’s website at https://investor.trueblue.com/corporate-governance/governance-documents. The charter is also available in print to any shareholder upon request. Additional information regarding the Compensation Committee and its procedures and processes for the consideration and determination of executive compensation are included under the Compensation Discussion and Analysis section of this proxy statement.
Corporate Governance and Nominating Committee
The Governance Committee is comprised solely of non-employee directors, all of whom the Board determined are independent pursuant to the NYSE rules. The Board has adopted a charter for the Governance Committee, which is available on the Company’s website at https://investor.trueblue.com/corporate-governance/governance-documents. The charter is also available in print to any shareholder upon request.
The Corporate Governance and Nominating Committee is responsible for the CEO succession planning process. During 2023, the Governance Committee oversaw the appointment of a new Chief Executive Officer (“CEO”), Taryn Owen. Ms. Owen’s appointment to the CEO role came after extensive planning and consideration. With Mr. Cooper’s return from retirement to lead the Company in 2022, the Governance Committee began planning for the appointment of a new CEO within one to three years. Ms. Owen had previously been selected to lead the Company’s most profitable divisions, PeopleReady (2019-2023) and PeopleScout (2014-2019 and again in 2021-2023). During late 2022 and early 2023, the Governance Committee engaged an outside executive training and development firm to further evaluate Ms. Owen’s preparation to eventually assume the CEO role. In 2022, Ms. Owen was promoted to Chief Operating Officer (“COO”) and President of the Company, which, in addition to leading all our operating divisions, included responsibility for overseeing the technology, human capital, and marketing/communications functions of the Company. As COO, Ms. Owen continued to serve as President to PeopleReady and
PeopleScout. After continuing to monitor and evaluate Ms. Owen’s performance as COO, the Governance Committee recommended to the Board that Ms. Owen be appointed CEO. On August 5, 2023, the Board appointed Ms. Owen as CEO, to be effective on September 12, 2023, after a brief transition period. With her promotion to CEO, Ms. Owen was appointed as a director on the Board, effective September 12, 2023, at which time Mr. Cooper simultaneously stepped down from the Board. After the transition was complete, and Ms. Owen had assumed the CEO position, Mr. Cooper remained with the Company to provide advice, counsel, and ensure a smooth transition for Ms. Owen, until his retirement from the Company on December 31, 2023.
Innovation and Technology Committee
The I&T Committee’s primary functions are to oversee the Company’s information risks, cybersecurity, technology strategy, artificial intelligence, and emerging innovation and business trends and their alignment with the Company’s business strategies and objectives. The Board has adopted a charter for the I&T Committee, which is available on the Company’s website at https://investor.trueblue.com/corporate-governance/governance-documents. The charter is also available in print to any shareholder upon request.
Corporate Environmental, Social, and Governance Responsibility
The Company sees environmental, social, and governance (“ESG”) matters as an essential component of sustainable Company performance and integral to the successful implementation of our long-term business strategy. ESG considerations inform how we manage the Company, including our risk management framework and our governance mechanisms for Board oversight and how we deliver sustainable growth that positively impacts our employees, clients, shareholders, and the communities in which we operate. In 2022, we joined the United Nations Global Compact on sustainability.
As the Company seeks to meet evolving stakeholder needs, the Board views ESG issues as increasingly essential to the Board’s oversight of our business strategy. The Governance Committee is responsible for overseeing our ESG efforts and receives regular updates from management on our sustainability strategy and activities. The Company’s ESG efforts are led by the chief legal officer, who chairs, leads, and manages our response to ESG issues for the Company, and engages stakeholders on our ESG initiatives. Other senior leaders provide input through corporate organizations such as the Diversity, Equity, & Inclusion Council (the “Council”). The Company implements day-to-day ESG programs with support from senior managers and relevant corporate functions.
Key ESG Factors
Our approach to ESG strategy and corporate sustainability begins with understanding and acting on the ESG issues that most impact our business performance and strategy. Since 2018, we have conducted assessments of significant ESG risks, based on input from across the Company and alignment with leading external reporting frameworks. In assessing key material topics for our business and industry, we referenced the Sustainability Accounting Standards’ Board and added components most important to stakeholders across the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 21

TABLE OF CONTENTS

CORPORATE GOVERNANCE
After considering the various ESG related risks and conducting a stakeholder materiality assessment in 2022, the Company found the following risks to be material or significant enough to warrant specific ESG reporting efforts:
Board Governance;
Diversity, Equity, and Inclusion;
Business Ethics;
Human Capital Management, including safety, health and well-being;
Data Protection and Cybersecurity;
Skills Development; and
Recruitment and Retention.
These ESG materiality issues have been used by the Company to guide our ESG programs and provide additional reporting through our Corporate Citizenship Report.
As a member of the United Nations Global Compact, we have further committed to acting on sustainable development goals related to:
Ensuring inclusive and equitable quality education and promotion of lifelong learning opportunities for all;
Achieving gender equality and empowering all women and girls;
Promoting sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all; and
Taking urgent action to combat climate change and its impacts.
Diversity, Equity, and Inclusion
The Board has long prioritized diversity, equity, and inclusion (“DE&I”) as a key aspect of corporate sustainability, setting an example for the Company's leadership. DE&I is seen as not just important for “sustainability” but as fundamental to our performance as a people-based company and critical to our strategic and competitive success. The Board has been recognized by the National Association of Corporate Directors (“NACD”) and other national and regional organizations for its efforts and success in becoming a diverse and inclusive board. The Board continues to foster and promote a diverse, talented, and well-trained workforce and a performance-driven workplace culture.
Management has also emphasized DE&I throughout the Company with our Chief Diversity Officer leading our DE&I programs. Additionally, the Council designs and launches initiatives that advance acceptance and inclusion. The Council reports regularly to executive leadership, who brief our Board periodically throughout the year. The Council also sponsors training to build diversity and inclusion awareness, and supports Employee Resource Groups (“ERGs”), which are employee-led groups that create opportunities for employees to collaborate based on shared characteristics or life experiences to support each other for enhanced career and personal development. ERGs seek to maximize employee engagement and contribute to our overall business objectives by offering diverse perspectives, networking opportunities, and increased cultural awareness. We currently have nine ERGs for employees sharing
similar ethnicity, nationality, gender, lifestyle choice, or life experience and their respective allies. Through these initiatives, we learn how our differences build stronger teams and how our histories reveal similarities.
Board Governance
Board and corporate governance have been a focus of the Company for over a decade, exemplified by the Company’s early adoption of a practice separating the CEO and Board Chair roles. The Governance Committee also receives frequent updates on evolving corporate governance best practices and implements those practices most impactful or useful to the Company.
Majority Voting for Directors
A nominee for director in an uncontested election who does not receive the majority vote required by our Amended and Restated Bylaws (the “Bylaws”) but who was a director at the time of the election shall not be elected, but shall continue to serve as a holdover director until the earliest of: (i) 90 days after the date on which an inspector determines the voting results as to that director pursuant to Section 23B.07 of the Washington Business Corporation Act; (ii) the date on which the Board appoints an individual to fill the office held by such director, which appointment shall constitute the filling of a vacancy by the Board; or (iii) the date of the director’s resignation. Any vacancy resulting from the nonelection of a director under these circumstances may be filled by the Board as provided in Article II, Section 2.11 of the Company’s Bylaws. The Governance Committee will promptly consider whether to fill the position of a nominee failing to receive a majority vote and make a recommendation to the Board to fill the position. The Board will act on the Governance Committee’s recommendation and, within 90 days after the certification of the shareholder vote, will publicly disclose its decision. Except as provided in the next sentence, a director who fails to receive a majority vote for election will not participate in the Governance Committee’s recommendation or the Board’s decision about filling his or her office. If no director receives a majority vote in an uncontested election, then the incumbent directors: (i) will nominate a slate of nominee directors and hold a special meeting for the purpose of electing those nominees as soon as practicable; and (ii) may in the interim fill one or more director positions with the same director(s) who will continue in office until their successors are elected.
Professional Integrity
Professional ethics are monitored at the Board level by the Audit Committee. The Chief Ethics and Compliance Officer oversees risks related to professional integrity and ethics, ensuring regular training for Company employees on our Code of Conduct and Business Ethics (“Code of Conduct”), anti-fraud, bribery and corruption efforts, third-party risk management program, and provides regular reports to the Audit Committee of these efforts and any breaches of ethical conduct by Company employees. Our Code of Conduct covers topics including avoiding conflicts of interest, maintaining confidentiality, anti-harassment and discrimination, among others.
We believe a strong corporate culture and employee engagement is key to attracting and retaining talented employees. To assess and improve our culture, we routinely utilize an independent third party to measure how favorably our employees view our organizational culture and engagement. These surveys include corporate culture assessments, as well as real-time feedback on employee
TrueBlue, Inc. 2024 Proxy Statement  P. 22

TABLE OF CONTENTS

CORPORATE GOVERNANCE
engagement and employee-management relations. We also engage an independent third party to measure the ethical culture of the Company by assessing employees’ and leaders’ perception of the Company’s ethical culture. The results of these surveys are reported and distributed throughout management and the Board, and are used to create actionable plans to improve employee engagement and retention. Our August 2023 engagement survey achieved an engagement score of 77, which exceeds the target benchmark of 74 set by the independent third-party survey provider.
Human Capital Management
Our human capital strategy is centered on our values and our employees. Ensuring a diverse and inclusive performance-driven culture is one of the key components of this corporate strategy and a corporate priority led by the Board. We invest in emerging talent through our DE&I program, recruitment strategies, talent management, and development programs for critical roles. Our human capital management (“HCM”) initiatives are included in the chartered responsibilities of the Compensation Committee. Relevant HCM metrics are reported on a regular basis to the Compensation Committee. Our online training platforms provide our employees with access to a multitude of training courses, videos, reference material, and other tools.
We also emphasize the health, safety, and wellness of our employees. We provide our employees and their families with flexible health and wellness programs, including competitive benefits. Our benefits include health, dental, and vision insurance, health savings and flexible spending accounts, paid time off, family leave, mental health resources, and family care resources.
Cybersecurity
The Board acknowledges the importance of assessing, identifying, and managing material risks associated with cybersecurity threats. Since 2011, our I&T Committee has been responsible for the oversight of risks from cybersecurity threats. All of our Board members are members of the I&T Committee. At least quarterly, management provides the I&T Committee with updates regarding our cybersecurity risks, threats, and efforts focused on mitigating those risks. These updates are provided by our Chief Digital Officer and our Chief Information Security Officer, and include recent developments in cybersecurity, the Company’s actual experience with cybersecurity incidents, and the systems and processes in place to defend against cyberattacks. Should a material or potentially material cybersecurity incident occur, the Board will immediately be notified of such event by the Company’s CEO. As part of our ongoing cybersecurity risk management and strategy processes, we leverage technology and established processes, procedures, risk assessments, third party due diligence and other controls to identify, assess, monitor, and manage material cybersecurity risks. Additional information on these processes can be found in Item 1C of the Company’s 10-K filed on February 21, 2024.
Corporate Environmental Stewardship & Management
We are committed to promoting environmental sustainability both internally, by minimizing our corporate environmental footprint, and externally by developing digital tools that modernize how people are connected with work and reducing our employees’ need for daily transportation to our branches or to face-to-face interviews.
We strive to reduce our corporate environmental footprint by seeking opportunities for increased efficiency and resource conservation. We
completed our first greenhouse gas assessment in 2022 and have continued to complete these on an annual basis. The results of these assessments are published in our Corporate Citizenship Report. In 2023, we established a GreenTeam composed of members across the Company to help establish goals with the information from the greenhouse gas assessments. We will continue to refer to the Task Force on Climate-Related Financial Disclosures (TCFD) framework to further develop measurable environmental goals for the Company. Since 2022, we have been disclosing our Scopes 1, 2, and 3 emissions through our Corporate Citizenship Report.
Corporate Citizenship Report
A more detailed disclosure of more of our ESG efforts as a Company can be found in our Corporate Citizenship Report on our website at trueblue.com/corporate-citizenship/. This report is updated from time to time and contains a description of our ESG efforts more broadly, as well as disclosure of some of the metrics we use to measure and improve our performance in these important areas for the Company. The Corporate Citizenship Report on our website does not form a part of this proxy statement.
Corporate Governance Guidelines
The Corporate Governance Guidelines (the “Guidelines”) are available at https://investor.trueblue.com/corporate-governance/
governance-documents. Shareholders may request a free printed copy by contacting TrueBlue, Inc., Investor Relations, 1015 A Street, Tacoma, Washington 98402. The Guidelines were adopted by the Board to best ensure that the Board is independent from management, that the Board adequately performs its function as the overseer of management, and that the interests of the Board and management align with the interests of the shareholders.
On an annual basis, each director and executive officer is obligated to complete a questionnaire which, among other things, requires disclosure of any transactions with the Company in which the director or executive officer, or any member of his or her immediate family, has a direct or indirect material interest.
Shareholder Engagement
We value our shareholders’ feedback and are committed to engaging in constructive and meaningful dialogue with shareholders regarding our strategic focus, operating results, capital allocation priorities, governance practices, executive compensation program, and other areas of shareholder focus throughout the year. As part of our ongoing outreach, members of senior management and investor relations routinely engage with investors in many different ways, including:
Hosting quarterly earnings calls with a live webcast, presentation materials, and a Q&A session.
Participating in industry conferences, non-deal roadshows, and one-on-one meetings.
Conducting an annual outreach program to solicit investor feedback and seek insight into our investors’ priorities.
Holding over 20 meetings with shareholders in the fourth quarter of 2023 to introduce key shareholders to our recently appointed CEO and CFO.
Requesting shareholder feedback after the 2023 Annual Meeting’s vote related to the Say on Pay vote results.
TrueBlue, Inc. 2024 Proxy Statement  P. 23

TABLE OF CONTENTS

CORPORATE GOVERNANCE
These activities allow our senior management and investor relations teams to share and discuss our business strategy and achievements with investors, solicit investor feedback on our performance, and seek insight into our investors’ priorities.
Any shareholder or interested party who wishes to communicate with our Board or any specific director, including non-employee directors, may write to Board of Directors, TrueBlue, Inc. c/o Corporate Secretary, 1015 A Street, Tacoma, Washington 98402. The mailing envelope must contain a clear notation indicating that the enclosed letter is a “Board Communication” or “Director Communication.” All such letters must indicate whether or not the author is a shareholder and clearly state whether the intended recipients are all members of the Board or specific individual directors. The Corporate Secretary will make copies of all such letters and circulate them to the appropriate director(s). If the Company develops any other procedures, they will be posted on the Company’s website at www.trueblue.com. Procedures addressing the reporting of other concerns by shareholders, employees, or other third parties are set forth in our Code of Conduct.
Board and Committee Self-Evaluations
The Board annually assesses the performance and effectiveness of the Board, the Audit, Compensation, and I&T Committees, these committee chairs, the Board Chair, and each director through an annual self-evaluation, discusses the results of each annual self-evaluation and, as appropriate, implements enhancements and other modifications identified during the self-evaluation process.
Self-Evaluation Questionnaires
The Board and the committees noted in the prior paragraph conduct annual self-evaluations by written questionnaire to provide feedback on performance and effectiveness of the Board and committees.
Ongoing Feedback
Directors provide ongoing, real-time feedback to management, committees, and the chairs of each committee, including the Board Chair, outside the formal annual self-assessment process, and specifically reserve time after each Board meeting to consider the effectiveness of that meeting and discuss potential improvements to various Board practices.
Review and Discussion
Independent legal counsel aggregates and summarizes the annual director questionnaire responses to promote candor and ensure feedback is not attributed to individual directors and provides guidance on material issues. The Governance Committee reviews the evaluation results for the Board and each committee and presents the results and findings to the full Board and each committee for further consideration and discussion.
Review of the Evaluation Process
The Governance Committee annually reviews the self-evaluation process to ensure that actionable and constructive feedback is solicited on the operations and performance of individual committees and the Board as a whole.
Feedback Incorporated
As an outcome of these discussions, the Board and its committees identify key substantive and procedural areas for increased Board effectiveness. Changes to the Board’s policies and practices are also considered and implemented based on self-evaluation results and ongoing feedback. Some of the actions taken recently in response to suggestions for improvement include:
Increasing the frequency of Board refreshment, reducing the average Board tenure from 10 years to under six years;
Including discussions with management on Company strategy at each Board meeting;
Increasing discussions with third-party experts and consultants on a range of topics to enhance Board education;
Creating a formalized policy to support Board education and professional development; and
Increasing time at Board meetings devoted to committee reports to ensure all Board members are aware of key developments and decision in all committees of the board.
Code of Conduct and Business Ethics
Our Code of Conduct and Business Ethics (“Code of Conduct”) is applicable to all directors, officers, and employees of the Company. Our Code of Conduct is available at www.trueblue.com/code-of-conduct. Shareholders may also request a free printed copy from TrueBlue, Inc., Investor Relations, 1015 A Street, Tacoma, Washington 98402.
The Company intends to disclose any amendments to the Code of Conduct (other than technical, administrative, or non-substantive amendments) and any waivers of a provision of the Code of Conduct for directors or executive officers on the Company’s website at www.trueblue.com. Information on the Company’s website, however, does not form a part of this proxy statement.
Related Person Transactions
The Board has adopted a Related Party Transaction Policy, which sets forth the policies and procedures for the review and approval or ratification of “Related Person Transaction(s).” A Related Person Transaction is defined to include transactions, arrangements, or relationships in which the Company is a participant, the amount involved exceeds $120,000, and a Related Person has or will have a direct or indirect material interest. “Related Person” is defined to include directors, executive officers, director nominees, beneficial owners of more than 5% of the TrueBlue shares (“Common Stock”), and members of their immediate families sharing the same household. A Related Person Transaction must be reported to the Company’s Chief Legal Officer and reviewed and approved by the Governance Committee. Under certain circumstances, a transaction may be approved by the Chair of the Governance Committee subject to ratification by the full Governance Committee at its next meeting. In determining whether to approve or ratify a Related Person Transaction, the Governance Committee, as appropriate, shall review and consider:
the Related Person’s interest in the Related Person Transaction;
TrueBlue, Inc. 2024 Proxy Statement  P. 24

TABLE OF CONTENTS

CORPORATE GOVERNANCE
the approximate dollar value of the Related Person Transaction;
the approximate dollar value of the Related Person’s interest in the Related Person Transaction without regard to the amount of any profit or loss;
whether the Related Person Transaction was undertaken in the ordinary course of business of the Company;
whether the Related Person Transaction is proposed to be, or was, entered into on terms no less favorable to the Company than terms that could have been reached with an unrelated third party;
the purpose of, and the potential benefits to the Company of, the Related Person Transaction; and
any other information regarding the Related Person in the context of the proposed Related Person Transaction that would be material to investors in light of the circumstances of the particular transaction.
After reviewing all facts and circumstances, the Governance Committee may approve or ratify the Related Person Transaction only if it determines that the transaction is in, or is not inconsistent with, the best interests of the Company.
There were no Related Person Transactions in 2023.
Nominations for Directors
Qualifications of Nominees
The Corporate Governance Guidelines include the criteria our Board believes are important in the selection of director nominees. While the Board has not established any minimum qualifications for nominees, the Board does consider the composition of the Board as a whole, the requisite characteristics (including independence, diversity, and experience in industry, finance, administration, and operations) of each candidate, and the skills and expertise of its current members while taking into account the overall operating efficiency of the Board and its committees. With respect to diversity, we broadly construe diversity to mean not only diversity of race, gender, and ethnicity, but also diversity of opinions, perspectives, and professional and personal experiences. Nominees are not discriminated against on the basis of race, gender, religion, national origin, sexual orientation, disability, or any other basis proscribed by law. Service on other boards of directors and other commitments by directors will be considered by the Governance Committee and the Board when reviewing director candidates and in connection with the Board’s annual self-assessment process for current members of the Board.
Nominee Identification and Evaluation
The Governance Committee may employ a variety of methods for identifying and evaluating nominees for director. The Governance Committee regularly assesses the size of the Board, the need for particular expertise on the Board, the need for diversity on the Board, and whether any vacancies on the Board are expected due to retirement or otherwise. In the event that vacancies are anticipated or arise, the Governance Committee considers potential candidates for director which may come to the Governance Committee’s attention through current Board members, professional search
firms, shareholders, or other persons. These candidates will be evaluated at regular or special meetings of the Governance Committee and may be considered at any time during the year.
Under the Guidelines, the Governance Committee is responsible for reviewing with the Board the requisite skills and characteristics of new Board nominees in the context of the current Board composition. This assessment will include experience in industry, finance, administration, operations, marketing, and technology, as well as diversity.
Although the Board does not have a formal policy specifying how diversity of background and personal experience should be applied in identifying or evaluating director nominees, to help ensure that the Board remains aware of and responsive to the needs and interests of our shareholders, employees, clients, and other stakeholders, the Board believes it is important to identify qualified director candidates that would increase the diversity of experience, profession, expertise, skill, background, gender, racial, ethnic, cultural, and other diversity characteristics (“Diversity Characteristics”) of the Board. Accordingly, the Governance Committee has made an effort when nominating new directors to ensure that the composition of the Board reflects broad Diversity Characteristics.
In recent years, the Governance Committee has directed its third-party search firm to present a slate of possible candidates which includes qualified potential nominees with broad Diversity Characteristics in considering nominees for the Board.
The Governance Committee considers the entirety of each candidate’s credentials, in addition to diversity, as they fit with the current composition and skills and experience of the Board. The Company considers the Board to be a valuable strategic asset of the Company. To maintain the integrity of this asset, the membership of the Board has been carefully crafted to ensure that its expertise covers broad Diversity Characteristics, and these Diversity Characteristics will continue to be considered when nominating individuals to serve on the Board.
The Governance Committee will consider candidates recommended by shareholders. The Governance Committee will make an initial analysis of the qualifications of any candidate recommended by shareholders or others pursuant to the criteria summarized in this section to determine whether the candidate is qualified for service on the Board before deciding to undertake a complete evaluation of the candidate. If a shareholder or professional search firm provides any materials in connection with the nomination of a director candidate, such materials will be forwarded to the Governance Committee as part of its review. If the Governance Committee determines that additional consideration is warranted, it may engage a third-party search firm to gather additional information about the prospective nominee’s background and experience and report its findings to the Governance Committee. Other than the verification of compliance with procedures, shareholder status, and the initial analysis performed by the Governance Committee, the Governance Committee will treat a potential candidate nominated by a shareholder like any other potential candidate during the review process. In connection with this evaluation, the Governance Committee will determine whether to interview the prospective nominee. One or more members of the Governance Committee, and others as appropriate, will interview the prospective nominees in person or by telephone. After completing this evaluation and interview, the Governance Committee will make a recommendation to the full Board as to the persons who should be nominated by the Board, and the Board will determine the nominees after considering the recommendation and report of the Governance Committee.
TrueBlue, Inc. 2024 Proxy Statement  P. 25

TABLE OF CONTENTS

CORPORATE GOVERNANCE
Delinquent Section 16(a) Reports
Section 16(a) of the Exchange Act requires the Company’s officers, directors, and certain other persons to timely file certain reports regarding ownership of, and transactions in, the Company’s securities with the SEC. Based solely on the Company’s review of forms received by it, or representations from certain reporting persons, the Company believes that during 2023 all applicable Section 16(a) filing requirements were met and that all such filings were timely, except for three transactions: (i) on December 1, 2023, that was reported for Mr. Sakaguchi on a Form 4 on December 6, 2023, due to an administrative error; (ii) on December 14, 2023, that was reported for Ms. Owen on a Form 4 on February 6, 2024, due to an administrative error; and (iii) on December 14, 2023, that was reported for Mr. Schweihs on a Form 4 on February 6, 2024, due to an administrative error.
TrueBlue, Inc. 2024 Proxy Statement  P. 26

TABLE OF CONTENTS

COMPENSATION OF DIRECTORS

Retainers and Committee Fees
Periodically, the Corporate Governance and Nominating Committee (“Governance Committee”) engages a third-party consultant to review the retainer and committee fees paid to the non-employee directors on our Board. This consultant provides information related to the retainer and fee levels of our peer companies, as well as information regarding best practices and emerging trends in the payments to non-employee directors. Information provided by the consultant is considered by the Governance Committee but does not directly determine any of the Company’s actual retainer or fee arrangements. The Governance Committee applies its informed judgment when establishing the levels and payments of retainers and fees. In September 2023, the Governance Committee performed a benchmarking study and found the current fees were positioned near the median of the peer group. In light of this information, the Governance Committee determined that the existing fee structure, outlined below, did not warrant any changes for 2024.
For 2023, non-employee directors received the following cash compensation paid in quarterly installments: (a) an annual cash Board retainer, (b) an annual cash committee retainer, and, if applicable (c) an annual cash committee chair supplement. The schedule of payments for 2023 are set forth in the table below.
Annual Cash Retainer
2023
Amount
Board Retainer
  Board Chair
$122,000
  Other Directors
$77,000
Committee Retainer
  Audit Committee
$12,500
  Compensation Committee
$12,500
  Governance Committee
$5,000
  Innovation and Technology Committee
$5,000
Committee Chair Supplement
  Audit Committee, Chair
$15,000
  Governance Committee, Chair
$15,000
  Compensation Committee, Chair
$15,000
  Innovation and Technology Committee, Chair
$15,000
Equity Grants
Each non-employee director also receives an annual grant of restricted stock units (“RSUs”) that is typically granted on the second day after the release of our annual earnings. The Common Stock underlying these RSUs fully vest on the first day of the Company’s fourth quarter in the year in which they are granted. Non-employee directors appointed during the year are entitled to receive a pro rata grant, on their first day of service to the Board, as follows: 100% if appointed on or prior to the first quarterly meeting, 75% if appointed on or prior to the second quarterly meeting, 50% if appointed on or prior to the third quarterly meeting, and 25% if appointed on or prior to the last quarterly meeting of the year.
In 2023, the Board Chair received an award of RSUs with a target value of $175,000. All other non-employee directors received an award of RSUs with a target value of $135,000. The Audit Committee and Compensation Committee Chairs received an additional award of RSUs with a value of $10,000 while all other committee chairs received an additional award of RSUs with a target value of $7,500. The Company determined the number of RSUs of each such award based on the average closing price of Common Stock during the 60 trading days prior to and including the second full trading day after the announcement of the Company’s fourth quarter and year-end financial results, which was approximately $20.03 per share.
Equity Retainer and Deferred Compensation Plan for Non-Employee Directors
Each non-employee director is able to participate in the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors (“Director Equity Plan”). Under this plan, a director may elect to modify the manner in which he or she receives the annual retainer from the Company. Directors are given the option to make an irrevocable election to convert up to 100% of his or her cash retainer to an equity retainer, and then further elect to receive up to 50% of the equity retainer in the form of stock options, rather than Common Stock. In addition, a director may make an irrevocable election to defer settlement of all or part of his or her annual RSU grant to a time after he or she leaves the Board.
TrueBlue, Inc. 2024 Proxy Statement  P. 27

TABLE OF CONTENTS

COMPENSATION OF DIRECTORS
Non-Employee Director Compensation Table
The following table discloses the compensation earned by each of the Company’s non-employee directors during the last completed fiscal year:
Name
Fees Earned and
Paid in Cash
Stock Award Grant
Date Fair Value(1)
Total
Colleen B. Brown
$114,500
$133,496
$247,996
William C. Goings(2)
$114,500
$135,822
$250,322
Kim Harris Jones(3)
$114,500
$135,822
$250,322
R. Chris Kreidler(4)
$99,500
$126,461
$225,961
Sonita Lontoh
$99,500
$126,461
$225,961
Paul G. Reitz(5)
$49,750
$61,412
$111,162
Jeffrey B. Sakaguchi
$144,500
$163,925
$308,425
Kristi A. Savacool(6)
$114,500
$133,496
$247,996
(1)
This column represents the grant date fair value of RSUs awarded to each of the non-employee directors in 2023 in accordance with Financial Accounting Standards Board Accounting Standards Codification Accounting for Stock Compensation (“FASB ASC Topic 718”). The amounts are calculated using the closing price of Common Stock on the grant date, which was $18.76 for all directors, except for Mr. Reitz’s grant on September 1, 2023, when the closing price of the Common Stock was $15.10. For additional information, refer to Note 10 to the Consolidated Financial Statements found in Item 8 of Part II of our 2023 Form 10-K (listed under Stock-Based Compensation).
(2)
Under the Director Equity Plan, Mr. Goings elected to defer settlement of 100% of his equity retainer in the form of 7,240 RSUs until 90 days after his separation from the Board.
(3)
Under the Director Equity Plan, Ms. Harris Jones elected to defer settlement of 100% of her equity retainer in the form of 7,240 RSUs until 90 days after her separation from the Board.
(4)
Under the Director Equity Plan, Mr. Kreidler elected to defer settlement of 100% of his equity retainer in the form of 6,741 RSUs until 90 days after his separation from the Board.
(5)
Mr. Reitz joined the Board on August 11, 2023.
(6)
Under the Director Equity Plan, Ms. Savacool elected to defer 100% of her equity retainer in the form of 7,116 RSUs until 90 days after her separation from the Board.  

Non-Employee Director Stock Ownership Guidelines
Each non-employee director is expected to hold shares of Common Stock having a value of not less than four times the director’s base annual cash retainer. Both directly and indirectly held RSUs and deferred shares are included in this calculation, but options for purchasing Common Stock in the future are not included in the calculation. New directors are allowed four years in which to reach the ownership guidelines. For the purpose of determining compliance, the Company determines the number of shares required on an annual basis with the value of the shares to be determined on a trailing 12-month average daily stock price. As of the end of the 2023 fiscal year, all non-employee directors either met these guidelines or were within the first four years and on track to meet these guidelines.
TrueBlue, Inc. 2024 Proxy Statement  P. 28

TABLE OF CONTENTS

PROPOSAL 2.
ADVISORY (NON-BINDING) VOTE APPROVING EXECUTIVE COMPENSATION
Our Board has adopted a policy providing for an annual “say-on-pay” advisory vote. In accordance with this policy and Section 14A of the Securities Exchange Act of 1934, as amended, we are asking shareholders to approve the following advisory (non-binding) resolution at the 2024 Annual Meeting of Shareholders:
RESOLVED, that the shareholders of TrueBlue, Inc. (the “Company”) approve, on an advisory basis, the compensation of the Company’s named executive officers disclosed in the Compensation Discussion and Analysis, the Summary Compensation Table, and the related compensation tables, notes, and narrative in the proxy statement for the Company’s 2024 Annual Meeting of Shareholders.
As an advisory vote, this proposal is not binding upon the Company or the Board. However, the Compensation Committee, which is responsible for designing and administering our executive compensation program, values the feedback received from shareholders in their vote on this proposal and will consider the outcome of the vote when making future compensation decisions for the Company’s named executive officers. Unless the Board modifies its policy, the next say-on-pay advisory vote will be held at our 2025 Annual Meeting of Shareholders.
FOR
OUR BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE ADVISORY (NON-BINDING) VOTE APPROVING EXECUTIVE COMPENSATION
TrueBlue, Inc. 2024 Proxy Statement  P. 29

TABLE OF CONTENTS

EXECUTIVE OFFICERS

Taryn R. Owen, 45, assumed the role of President and Chief Executive Officer and was appointed as a Director of the Company in September 2023, after serving as President and Chief Operating Officer of TrueBlue and President of PeopleReady and PeopleScout since September 2022. Over her 13-year tenure, she has led TrueBlue through significant periods of growth, was instrumental in its pandemic response and recovery, spearheaded its digital transformation strategies, and successfully led several acquisitions and substantial international expansion. Previously at TrueBlue, Ms. Owen served as Executive Vice President of TrueBlue and President of PeopleReady and PeopleScout from 2021 to 2023, Executive Vice President and President of PeopleReady from 2019 to 2021, and Executive Vice President and President of PeopleScout from 2014 to 2019. Prior to these roles, she served as Senior Vice President of Global Operations and as Vice President of Client Delivery at PeopleScout. Ms. Owen has more than 25 years of staffing and talent acquisition experience. Before joining TrueBlue, she was an Operations Director at Randstad Sourceright Solutions, where she led global RPO engagements. She formerly served as a member of the Board of Advisors of HRO Today and as a member of the Human Capital Industry Advisory Board for Wharton’s Center for Human Resources. Ms. Owen has been recognized for her industry leadership, including annual appearances on the Staffing Industry Analysts’ (SIA) Staffing 100 and Global Power 150.
Carl R. Schweihs, 39, has served as Executive Vice President and Chief Financial Officer since October 2023. He previously served as Executive Vice President of the Company and President of PeopleManagement, TrueBlue’s staffing business that is made up of Staff Management SMX, SIMOS Insourcing Solutions, and Centerline Drivers, from June 2019 until October 2023, after serving as Senior Vice President of the Company for Strategic Accounts since June 2017. Prior to that, he served as Vice President of Finance for the Company since November 2015, after serving as Controller since June 2014. Mr. Schweihs joined the Company following its acquisition of Seaton in 2014. Prior to joining the Company, he served in a variety of financial leadership roles at Seaton and Grant Thornton.
Garrett R. Ferencz, 47, has served as Executive Vice President and Chief Legal Officer of the Company since July 2020, after serving as Senior Vice President, General Counsel and Chief Ethics and Compliance Officer since December 2019. Prior to these roles, he served as Vice President, Deputy General Counsel and Chief Compliance Officer since April 2018, and served as Vice President, Deputy General Counsel, Litigation since July 2014. Mr. Ferencz joined the Company in January 2007 as Senior Director of Litigation, Assistant General Counsel. Prior to joining the Company, Mr. Ferencz practiced litigation at The Blankenship Law Firm, P.S. and Perkins Coie LLP. Mr. Ferencz has served as a Director on the American Cancer Society’s Board for Washington State since 2017.
Richard P. Betori, 63, has served as Executive Vice President of the Company and President of PeopleScout since March 2023, after serving as Managing Director of the Americas of PeopleScout since November 2021. Prior to these roles, he served as Senior Vice President, On Demand Operations since June 2020, after serving as Senior Vice President, Operation and Innovation since April 2015. Mr. Betori joined the Company in January of 2011 as President of StudentScout. Prior to joining the Company, Mr. Betori served as President of Wonderlic, Inc. and had founded and served as President of INSinc Management Consulting.
Kristy A. Willis, 54, has served as Executive Vice President of the Company and President of PeopleReady since March 2023, after serving as Senior Vice President, Chief Sales and Operations Officer of PeopleReady since November 2021. Prior to these roles, she served as Senior Vice President, Sales at PeopleReady since August 2018. Prior to joining the Company, Ms. Willis served in a variety of leadership roles at The Adecco Group.
TrueBlue, Inc. 2024 Proxy Statement  P. 30

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS

EXECUTIVE SUMMARY
2023 was a year of transition for our executive team and economic challenges for our Company. Our Compensation Committee established and adjusted our 2023 compensation program to manage these transitions and economic head winds.
As part of our planned succession process managed by our Corporate Governance and Nominating Committee, on August 15, 2023, the Company announced that our then current President and Chief Operating Officer (“COO”), Taryn Owen, would become President and Chief Executive Officer (“CEO”) of the Company, succeeding Steve Cooper, effective September 12, 2023. Mr. Cooper continued to serve in an advisory role, to ensure a smooth transition for Ms. Owen, until his retirement from the Company on December 31, 2023. Ms. Owen had previously served as COO and President of PeopleReady and PeopleScout, our two most profitable lines of business since September 22, 2022, and prior to this position had served as Executive Vice President (“EVP”) of the Company and President of PeopleReady and PeopleScout. For more information regarding the process followed by the Company regarding the appointment of Ms. Owen, please see the Corporate Governance section above.
On October 10, 2023, the Company announced that Carl Schweihs, then EVP and President of the Company’s PeopleManagement Division, would become EVP and Chief Financial Officer (“CFO”) of the Company, succeeding Derrek Gafford, effective October 30, 2023. Mr. Gafford also continued to serve in an advisory role until December 31, 2023, to ensure a smooth transition to Mr. Schweihs as CFO.
In March 2023, the Company appointed Richard Betori as EVP and President of PeopleScout and Kristy Willis as EVP and President of PeopleReady.
As a result of these transitions, as of December 31, 2023, our Named Executive Officers (“NEOs”) were:
Executive
Position
Taryn R. Owen
President, Chief Executive Officer, effective September 12, 2023. Previously serving as President, Chief Operating Officer of the Company and President of PeopleReady and PeopleScout since September 2022.
Steven C. Cooper
Former Chief Executive Officer, stepped down from CEO role effective September 12, 2023, and retired from the Company on December 31, 2023, after previously serving as the Company’s Board Chair or CEO since 2006.
Carl R. Schweihs
Executive Vice President, Chief Financial Officer, effective October 30, 2023. Previously serving as EVP and President of PeopleManagement.
Derrek L. Gafford
Former Executive Vice President, Chief Financial Officer, stepped down from CFO role effective October 30, 2023 and separated from the Company on December 31, 2023, after serving as EVP, CFO since 2005.
Garrett Ferencz
Executive Vice President, Chief Legal Officer since July 1, 2020.
Richard P. Betori
Executive Vice President, TrueBlue and President, PeopleScout, effective March 20, 2023, after serving as Managing Director of the Americas of PeopleScout.
Kristy A. Willis
Executive Vice President, TrueBlue and President, PeopleReady, effective March 20, 2023, after serving as Senior Vice President, Chief Sales and Operations Officer of PeopleReady.
The Committee set meaningful goals to motivate NEO performance, manage these transitions and create value for shareholders. Despite the challenging market conditions, our NEOs provided operational control through disciplined cost management, maintaining a strong balance sheet and liquidity position while returning capital to shareholders via share repurchases. The Company generated over $1.9 billion of revenue, generated $29.0 million of Adjusted EBITDA1, and returned $33.9 million to shareholders in stock repurchases during the year.
1
For detailed definitions and reconciliation of non-generally accepted accounting principles (“non-GAAP”) financial measures to the most directly comparable GAAP financial measure, please see Appendix A to this proxy statement. The Executive Compensation Process, Governance, and Philosophy, Incentive Plan Metrics section below also provides a detailed definition of these measures for 2023.
TrueBlue, Inc. 2024 Proxy Statement  P. 31

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Departing executives received meaningful, but not excessive separation packages as part of employment agreements established in prior years and reflecting decades of service to the Company.
With the appointment of each new executive, the Compensation Committee considered the appropriate level of salary, short-term incentive (“STI”) and long-term incentive (“LTI”) levels and consulted with their independent compensation consultant where appropriate to ensure that compensation levels for individuals in new roles reflected the Company’s compensation goals for each position. When Ms. Owen was appointed to serve as CEO, the Compensation Committee also discussed her compensation and individual incentive goals with all other independent members of the Board. The Compensation Committee approved the compensation for all new NEOs in 2023 prior to their appointment.
2023 Results Reflect a Challenging Environment
Our executive compensation programs are designed to reflect performance, and our 2023 results fell short of the challenging annual and multi-year performance targets set by the Compensation Committee. Reflecting the Company’s commitment to pay for performance, the Company’s financial outcomes resulted in our NEOs achieving only a portion of the compensation targets established by our Compensation Committee for 2023.
Short-Term Incentive Plan
Below is a summary of each of the components of the 2023 STI plan for the NEO's as approved by the Compensation Committee.
No Adjusted EBITDA Award. 25% of our STI plan is based on a key financial metric, Adjusted EBITDA. In 2023, the Company overall, and individual business units, generated an Adjusted EBITDA amount that was below the threshold payout level set by the Compensation Committee. Accordingly, our NEOs received no payouts related to the Adjusted EBITDA performance components of the STI plan.
A portion of the Relative Revenue Award. 25% of our STI plan is based on another key financial metric, Company revenue growth relative to a select peer group of industry competitors (“Revenue Peer Group”). During 2023, the Company’s revenue was within the established range of the Revenue Peer Group and this portion of the STI plan provided an above threshold, but below target, payment to the NEOs for 2023.
Individual Performance Goals. 50% of our STI plan includes goals specific to the individual role of our NEOs and includes performance goals related to long-term strategic operations, resource management, leadership development, ESG initiatives, industry disruption, and risk management. The amounts received by our NEOs for this component of the STI plan reflect their individual performance against these goals during 2023.
Long-Term Incentive Plan
2023 Equity Grants. The long-term component of our NEO compensation program also contributed to our NEOs’ 2023 compensation. In 2023, the NEOs received an equity grant split between time-based restricted stock units (“RSUs”) and performance share units (“PSUs”), which will vest only if certain Return on Equity (“ROE”)1 goals are met during the 2023-2025 performance period.
No Vesting of 2021 Annual PSU Awards. Payouts under the annual PSU awards granted in 2021 under our LTI plan for the 2021-2023 performance period were based on the Company’s Adjusted EBITDA compound annual growth rate (“CAGR”)1. No PSUs were earned related to the 2021 annual PSU grant because the Company's performance during this period did not achieve threshold performance.
EXECUTIVE COMPENSATION PROGRAM OVERVIEW
Pay-for-Performance Emphasis
The Compensation Committee designs our executive compensation program to appropriately align the interests of the Company’s management team with shareholders. We expect executive compensation to reflect Company and individual performance. Key pay-for-performance features of our 2023 compensation program included:
Short-term incentive compensation linked to strategic business plans. The Company’s business plan emphasizes the continuous growth of Adjusted EBITDA and outperforming our Revenue Peer Group in the marketplace. The CEO’s financial and non-financial goals under the 2023 STI plan were linked directly to the annual and strategic business plans reviewed and approved by the Compensation Committee and the Board.
Long-term incentive compensation linked to long-term value creation and returning value to shareholders. The Company’s long-term business plan emphasizes the continuous growth of value for shareholders. Our LTI program provides value to our NEOs both through RSUs that vest over a three-year term and PSUs that vest only upon the achievement of ROE targets over the three-year performance period.
Incorporating Environmental, Social, and Governance-Related Objectives
The Company has made environmental, social, and governance (“ESG”) best practices a part of its corporate practices and initiatives, with a specific focus on human capital management (“HCM”). The Company also incorporates ESG and HCM goals in its executive compensation program. During 2023, the CEO’s (and COO’s) STI plan included individual objectives tied to leadership development, succession planning for management positions, and enhancing the employee experience to increase retention. Goals for other NEOs tied to ESG included establishing our first ever carbon and emission goals, expanding our WorkUp program to upskill workers, piloting a nationwide second chance initiative, building a positive culture in individual business units, leadership development and succession planning, and increasing participation in our ethics programs across the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 32

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Our executive compensation program is made up of several components which have a specific purpose and contribute to a well-balanced, competitive program. The chart below summarizes our 2023 executive compensation program.
Component
Form
Characteristic
Metric
(% of STI or
LTI plan)
Purpose
Fixed
Base Salary
Cash
Paid Annually
N/A
An annually fixed level of pay that reflects the role, scope, and complexity of each NEO’s position relative to the market and to other NEOs.
Performance
Short-Term Incentive
Cash
Completely at Risk
Adjusted EBITDA
(25%)
Company performance-based compensation payable only upon achievement of Company-wide or business unit-specific performance metrics.
Revenue Growth Relative to Revenue Peer Group
(25%)
Company performance-based compensation payable only upon achievement of metrics comparing the Company’s revenue growth with that of the Revenue Peer Group.
Individual Performance Goals
(50%)
Individual performance-based compensation payable only upon achievement of specific objectives related to achieving the Company’s operating plan.
Long-Term Incentive
Performance Share Unit Awards
ROE and EBITDA CAGR
(50%)
Company performance-based compensation that delivers shares of Common Stock only if the Company meets certain performance metrics over a multi-year period.
Time-Based
Long-Term Incentive
Restricted Stock Unit Awards
Three-year vesting
N/A
(50%)
Retention-oriented compensation.
Fixed
Benefits
Health, welfare, and retirement programs
Generally available
N/A
NEOs participate in the same benefit programs that are offered to other highly compensated employees.
TrueBlue, Inc. 2024 Proxy Statement  P. 33

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
As seen in the charts below, a significant portion of each NEO’s target compensation is at risk and dependent on the achievement of annual and long-term performance targets. These charts reflect the percentages of our 2023 CEO and other NEO compensation that represent base salary, STI (at target), PSUs (at target), and RSU awards, as applicable. These charts reflect Ms. Owen’s compensation plan as CEO, and the average of the other NEOs’ compensation plans based on each of their positions as of the end of 2023; these charts do not include the compensation of Mr. Cooper or Mr. Gafford since they are no longer serving the Company.
2023 Target Total Compensation Mix


(1)
Ms. Owen became CEO of the Company as of September 12, 2023. These amounts reflect her target compensation as CEO and are not prorated with her target compensation as COO.
(2)
Consistent with Company policies, Ms. Owen received a promotional RSU award upon assuming the CEO position. This amount does not include her promotional award.

(1)
As discussed above, Messrs. Schweihs and Betori and Ms. Willis were promoted during 2023. These amounts reflect each of their target compensation in the role for which they were serving at the end of the fiscal year and are not prorated with their pre-promotion compensation.
(2)
Consistent with Company policies, Messrs. Schweihs and Betori and Ms. Willis received a promotional RSU award upon each of their promotions. This amount does not include their promotional awards.
Strong Governance and Best Pay Practices
Our executive compensation philosophy is reflected in the programs and practices we embrace and how they align with shareholders’ long-term interests. Below is a summary of these programs and practices.
What We Do
What We Do Not Do
 Pay for performance by delivering a significant portion of
compensation through performance and equity-based plans
 
X No excessive or guaranteed pay targets. All potential
payouts are capped and tied to measurable targets
 Request annual shareholder advisory say-on-pay votes
 
X No re-pricing of options or equity grants
 Target total compensation near the median of relevant peers
 
X No pension benefits
 Maintain meaningful stock ownership guidelines for all
named executive officers
 
X No gross-up of excise taxes upon a change in control
 Engage an independent compensation consultant
 
X No hedging or short sales of Company stock, with pledging
discouraged
 Retain double trigger change-in-control agreements
 
X No reward for excessive risk-taking
 Conduct an annual risk analysis of compensation programs
 
X No excessive executive perquisites
 Maintain clawback policies
 
X No cash buyouts of underwater options
 Require minimum vesting period for equity grants
 
X No special health or welfare benefits for executives
 Include ESG goals in executive compensation
 
 
 Maintain a Compensation Committee comprised solely of
independent directors
 
 
TrueBlue, Inc. 2024 Proxy Statement  P. 34

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Shareholder Feedback
The Company provides shareholders an annual “say-on-pay” advisory vote on its executive compensation program. At our 2023 Annual Meeting of Shareholders, shareholders expressed support for the compensation of our NEOs, with 88% of the votes cast for approval of the “say-on-pay” advisory vote. After our 2023 annual meeting, our CEO, CFO, and other members of management met with over 30 investors to introduce our new leadership structure and discuss matters of concern to these shareholders. The Compensation Committee discussed and considered shareholder feedback provided directly to management during these shareholder engagement activities. The Compensation Committee considered this shareholder feedback and the results of the 2023 advisory vote in evaluating the Company’s executive compensation programs. In light of investor feedback, the Compensation Committee has continued to improve disclosures related to the executive compensation program and considered additional modifications to the executive compensation program in 2024.
Effective Risk Management
As part of its oversight of our compensation program, the Compensation Committee regularly reviews the various components of our executive compensation plans. The Compensation Committee concluded that the plans do not create risks reasonably likely to have a material adverse effect on the Company and the plans encourage appropriate, but not excessive, levels of risk-taking.
The 2023 STI plan focused on multiple goals, including Adjusted EBITDA, revenue growth measured against our Revenue Peer Group, resource management, leadership development, ESG and HCM initiatives, operational goals, and Company profitability. Appropriate payouts were provided for achieving these goals. Another component of the Company’s balanced compensation approach is the LTI plan, which is a significant portion of the NEOs’ compensation, and includes time-based RSU awards and performance-based PSU awards. The vesting and performance requirements of these awards provide meaningful alignment with shareholder interests.
The Compensation Committee believes the following features of our 2023 compensation program served to mitigate excessive or unnecessary risk-taking:
Compensation Risk Mitigation Features
Pay Mix
Compensation is a mix of base salary and short- and long-term incentives providing compensation opportunities measured by a variety of time horizons to balance our operational and strategic goals.
Metrics
Short- and long-term incentives included financial and non-financial metrics or objectives that required substantial performance on a broad range of significant initiatives and/or sustained financial performance and growth.
Caps
Performance-based incentives are capped with a maximum limit on the amount that could be earned.
Performance Goals
Goals are approved by our independent directors and take into account our historical performance, current strategic initiatives, and the expected economic environment.
Equity
Equity incentive programs and stock ownership guidelines are designed to align management and shareholder interests by providing vehicles for executive officers to accumulate and maintain an ownership position in the Company.
Risk Mitigation Policies
Clawback policies
Equity Ownership Guidelines
Insider Trading Policy
Related Party Policy
Anti-hedging policies
Minimum vesting periods for equity awards
EXECUTIVE COMPENSATION PROCESS, GOVERNANCE, AND PHILOSOPHY
Compensation Program Objectives
The Compensation Committee designs our annual executive compensation program with the goal of achieving the following objectives:
Attracting and retaining the key executive talent needed to achieve our long-term business strategies;
Basing a significant portion of each NEO’s annual compensation opportunity on both Company and individual performance;
Establishing performance targets for incentive compensation that align with both our short- and long-term business strategies;
Motivating NEOs to create long-term shareholder value;
Reflecting the role, scope, and complexity of each NEO’s position relative to other NEOs;
Balancing the need to be competitive with our industry peers with our commitment to control costs; and
Targeting total direct compensation near the median of our peers.
TrueBlue, Inc. 2024 Proxy Statement  P. 35

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Compensation Committee Oversight of NEO Compensation
Compensation for our executives is determined by the Compensation Committee. The Compensation Committee sets and approves the CEO’s compensation levels and awards. This Committee, with participation from the other independent directors on the Governance Committee, is also responsible for reviewing the corporate goals and objectives relevant to the compensation of the CEO and evaluating the CEO’s performance in light of those goals and objectives. The Compensation Committee oversees, regularly reviews, and approves compensation programs for our CEO and other NEOs.
The Compensation Committee has regularly scheduled meetings each quarter and has additional meetings as appropriate. During 2023, the Compensation Committee met seven times. The agenda for each meeting is set by the Chair of the Compensation Committee. The Compensation Committee has full authority to directly retain the services of outside counsel and compensation consultants and has done so on a regular basis. Our CEO and other NEOs may also attend portions of the Compensation Committee meetings in order to provide information and help explain data relating to matters under consideration by the Compensation Committee. They are not present during deliberations or determinations of their respective compensation or during executive sessions that occur without management present in connection with each meeting. Outside counsel and independent compensation consultants also regularly attend Compensation Committee meetings.
In determining executive compensation plans and approving incentive targets, the Compensation Committee considers its compensation objectives, shareholder value creation, compensation practices of our peers in the marketplace, the roles and responsibilities of each NEO, and internal pay equity. The Compensation Committee seeks to align compensation with our current and long-term business strategy and goals. There is no formal weighting of any of these factors; the Compensation Committee uses its informed judgment in determining pay targets and amounts. The Compensation Committee reviews and discusses annual pay elements each year. The Compensation Committee uses the target amounts of these key elements to determine the annual at-target total direct compensation of our NEOs, which is a useful measure of pay because it reflects the intended aggregate value of those key elements of pay at the time the pay decision is made. It evaluates other programs as needed based on changes in compensation objectives, alignment with overall Company direction and business strategy, competitive trends, accounting rules, and changes in tax and other laws and regulations.
Independent Compensation Consultant
The Compensation Committee engages an independent compensation consultant. In 2023, this consultant was Mercer US LLC (“Mercer”). The Compensation Committee evaluates the independence of Mercer to ensure that no conflicts of interest of any kind exist between Mercer and the Company, including personal or business relationships between Mercer and the Company, Company directors, or Company executive officers, Company stock ownership by Mercer, or engagement of Mercer by the Company for other material services. Mercer attends key meetings of the Compensation Committee and is available to the Compensation Committee as necessary.
Information provided by Mercer is considered by the Compensation Committee but does not directly determine any of the Company’s actual compensation decisions. The Compensation Committee applies its informed judgment when establishing the compensation elements, targets, and final awards.
Peer and External Market Data
Our executive compensation program is reviewed annually, with a detailed review of peer compensation every two years or as needed, so that the Compensation Committee can remain informed of changes in the compensation programs maintained by similarly-situated peer companies. For executive compensation during 2023, this review occurred in late 2021. This study was updated during 2023 for considering the salary levels applicable to Ms. Owen and Mr. Schweihs with their appointment to CEO and CFO, respectively. For this review, the Compensation Committee retained Mercer to provide an in-depth external review of our executive compensation programs as compared to a peer group (“Compensation Peer Group”). The Compensation Committee selects the Compensation Peer Group from similarly-sized companies engaged in staffing, outsourced human resources services, or companies that operated in industries with multi-unit branches on a national basis.
TrueBlue, Inc. 2024 Proxy Statement  P. 36

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
The report received from Mercer (“2021 Mercer Report”) of external Compensation Peer Group pay practices provided comparative data related to base salaries, actual and target STI and LTI, and total direct compensation. The 2021 Mercer Report was based on information compiled from both Compensation Peer Group proxy data and published salary surveys compiled by Mercer. The data from the Compensation Peer Group was combined with national published
surveys compiled by Mercer (U.S. Global Premium Executive Remuneration Suite) and Willis Towers Watson (Survey Report on Top Management Compensation). The Compensation Peer Group for 2022-2023 included the 16 companies set forth in the table below, which remained unchanged from the 2020-2021 Compensation Peer Group:
2022 - 2023 Compensation Peer Group
Peer
Employment Services
Multi-Branch
Locations
Revenue within 0.3 to
3.0x of TBI’s Revenue
AMN Healthcare Services, Inc.
 
ASGN Incorporated
 
Barrett Business Services, Inc.
 
Cintas Corporation
 
 
H&E Equipment Services, Inc.
 
Healthcare Services Group, Inc.
 
Herc Holdings Inc.
 
Insperity, Inc.
 
Kelly Services, Inc.
 
Kforce Inc.
 
Korn Ferry
 
Robert Half International, Inc.
 
TriNet Group, Inc.
 
Unifirst Corporation
 
United Rentals, Inc.
 
 
Volt Information Sciences, Inc.
 
Based on the 2021 Mercer Report, the Company’s size relative to the Compensation Peer Group is shown below:


TrueBlue, Inc. 2024 Proxy Statement  P. 37

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
The 2021 Mercer Report found the following with respect to the Company’s executive compensation:
Base salaries were generally between the 25th percentile and market median, with variability by position;
Short-term cash incentive targets approximate the market median, with variability by position;
Target long-term equity incentive grant value was generally between the 25th percentile and market median, with variability by position;
Total direct compensation was generally between the 25th percentile and market median.
The Company strives for total direct compensation to be approximately at the median of the Compensation Peer Group. After referring to the data provided, the Compensation Committee approved increases to the 2023 compensation targets for Mr. Gafford and Mr. Ferencz. During 2023, when considering the compensation levels of newly promoted NEOs, the Compensation Committee referred to this study, as well as updates to the study provided by the independent compensation consultant, when considering pay levels for NEOs.
Incentive Plan Metrics
The Compensation Committee set targets for Company and business unit performance, as applicable, under the 2023 STI plan based on target levels of achieved Adjusted EBITDA, a non-GAAP measure defined below. For purposes of the 2023 STI plan, consistent with our investor presentations, the Compensation Committee excluded from earnings before interest, taxes, depreciation and amortization (“EBITDA”): third-party processing fees for hiring tax credits, PeopleReady technology upgrade costs, amortization of software as a service assets, goodwill and intangible asset impairment charges, executive leadership transition expenses, and other adjustments (“Adjusted EBITDA”)2. The Compensation Committee decided that excluding such items in assessing management performance more closely aligned management incentives with shareholder interests. Adjusted EBITDA is a key metric used by management to evaluate the performance of the Company. The Compensation Committee also believes aligning executive compensation with Adjusted EBITDA incentivizes management to appropriately control costs while increasing revenue. Finally, Adjusted EBITDA is a metric that is reviewed by, and considered important to, our investors in measuring our performance.
In 2023, the Compensation Committee selected ROE as the performance metric for the 2023 PSUs after considering several other potential targets and metrics, including stock price, total shareholder return, earnings per share, and other relative and absolute metrics. The Compensation Committee believed ROE was an appropriate performance metric for aligning the NEOs’ interests with the Company’s long-term goals and shareholder interests. Among other benefits, a focus on ROE encourages our NEOs to make business decisions with a balanced view of increasing Company profitability, the effective use of capital, and value creation for shareholders. ROE is calculated as adjusted net income, divided by average equity, which is measured quarterly during the performance period.
Meaningful Targets Put Compensation at Risk
The LTI plan was designed to align the interests of the NEOs with those of our shareholders. The combination of vesting requirements and stock ownership guidelines is intended to promote retention and a long-term commitment to the Company. The Compensation Committee has determined that PSUs provide the most direct link between executive compensation and specific long-term performance goals that are aligned with the Company’s business objectives and shareholder interests.
Our pay-for-performance philosophy and the meaningful goals we apply to our executive compensation program are evidenced by our payouts over the past nine years for our PSU awards as shown below. Participants in our LTI plan have not received a PSU payout for three of the last nine years. As disclosed in prior proxy statements and this proxy statement, PSU awards for the 2015-2017, 2016-2018 and 2021-2023 performance periods were not earned because the Company did not meet the minimum performance conditions approved by the Compensation Committee. In the past few years, PSU payouts have been meaningful but below target as Company performance levels have not met targets set by the Compensation Committee.

TrueBlue, Inc. 2024 Proxy Statement  P. 38

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
2023 NEO COMPENSATION
Base Salaries
We provide base salaries to give NEOs a stable amount of cash compensation, but ensure salary represents only a portion of each NEO’s target compensation. In 2023 the base salaries of our NEOs were as follows:
NEO(1)
2022 Base
Salary
2023 Base
Salary
Percentage
Increase
Rationale for Salary Increases
Taryn R. Owen(2)
$660,000
$860,000
30%
This increase in salary reflects Ms. Owen’s additional responsibilities and duties associated with her promotion to CEO.
Steven C. Cooper
$1,000,000
$1,000,000
—%
 
Carl R. Schweihs(3)
$500,000
$550,000
10%
This increase in salary reflects Mr. Schweihs’s additional responsibilities and duties associated with his promotion to CFO.
Derrek L. Gafford
$550,000
$605,000
10%
These salary increases reflect an increase to better align Mr. Gafford’s salary with the Compensation Committee’s intent to target salary levels appropriately within the Company’s Compensation Peer Group. As a result of this increase, Mr. Gafford’s total compensation increased from the 50th percentile to the target position within the Compensation Peer Group. The Compensation Committee determined this was an appropriate level of compensation due to Mr. Gafford’s long tenure with the Company and time in the CFO position.
Garrett R. Ferencz
$450,000
$495,000
10%
These salary increases reflect an increase to better align Mr. Ferencz’s salary with the Compensation Committee’s intent to target salary levels appropriately within the Company’s Compensation Peer Group. As a result of this increase, Mr. Ferencz’s compensation increased from the 40th percentile to the target position within the Compensation Peer Group. The Committee determined this was an appropriate level of compensation due to Mr. Ferencz’s long tenure with the Company and critical role on the executive team.
Richard P. Betori(4)
$432,000
N/A
 
Kristy A. Willis(5)
$432,000
N/A
 
(1)
Please refer to the Summary Compensation Table for details regarding actual salaries received by each of the NEOs for 2023.
(2)
Ms. Owen assumed the role of CEO on September 12, 2023, and thus received a pro-rated amount of this annual salary based on the date she assumed the position.
(3)
Mr. Schweihs assumed the role of CFO on October 30, 2023, and thus received a pro-rated amount of this annual salary based on the date he assumed the position.
(4)
Mr. Betori assumed the role of President of PeopleScout on March 20, 2023, and thus received a pro-rated amount of this annual salary based on the date he assumed the position.
(5)
Ms. Willis assumed the role of President of PeopleReady on March 20, 2023, and thus received a pro-rated amount of this annual salary based on the date she assumed the position.
TrueBlue, Inc. 2024 Proxy Statement  P. 39

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Short-Term Incentive Plan
The 2023 STI plan for our NEOs measured and rewarded performance against three components, weighted as follows:
(1) 25% for the Company’s Adjusted EBITDA performance for Ms. Owen and Messrs. Cooper, Schweihs (as CFO), Gafford, and Ferencz and Adjusted EBITDA performance of the business unit directly under their respective control for Messrs. Schweihs (as President of PeopleManagement) and Betori and Ms. Willis (as President of PeopleScout, and PeopleReady, respectively); (2) 25% for the Company’s relative revenue growth as compared to the Revenue Peer Group, defined in the Executive Compensation Process, Governance, and Philosophy section above; and (3) 50% for individual performance. The table below shows the performance components (Company/Business Unit, and Relative Revenue Growth, and Individual) and threshold, target, and maximum payout levels approved by the Compensation Committee for the 2023 STI plan.
Consistent with the objective that potential compensation reflects the role and responsibilities of each NEO, the STI potential varies by NEO to reflect the individual’s market value and role within the Company. The STI is completely at risk, and no cash award will be made unless the individual, Company/business unit, or relative revenue growth thresholds are met.
The individual performance component of the 2023 STI plan allowed NEOs to earn up to 120% of their target award. The Compensation Committee considers this exercise of discretion appropriate in order to have the ability to acknowledge and reward possible extraordinary achievement in some portions of the individual performance goals. The Committee also approved threshold, target, and maximum potential payouts according to potential Adjusted EBITDA and relative revenue growth results for the Company. Award levels are interpolated between levels beginning at the threshold level where 25% of the target is awarded, up to the maximum level where 200% of the target is awarded.
STI Plan Opportunity
The following table shows the STI opportunity for each NEO, including the threshold, target, and maximum opportunities for each financial performance component (award payouts are interpolated between levels):
Executive
Individual
Performance(1)
Company
Adjusted EBITDA
Business Unit
Adjusted EBITDA(2)
Company
Relative Revenue Growth
 
Target
Maximum(3)
Threshold
($50 million)
Target
($80 million)
Maximum
($120 million)
Threshold
Target
Maximum
Threshold
(-5%)
Target
(0%)
Maximum
(5%)
Taryn R. Owen(4)
$448,759
$538,511
$56,095
$224,379
$448,759
$56,095
$224,379
$448,759
Steven C. Cooper
$750,000
$900,000
$93,750
$375,000
$750,000
$93,750
$375,000
$750,000
Carl R. Schweihs(5)
$190,685
$228,822
$4,379
$17,517
$35,034
$19,456
$77,825
$155,651
$23,836
$95,342
$190,685
Derrek L. Gafford
$226,875
$272,250
$28,359
$113,438
$226,875
$28,359
$113,438
$226,875
Garrett R. Ferencz
$185,625
$222,750
$23,203
$92,813
$185,625
$23,203
$92,813
$185,625
Richard P. Betori(6)
$145,960
$171,436
$20,567
$82,269
$155,249
$15,923
$63,690
$127,381
Kristy A. Willis(7)
$147,016
$172,492
$20,831
$83,326
$156,834
$15,923
$63,690
$127,381
(1)
There was no threshold applicable to the individual performance component.
(2)
For Mr. Schweihs, PeopleManagement’s threshold, target, and maximum Adjusted EBITDA targets were set at $10 million, $14.0 million, and $19.3 million, respectively. For Mr. Betori, PeopleScout’s threshold, target, and maximum Adjusted EBITDA targets were set at $32.0 million, $45.0 million, and $61.9 million, respectively. For Ms. Willis, PeopleReady’s threshold, target, and maximum Adjusted EBITDA targets were set at $37.5 million, $53.0 million, and $73.2 million, respectively.
(3)
Each of the NEOs could have earned up to 120% of the target if their performance exceeded expectations, provided that Mr. Betori and Ms. Willis could only earn up to 100% for their pre-promotion compensation package.
(4)
Effective September 12, 2023, Ms. Owen became the Company’s CEO. These amounts reflect the prorated amount of her STI award, including her former role as COO.
(5)
Effective October 30, 2023, Mr. Schweihs became the Company’s CFO. These amounts reflect the prorated amount of his STI award, including his former role as President of PeopleManagement.
(6)
Effective March 20, 2023, Mr. Betori became the President of PeopleScout. These amounts reflect the prorated amount of his STI award, including his former role with the Company.
(7)
Effective March 20, 2023, Ms. Willis became the President of PeopleReady. These amounts reflect the prorated amount of her STI award, including her former role with the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 40

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Total Target and Actual 2023 STI Award
The following table shows the total STI target award in 2023 for each NEO compared to the actual STI award, based on the performance results described below:
Executive
STI Target
Actual Award
Percentage of Target Awarded
Taryn R. Owen(1)
$897,518
$689,931
77%
Steven C. Cooper
$1,500,000
$1,087,500
73%
Carl R. Schweihs(2)
$381,370
$283,500
74%
Derrek L. Gafford
$453,750
$328,969
73%
Garrett R. Ferencz
$371,250
$297,000
80%
Richard P. Betori(3)
$291,920
$197,442
68%
Kristy A. Willis(4)
$294,033
$192,576
65%
(1)
Effective September 12, 2023, Ms. Owen became the Company’s CEO. As such, these amounts reflect her prorated STI award.
(2)
Effective October 30, 2023, Mr. Schweihs became the Company’s CFO. As such, these amounts reflect his prorated STI award.
(3)
Effective March 20, 2023, Mr. Betori became the President of PeopleScout. As such, these amounts reflect his prorated STI award.
(4)
Effective March 20, 2023, Ms. Willis became the President of PeopleReady. As such, these amounts reflect her prorated STI award.
2023 Company Adjusted EBITDA Performance
The Company’s Adjusted EBITDA target for the STI plan in 2023 was $80.0 million, with the threshold set at $50.0 million and maximum set at $120.0 million. Due to the challenging economic environment, the Company generated only $29.0 million in Adjusted EBITDA, and as a result, Ms. Owen, and Messrs. Cooper, Gafford, and Ferencz earned zero payout for this component of the STI plan. These targets were set in early 2023 to align with the Company’s internal forecasts which anticipated that 2023 would reflect a challenging economic cycle for the Company’s markets and aligned with guidance provided quarterly to investors during the year.
2023 Business Unit Adjusted EBITDA Performance
The 2023 STI opportunity for Mr. Schweihs included a component focused on the performance for PeopleManagement, the specific business unit under his management. The 2023 Adjusted EBITDA target for PeopleManagement was $14.0 million, with the threshold at $10.0 million and the maximum at $19.3 million. PeopleManagement’s actual Adjusted EBITDA was $7.0 million, resulting in zero payout to Mr. Schweihs for this component of his STI plan.
The 2023 STI opportunity for Mr. Betori included a component focused on the performance for PeopleScout, the specific business unit under his management. The 2023 Adjusted EBITDA target for PeopleScout was $45.0 million, with the threshold at $32.0 million and the maximum at $61.9 million. PeopleScout’s actual Adjusted EBITDA was $26.9 million, resulting in zero payout to Mr. Betori for this component of his STI plan.
The 2023 STI opportunity for Ms. Willis included a component focused on the performance for PeopleReady, the specific business unit under her management. The 2023 Adjusted EBITDA target for
PeopleReady was $53.0 million, with the threshold at $37.5 million and the maximum at $73.2 million. PeopleReady’s actual Adjusted EBITDA was $26.6 million, resulting in zero payout to Ms. Willis for this component of his STI plan.
2023 Company Relative Revenue Growth Performance
The Compensation Committee selected the following Revenue Peer Group (as measured by specific revenue segments) for the relative revenue growth component of the 2023 STI plan:
Manpower Group, Inc. (U.S. Manpower brand);
Randstad N.V. (U.S. Staffing/In-House);
Kelly Services, Inc. (Professionals & Industrial - Americas Staffing); and
Adecco Group (North America General Staffing).
In each case, the Compensation Committee selected the reporting segment most comparable to the Company’s business, adjusted for organic results, consistent billing days, constant currency, and similar factors. The Company’s relative revenue growth target as compared to the Revenue Peer Group for the 2023 STI plan was 0%, or the same revenue growth as the average revenue growth for the Revenue Peer Group, with the threshold set at the Company’s revenue growth being 5% lower than the average revenue growth of the Revenue Peer Group and maximum set at the Company’s revenue growth being 5% greater than the average revenue growth of the Revenue Peer Group. As a result of the NEOs’ management efforts during 2023, the Company achieved revenue growth that was 0.7% lower than the average revenue growth of the Revenue Peer Group during 2023. As a result, the NEOs earned a payout of 90% of target for this component of the STI plan.
TrueBlue, Inc. 2024 Proxy Statement  P. 41

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
2023 Individual Performance Goals
The Company’s STI program includes a component for the accomplishment of non-financial or strategic individual goals. These individual goals comprise 50% of the total target STI award available. The Committee determined this was an appropriate portion of the STI award in light of the cyclical nature of the Company's business cycle. The achievement of these goals for the CEO and COO was reviewed and evaluated by the independent directors of our Governance Committee, which recommended an achievement level to the Compensation Committee for approval. The achievement of individual goals for the other NEOs is evaluated by the CEO and recommended to the Compensation Committee for final approval. The table below summarizes the individual strategic goals achieved by our NEOs during 2023.
Executive
Individual Performance Goals
Taryn R. Owen, CEO
• Leadership Development and Succession Planning
• Three-Year Strategy Planning, Business Line Portfolio Management and Enterprise Risk Management
Taryn R. Owen, COO
• Differentiation Through Technology
• Delivery Model
• Gross Margin
• Expand Skilled Trades, CPU, and Renewable Energy Business
Steven C. Cooper
• Leadership Development and Succession Planning
• Three-Year Strategy Planning, Business Line Portfolio Management
• Core PeopleReady Technology
Carl R. Schweihs, CFO
• Initial Investor Meetings and Conferences
• Capital Spending Controls
Carl R. Schweihs, PeopleManagement
• Segment Gross Margin
• Segment Geographic Expansion
• Cross-Selling
Derrek L. Gafford
• Strategic Planning
• Emerging Technologies in Finance
• Internal and external satisfaction scores
Garrett R. Ferencz
• Government Relations Program
• ESG Program
• Ethics Program
• DE&I
Richard P. Betori
• Segment Gross Margin
• Global Leadership Structure
Kristy A. Willis
• Launch New Jobstack Application
• Alternative Delivery Models
Ms. Owen’s individual performance incentive for 2023 was based on specific performance goals first in her role as COO and then in her role as CEO as reflected in the chart above. At the end of the year, each director, except Ms. Owen, independently evaluated each area of Ms. Owen’s performance in both the COO and CEO role. The evaluations were aggregated and discussed at the December 2023 meeting of the Governance Committee. All members of the Compensation Committee were present and participated in this evaluation discussion. The Governance Committee made its performance evaluation recommendations. The Compensation Committee considered this recommendation and determined the amount of compensation that was appropriate to reward for this performance, concluding that Ms. Owen performed at a level that entitled her to receive 100% of her target for the individual performance component of the STI plan as COO, or $252,608, and 120% of her target award in her role as CEO, or $235,381.
Mr. Cooper’s individual performance incentive for 2023 was based on specific performance goals involving his areas of responsibility as reflected in the chart above. At the end of the year, each director,
except Ms. Owen, independently evaluated each area of Mr. Cooper’s performance. The evaluations were aggregated and discussed at the December 2023 meeting of the Governance Committee. All members of the Compensation Committee were present and participated in this evaluation discussion. The Governance Committee made its performance evaluation recommendations. The Compensation Committee considered this recommendation and determined the amount of compensation that was appropriate to reward for this performance, concluding that Mr. Cooper performed at a level that entitled him to receive 100% of his target for the individual performance component of the STI plan, or $750,000.
The individual performance goals for other NEOs focused on categories such as growth, HCM, profit and loss responsibilities, strategic planning, change leadership, and our ethics program, as more specifically reflected in the chart above. Based on Ms. Owen’s recommendations, where applicable, as reviewed and approved by the Compensation Committee, Mr. Schweihs received 100% in his role as President of PeopleManagement and 120% in his role as CFO,
TrueBlue, Inc. 2024 Proxy Statement  P. 42

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
Mr. Gafford received 100%, Mr. Ferencz received 115%, Mr. Betori received 96%, and Ms. Willis received 92%, of his or her respective target for the individual performance component of the STI plan.
Long-Term Equity Incentive Plan
Similar to previous years, the 2023 annual equity awards for NEOs were comprised of a combination of RSU and PSU awards. The value of the annual long-term equity awards is allocated equally between annual PSU grants and RSU grants to provide an appropriate balance between long-term performance incentives and retention goals.
In addition, consistent with our Company policy that is generally applicable to all employees who participate in the annual equity award program, our NEOs promoted in 2023 also received equity grants according to this policy.
2023 Award of RSUs
The number of RSUs granted was calculated by dividing the target dollar value of the award by the average closing price of the Common Stock during the 60 trading days preceding and including the grant date. The annual grant date is the second trading day after the announcement of fourth quarter and year-end results, which, for the 2023 grant, was February 3, 2023.
2023 Award of PSUs
In early 2023, the Compensation Committee determined that ROE was the best available measure of the Company’s performance to align our NEO’s interests with shareholders. As in prior years, the Compensation Committee determined that a return metric has a high correlation with value creation for shareholders. Among other benefits, maintaining long-term ROE encourages our NEOs to make business decisions with a focus on the effective use of capital.
As such, the PSUs awarded in 2023 are earned and have the potential to vest depending on the Company’s cumulative average ROE over a three-year performance period. The Compensation Committee established the target ROE at the beginning of the performance period and will compare that growth target to the three-year cumulative ROE upon completion of the performance period to determine achievement. The PSU awards are completely at risk and the underlying shares of Common Stock will be issued only if the established targets are met at the completion of the three-year performance period.
The Compensation Committee calculated the target number of PSUs awarded by dividing the target dollar value of the award by 80% of the average closing price of Common Stock during the 60 trading days preceding and including the grant date. Mercer recommended this 20% discount to reflect the contingent nature of the PSUs and the risk of forfeiture.
The Compensation Committee established and approved threshold, target, and maximum vesting rates of PSUs according to potential ROE results for the Company. Award levels will be interpolated between levels beginning at the 25% threshold level up to the 150% maximum level. The number of PSUs earned and vested at the end of the three-year award period will be determined by the ROE achieved during the performance period as shown in the table below. These targets were set in early 2023 to align with the Company’s internal forecasts which anticipated challenging economic conditions for the Company and its customers. These forecasts were generally reflected in the guidance provided quarterly to investors during the year. In 2023, target performance level remained unchanged from prior years to reflect the Committee’s desired performance level but reduced both the threshold performance level and payout amount to provide a meaningful opportunity to achieve a portion of this component of the long-term incentive program.
3-Year average ROE
Performance Target
% of Target PSUs Earned
3-Year Average Return on Equity
Maximum
18%
150%
Target
14%
100%
Threshold
8%
25%
TrueBlue, Inc. 2024 Proxy Statement  P. 43

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
2023 Total Target Long-Term Incentive Awards
The following table sets forth the total allocation of RSU and PSU awards at target granted to our NEOs during 2023, with the percentages applicable to the base salary that was in effect at the time of the award:
NEO
Promotional RSU
Grants as a % of
Base Salary(1)
Total Target
Annual Equity
Grant as a % of
Base Salary
Components of Total
Target Annual Equity Grant
Restricted
Stock Units
as a % of
Base Salary
PSUs
as a % of
Base Salary
Taryn R. Owen
40%(2)
175%
87.5%
87.5%
Steven C. Cooper
350%
175%
175%
Carl R. Schweihs
40%(3)
110%
55%
55%
Derrek L. Gafford
150%
75%
75%
Garrett R. Ferencz
125%
62.5%
62.5%
Richard P. Betori
40%(4)
110%
55%(5)
55%
Kristy A. Willis
40%(6)
110%
55%(5)
55%
(1)
These amounts reflect the percentage of the NEOs’ base salary upon promotion.
(2)
Ms. Owen received a promotional RSU award upon assuming the role of President and CEO of the Company on September 12, 2023.
(3)
Mr. Schweihs received a promotional RSU award upon assuming the role of EVP, CFO of the Company on October 30, 2023.
(4)
Mr. Betori received a promotional RSU award upon assuming the role of EVP, President of PeopleScout on March 20, 2023.
(5)
These amounts reflect the intent of the Company through the combination of two RSU awards. Due to an administrative delay, Mr. Betori and Ms. Willis were promoted shortly after the annual equity award dates. As such, they were each awarded a top-up grant in an amount equal to the difference between their annual RSU grant, which was granted based on their pre-promotion salary on February 3, 2023, and the amount their annual RSU grant should have been, based on the compensation package approved by the Compensation Committee for their new roles. As such, Mr. Betori’s total annual RSU award had a target value of $237,600 of which $139,104 was granted on February 3, 2023, and the top-up portion of $98,496 was granted on April 3, 2023, the first business day of the next month after his promotion. Ms. Willis’s total annual RSU award had a target value of $237,600 of which $147,014 was granted on February 3, 2023, and the top-up portion of $90,586 was granted on April 3, 2023, the first business day of the next month after her promotion.
(6)
Ms. Willis received a promotional RSU award upon assuming the role of EVP, President of PeopleReady on March 20, 2023.
2023 Promotion Awards
Consistent with our Company policy that is generally applicable to all employees who participate in the annual equity award program, our NEOs promoted in 2023 also received equity grants according to this policy.
On October 2, 2023, Ms. Owen received a grant of RSUs targeted at $344,000 as an award for her promotion to President and CEO of the Company.
On November 1, 2023, Mr. Schweihs received a grant of RSUs targeted at $220,000 as an award for his promotion to EVP, CFO of the Company.
On April 3, 2023, Mr. Betori received a grant of RSUs targeted at $172,800 as an award for his promotion to EVP of the Company and President of PeopleScout.
On April 3, 2023, Ms. Willis received a grant of RSUs targeted at $172,800 as an award for her promotion to EVP of the Company and President of PeopleReady.
The number of shares for these awards was calculated by dividing the award’s target dollar value by the average closing price of the Company’s stock during the 60 trading days preceding and including the grant date. These promotional awards will vest in equal annual installments over four years.  
Additional 2023 NEO Compensation Considerations
2021 PSU Award Determination (2021-2023) Performance Period)
Messrs. Gafford, Schweihs, and Ferencz and Ms. Owen each received PSUs as a component of their total long-term equity awards in 2021, which would vest, if at all based on the Company’s achievement of Adjusted EBITDA CAGR goals over the three-year performance period. During the 2021-2023 performance period the Company achieved an Adjusted EBITDA CAGR of -9.2%, which was below the threshold Adjusted EBITDA CAGR of 25%, resulting in zero PSUs being earned for this award.
2021 Retention PSU Award Determination (2021-2023 Performance Period)
In 2021 the Compensation Committee considered the need to ensure the retention and engagement of the experienced and tenured leadership of the Company during the Company’s recovery from the pandemic-related recession and in light of the increasingly competitive market for talent in the industry and made certain one-time additions to the compensation packages of three NEOs. As a result, Ms. Owen, and Messrs. Gafford and Schweihs received one-time retention grants of PSUs (“Retention PSUs”) with a grant date of February 5, 2021.
TrueBlue, Inc. 2024 Proxy Statement  P. 44

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
The Retention PSU grants were based on a target value of $700,000 for Ms. Owen, $600,000 for Mr. Schweihs, and $400,000 for Mr. Gafford. Up to 50% of these awards vested on the second anniversary of the grant for the 2021-2022 performance period (“Tranche 1”), and up to 50% plus any portion of Tranche 1 not previously earned could be earned based on performance over the 2021-2023 performance period and vest on the third anniversary of the grant (“Tranche 2”), in each case, only if certain individual performance criteria were met. In no event would more than 100% of the award be earned by the NEOs. These Retention PSUs were completely at risk and would not vest in any amount if the individual performance goals were not met. The individual performance goals were oriented to the long-term strategic growth plans of each individual’s business unit or support function. The Compensation Committee calculated the target number of Retention PSUs awarded by dividing the target dollar value of the award by the average closing price of the Common Stock during the 60 trading days preceding and including the grant date.
As mentioned in last year’s proxy statement, in January 2023, the Compensation Committee met and discussed the level of achievement of each of the executives’ individual performance goals for Tranche 1 within their respective Retention PSU performance criteria. As a result of those discussions, Ms. Owen and Messrs. Gafford and Schweihs earned 40%, 40%, and 50%, of their respective Retention PSUs which resulted in the vesting of that portion of the Retention PSUs into shares of Common Stock on February 5, 2023.
In December 2023, the Compensation Committee met and discussed the level of achievement of each of the executives’ individual performance goals for Tranche 2 within their respective Retention PSU performance criteria. As a result of those discussions, Ms. Owen and Messrs. Gafford and Schweihs earned 60%, 60%, and 50%, of their respective Retention PSUs which resulted in the vesting of that portion of the Retention PSUs into shares of Common Stock on February 5, 2024.
Preview of Changes for 2024 Compensation Program
During late 2023 and early 2024, the Committee, the Company’s management, and the Committee’s independent compensation consultant considered changes to the executive compensation program for Company executives. The Committee considered evolving market practices, changes in Company strategy, and the need to properly incentivize NEOs to focus on Company growth and increasing shareholder value. The Committee decided that an effective way to emphasize both of these goals was to split the PSU portion of the LTI plan into two components. The first component, comprised of a majority of the award, would vest based upon Adjusted EBITDA levels achieved and aggregated over the 2024-2026 performance period. The second component of the 2024 LTI plan will be based on the achievement of relative total shareholder return targets over this same period, as measured against a designated peer group.
TrueBlue, Inc. 2024 Proxy Statement  P. 45

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
OTHER COMPENSATION ELEMENTS
Nonqualified Deferred Compensation Plan
The NEOs, on the same basis as our other highly compensated employees, as defined in Internal Revenue Service (“IRS”) regulations, are entitled to participate in the Deferred Compensation Plan. The NEOs are not entitled to participate in the Company’s 401(k) plan. The Company’s Deferred Compensation Plan allows participants to maintain their balances in the Deferred Compensation Plan upon termination of employment if a participant has attained the age of 65 years or attained the age of 40 years and achieved five years of credited service.
Under the Deferred Compensation Plan, eligible employees may defer up to 75% of base salary and up to 100% of amounts received under the STI plan. The Deferred Compensation Plan also includes in-service accounts that allow distribution of contributions during employment and installment payments for distributions (up to 10 years) for additional flexibility for tax purposes and retirement planning. Under the Deferred Compensation Plan, the Company can match employee contributions at double the rate matched under the Company’s 401(k) plan and such matching funds will be immediately vested. In 2023, the match was 50% of contributions to the plan up to $22,500. Details of amounts contributed to each NEO’s 2023 deferrals are provided in the Nonqualified Deferred Compensation Table in the Executive Compensation Tables section. Under the Deferred Compensation Plan, the Company can also make contributions with different vesting schedules for retention purposes, but no such contributions were made during 2023.
The Compensation Committee believes the Deferred Compensation Plan is necessary as a competitive, meaningful retirement benefit for those employees who are eligible to participate, which includes the NEOs, and does not impose any significant risk to or burden on the Company.
Employee Stock Purchase Plan
The NEOs, on the same basis as other employees, are entitled to participate in the Company Employee Stock Purchase Plan. This plan allows NEOs to contribute up to 10% of their earnings toward the monthly purchase of Common Stock. The employees’s purchase price is 85% of the lesser of the fair market value of the shares on either the first day or the last day of each month.
Employment Agreements
The Company has entered into employment agreements with each of the NEOs, under which each NEO may be entitled to payments upon termination of employment under the circumstances described in the Post-Employment Payments section below. The Compensation Committee believes that the termination payments under the employment agreements are necessary to attract and retain high caliber executives in a competitive labor market and to motivate them to contribute to our short- and long-term success for the benefit of our shareholders. The Compensation Committee designed the termination payments, which are competitive with our Compensation Peer Group and general industry practices, to achieve a balance between these objectives and the potential impact on shareholders.
Change-in-Control Agreements
The Company has entered into change-in-control agreements with certain executive officers, including all NEOs, which were approved by all the independent directors. These agreements are described in greater detail in the Post-Employment Payments section below. The change-in-control agreements are intended to protect the interests of our shareholders by providing short-term security for the executives in the event management and the Board are presented with a business combination or other opportunity that is determined to be in the best interest of our shareholders. The Compensation Committee designed the change-in-control agreements to achieve a balance between the benefits of providing executives with security and the potential impact on the shareholders.
ADDITIONAL POLICIES
Stock Ownership Guidelines
During 2023, the following stock ownership guidelines applied to the NEOs based on a multiple of annual RSU grants.
NEO
Multiple of Annual
RSU Grant
Effective Multiple
of 2023 Salary(1)
Meeting Guidelines as of December 31, 2023
Taryn R. Owen(2)
4x
6.00
On track to meet guidelines by September 12, 2028
Steven C. Cooper
4x
7.00
Carl R. Schweihs(3)
3x
2.63
On track to meet guidelines by October 30, 2028
Derrek L. Gafford
3x
2.25
Garrett R. Ferencz
3x
1.88
Richard P. Betori
3x
1.65
Kristy A. Willis
3x
1.65
On track to meet guidelines by March 20, 2028
(1)
The salaries for Mss. Owen and Willis and Messrs. Schweihs and Betori were prorated for 2023 between their former and current positions. The amounts in this table are calculated based on the compensation in each of their new roles.
(2)
This table reflects the guidelines for Ms. Owen in her role as CEO. This information reflects Ms. Owens’s salary effective on September 12, 2023, and the annual RSU grant that she would receive in her role as CEO which is 150% of base salary or $1,290,000, rather than her annual grant received prior to promotion.
(3)
This table reflects the guidelines for Mr. Schweihs in his role as CFO. This information reflects Mr. Schweihs’s salary effective on October 30, 2023, and the annual RSU grant he would receive in his role as CFO which is 87.5% of base salary or $481,250, rather than his annual grant received prior to promotion.
TrueBlue, Inc. 2024 Proxy Statement  P. 46

TABLE OF CONTENTS

COMPENSATION DISCUSSION AND ANALYSIS
The Compensation Committee has established stock ownership guidelines for executive officers as follows: a multiple of four times the annual RSU grant for the CEO and a multiple of three times the annual RSU grant for EVPs.
NEOs are expected to achieve their targets within five years of becoming subject to the ownership guidelines. As of the date of this proxy, all NEOs that are employed by the Company met these guidelines or were within the five-year period and on track to meet these guidelines.
The ownership guidelines recognize the significant range of equity awards each NEO is eligible to receive annually, while continuing to require a substantial personal commitment to the Company’s long-term financial performance. The guidelines may be satisfied by shares owned outright (regardless of whether acquired through a Company plan or other acquisition), unvested restricted shares or RSUs, or shares held in the NEO’s account under our employee stock purchase plan. Unvested PSUs may not be used to satisfy the stock ownership guidelines. Compliance with the guidelines is reviewed on an ongoing basis. NEOs who have not satisfied the applicable guidelines after becoming subject to them are encouraged to retain 50% of the net amount of their shares (after applicable taxes) on each vesting date for their RSU awards.
Clawback Policies
In 2023, the Company adopted the Incentive Compensation Recovery Policy (the “Clawback Policy”) in response to the new SEC and NYSE rules. The Clawback Policy was effective as of September 14, 2023 and applies to all current and former NEOs and certain other executives who receive incentive-based compensation on or after the effective date. Under this policy, the Company will recover the incentive compensation awarded or paid that exceeds the amount of incentive compensation that would have been received had it been determined based on the restated amount in the event of an accounting restatement of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any accounting restatement required to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period. The recovery of such compensation applies regardless of whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement for a restatement.
In addition, the clawback policy in effect prior to September 14, 2023 will continue to apply to all current and former NEOs and certain other executives who received incentive-based compensation prior to September 14, 2023. Under this policy, the Company may seek to recover the incentive compensation awarded or paid where: (i) the incentive compensation was calculated based wholly or in part upon the achievement of certain financial results that were subsequently the subject of a restatement; (ii) in the Compensation Committee’s view, the executive engaged in fraud or illegal conduct that materially contributed to or caused the restatement; and (iii) a lower payment would have been made to the executive based upon the restated financial results. The Compensation Committee retains discretion regarding the application of this policy and may determine not to seek recovery from an executive if it determines that to do so would be unreasonable or that it is not in the best interest of the Company and its shareholders.
Insider Trading and Anti-Hedging Policy
Under the Company’s Insider Trading Policy, all directors, NEOs, and all other employees are prohibited from hedging the economic interest in our securities that they hold. In addition, we prohibit Company employees, including the NEOs, from engaging in any short-term, speculative securities transactions, including purchasing Company securities on margin, engaging in short sales, buying or selling put or call options, and trading in options (other than those granted by the Company).
COMPENSATION COMMITTEE REPORT
The Compensation Committee has reviewed and discussed with management this Compensation Discussion and Analysis as required by Item 402(b) of Regulation S-K. Based on such review and discussions, the Compensation Committee recommended to the Board, and the Board agreed, that the Compensation Discussion and Analysis be included in this proxy statement and our Annual Report on Form 10-K for the year ended December 31, 2023.
Members of the Compensation Committee
William C. Goings, Chair
Colleen B. Brown
Kristi A. Savacool
TrueBlue, Inc. 2024 Proxy Statement  P. 47

TABLE OF CONTENTS


As discussed in the Compensation Discussion and Analysis section above, our Compensation Committee has implemented an executive compensation program designed to link a substantial portion of our NEOs’ compensation to the achievement of the Company’s financial and strategic objectives, and to align our executive pay with changes in the value of our shareholders’ investments. The following table shows the CAP to our Principal Executive Officer (“PEO” or “CEO”) for fiscal 2023, 2022, 2021 and 2020 and the average CAP to our non-PEO NEOs for each fiscal year as compared with the performance of the Company as measured by the total shareholder return (“TSR”), net income, and Adjusted EBITDA and the performance of our peer group’s TSR. The dollar values shown for CAP in the table below do not reflect the actual amount of compensation earned or paid during the applicable year.
Year
Summary
Compensation
Table Total
for PEO
(Current
CEO)(1)
Compensation
Actually Paid
to PEO
(Current
CEO)(1)(9)
Summary
Compensation
Table Total
for PEO
(2023 Former
CEO)(2)
Compensation
Actually Paid
to PEO
(2023 Former
CEO)(2)(9)
Summary
Compensation
Table Total
for PEO
(2022 Former
CEO)(3)
Compensation
Actually Paid
to PEO
(2022 Former
CEO)(3)(9)
Average
Summary
Compensation
Table Total
for Non-PEO
NEOs(4)
Average
Compensation
Actually Paid
to Non-PEO
NEOs(4)(9)
Value of Initial Fixed $100
Investment Based On:
Net Income
(Loss) ($ in
thousands)(7)
Adjusted
EBITDA ($ in
thousands)(8)
Total
Shareholder
Return(5)
Peer Group
Total
Shareholder
Return(5)(6)
2023
$3,128,681
$1,585,310
$5,819,313
$2,863,033
$
$
$1,657,452
$986,971
$65
$122
$(14,173)
$28,984
2022
$
$
$5,824,544
$5,513,187
$4,425,156
$(6,387,623)
$2,059,452
$897,701
$81
$115
$62,273
$116,999
2021
$
$
$
$
$5,811,254
$9,920,085
$2,125,200
$3,203,326
$117
$151
$61,634
$103,820
2020
$
$
$
$
$3,420,004
$1,999,169
$1,241,280
$815,963
$81
$103
$(141,841)
$38,728
(1)
These amounts reflect the compensation of Ms. Owen (our “Current CEO”) who was appointed as the Company’s CEO effective September 12, 2023.
(2)
These amounts reflect the compensation of Mr. Cooper (our “2023 Former CEO”) who retired as the Company’s CEO effective September 12, 2023.
(3)
These amounts reflect the compensation of Mr. Beharelle (our “2022 Former CEO”) who resigned as the Company’s CEO effective June 14, 2022.
(4)
For 2023, the Non-PEO NEOs were Messrs. Schweihs, Gafford, Ferencz, and Betori and Ms. Willis. For 2022 and 2021, the Non-PEO NEOs were Messrs. Ferencz, Gafford, and Schweihs and Ms. Owen. For 2020, the Non-PEO NEOs were Messrs. Defebaugh, Ferencz, Gafford, and Schweihs and Ms. Owen.
(5)
These amounts are based on information prepared by Zacks Investment Research, Inc. and assume a $100 investment on fiscal year end (“FYE”) 2019 which was December 29, 2019. Used with permission. All rights reserved. Copyright 1980-2024. Index Data: Copyright Standard and Poor’s, Inc. Used with permission. All rights reserved.
(6)
These amounts represent the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization. The peer group used is the S&P 1500 Human Resources and Employment Services Index. The S&P 1500 Human Resources and Employment Services Index is the same index we use in our performance graph in Form 10-K for the applicable year.
(7)
These amounts represent net income (loss) reflected in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss) in Form 10-K for the applicable year.
(8)
The Company has determined that Adjusted EBITDA, a non-GAAP financial measure, is the most important financial measure (not otherwise required in the table) used by the Company to link CAP to Company performance for the most recently completed fiscal year. See Appendix A for definition of Adjusted EBITDA as well as the reconciliation of net income (loss) to Adjusted EBITDA.
(9)
CAP was calculated according to applicable SEC rules. For 2023 CAP, the following adjustments were made to 2023 total compensation amounts shown in the Summary Compensation Table in this proxy statement:
Year
Executive(s)
Summary
Compensation
Table Total
Subtract
Stock
Awards
Add Year-
End Fair
Value of
Current
Year RS
and RSU
Awards
Add Year-
End Fair
Value of
Current
Year PSU
Awards(a)(b)
Add
Change in
Fair Value
of Prior
RS and
RSU
Awards
Add
Change in
Fair Value
of Prior
PSU
Awards(a)(b)
Add
Change in
Fair Value of
Current Year
Vested Equity
Awards(c)
Add
Change in
Fair Value of
Prior Vested
Equity Awards
Compensation
Actually Paid(d)
2023
Current CEO
$3,128,681
$1,660,749
$828,498
$317,691
$(114,068)
$(848,911)
$
$(65,832)
$1,585,310
2023 Former CEO
$5,819,313
$3,658,908
$
$730,920
$
$
$893,601
$(921,893)
$2,863,033
Non-PEO NEOs
$1,657,452
$716,874
$268,815
$135,532
$(38,015)
$(336,466)
$46,342
$(29,816)
$986,971
(a)
The following table shows the estimated and actual payouts of the annual PSUs awarded as of each FYE date noted, used to calculate the CAP above.
Estimated/Actual Payout as of:
2020 PSU Award
2021 PSU Award
2022 PSU Award
2023 PSU Award
Vest Date in 2023
76.8%
FYE 2023
%
%
50.0%
TrueBlue, Inc. 2024 Proxy Statement  P. 48

TABLE OF CONTENTS

(b)
On February 5, 2021, Messrs. Gafford and Schweihs and Ms. Owen each received a PSU award based on individual performance metrics (“Retention PSUs”), of which up to one-half vested on the second anniversary of the grant, and the remaining portion of these shares could have vested on the third anniversary of the grant, in each case, only if certain individual performance criteria are met. For further details about the outstanding awards of our NEOs, please refer to the Outstanding Equity Awards at Fiscal Year-End Table in the Executive Compensation Tables Section of this proxy statement and prior proxy statements. The following table shows the estimated and actual payouts of the Retention PSUs awarded as of each FYE date noted, used to calculate the CAP above.
Taryn R. Owen
Derrek L. Gafford
Carl R. Schweihs
Estimated/Actual Payout as of:
2021 Retention
PSU Tranche 1
2021 Retention
PSU Tranche 2
2021 Retention
PSU Tranche 1
2021 Retention
PSU Tranche 2
2021 Retention
PSU Tranche 1
2021 Retention
PSU Tranche 2
Vest Date in 2023
80.0%
80.0%
100.0%
FYE 2023
120.0%
120.0%
100.0%
(c)
These amounts include awards that were granted and vested during the same fiscal year. In 2023, this amount includes $893,601 for the fair value of RSUs, which were granted as part of Mr. Cooper’s annual RSU award and vested upon Mr. Cooper’s retirement from the Company’s CEO position. Additionally in 2023, this amount includes an increase of $46,342 for the average fair value of awards which were granted and vested for Non-PEO NEOs (as a result of shares that vested upon Mr. Gafford’s retirement).
(d)
In 2023, this amount does not include 29,127 RSUs or 18,809 PSUs which were granted to Mr. Cooper during 2023 and forfeited upon Mr. Cooper’s retirement date. Additionally, this amount does not include 7,552 RSUs or 4,877 PSUs which were granted to Mr. Gafford during 2023 and forfeited upon Mr. Gafford’s separation date.
The most important financial performance measures used by the Company to link CAP to our NEOs, for the most recently completed fiscal year, to the Company’s performance are listed in the table below, each of which is described in more detail in the Compensation Discussion and Analysis section above or in prior proxy statements.
Financial Performance Measures
Adjusted EBITDA
Revenue
Return on Equity
Adjusted EBITDA Compound Annual Growth Rate
TrueBlue, Inc. 2024 Proxy Statement  P. 49

TABLE OF CONTENTS

Our Compensation Committee is focused on the link between executive compensation, Company performance, and value creation for shareholders. While net income is a commonly used indicator of Company performance, our Compensation Committee believes that using Adjusted EBITDA in our compensation program focuses our executive’s attention on core profitability matters that lead to long-term value creation. Adjusted EBITDA is also a measure used by shareholders when evaluating the performance of the Company. Our use of Adjusted EBITDA in the STI program significantly impacts the NEO’s STI program and has a direct impact on the CAP to the NEOs in a given year. Shareholders may also use the Company’s TSR when evaluating the performance of the Company. This relationship between net income, Adjusted EBITDA, and the CAP to our PEO and the average of Non-PEO NEOs, which is further supported by the relationship between the CAP to our PEO and Non-PEO NEOs and the Company’s TSR, can be seen in the charts below.




TrueBlue, Inc. 2024 Proxy Statement  P. 50

TABLE OF CONTENTS

EXECUTIVE COMPENSATION TABLES

Summary Compensation Table
The following table shows all compensation paid by the Company in fiscal 2023, 2022, and 2021, as applicable, to our CEO, former CEO, CFO, former CFO, and the other three most highly paid executive officers, with the exception of Mr. Betori and Ms. Willis as they were first determined to be one of the three most highly paid executive officers in 2023, so compensation is only reported for the years they have been an NEO. The individuals listed in the following tables are the “named executive officers” or “NEOs” referred to in this proxy statement.
Name and Principal
Position / Year
Salary
($)
Bonus
($)
Stock Awards
($)(1)
Non-Equity
Incentive Plan
Compensation
($)(2)
All Other
Compensation
($)
Total
($)
Taryn R. Owen,
President, Chief Executive Officer(3)
2023
$766,751
$1,660,749
$689,931
$11,250(7)
$3,128,681
2022
$660,000
$1,557,377
$825,000
$9,969
$3,052,346
2021
$521,250
$1,551,234
$705,301
$9,750
$2,787,535
Steven C. Cooper,
Former Chief Executive Officer
2023
$1,000,000
$3,658,908
$1,087,500
$72,905(8)
$5,819,313
2022
$550,209
$250,000
$3,740,891
$1,045,083
$238,361
$5,824,544
Carl R. Schweihs,
Executive Vice President, Chief Financial Officer(4)
2023
$508,493
$746,164
$283,500
$11,250(7)
$1,549,407
2022
$500,000
$618,221
$585,000
$10,273
$1,713,494
2021
$400,000
$1,071,566
$426,400
$9,750
$1,907,716
Derrek L. Gafford,
Former Chief Financial Officer
2023
$605,000
$948,717
$328,969
$918,750(9)
$2,801,436
2022
$550,000
$927,304
$522,542
$10,273
$2,010,119
2021
$500,000
$1,448,555
$585,000
$9,750
$2,543,305
Garrett R. Ferencz,
Executive Vice President, Chief Legal Officer
2023
$495,000
$646,866
$297,000
$9,894(10)
$1,448,760
2022
$450,000
$632,293
$370,529
$9,027
$1,461,849
2021
$400,000
$459,245
$403,000
$1,262,245
Richard P. Betori,
Executive Vice President, TrueBlue and President, PeopleScout(5)
2023
$413,998
$621,423
$197,442
11,250(7)
$1,244,113
Kristy A. Willis,
Executive Vice President, TrueBlue and President, PeopleReady(6)
2023
$418,224
$621,200
$192,576
11,544(11)
$1,243,544
(1)
The value in this column for 2023 represents the aggregate amount of restricted stock units (“RSUs”), performance share units awarded based on Company performance (“PSUs”) granted to NEOs in 2023 and calculated according to FASB ASC Topic 718. These amounts do not necessarily correspond to the actual value that will be realized by the NEO, or the manner of calculating the RSU or PSU award used by the Compensation Committee. For example, in 2023, Ms. Owen received a target value of $635,250 in RSUs with the actual number of shares granted being calculated using the average closing price of our stock during the 60 trading days preceding and including the grant date, which was approximately $20.03. In 2023, Ms. Owen also received a target value of $635,250 in PSUs with the actual number of PSUs being calculated using 80% of the average closing price of our stock during the 60 trading days preceding and including the grant date, which was approximately $15.34. In addition to the RSUs and PSUs received from the annual grants, Ms. Owen also received a promotional grant in 2023 for which the actual number of shares granted were calculated using the average closing price of our stock during the 60 trading days preceding and including the grant date, which was approximately $15.43. The FASB ASC Topic 718 grant date fair value of Ms. Owen’s RSUs, target PSUs, and promotional RSUs was $595,048, $733,134, and $332,567, respectively, each of which is included in the table above. Equity awards are described in more detail in the Compensation Discussion and Analysis section of this proxy statement and in the Grants of Plan-Based Awards table. For additional information, refer to Note 10 to the Consolidated Financial Statements found in Item 8 of Part II of our 2023 Form 10-K (listed under Stock-Based Compensation). The value of the PSUs granted in 2023 is based upon the target outcome of the performance conditions at the grant date. The maximum value of the 2023 PSUs, assuming that the highest level of performance conditions is achieved, based on the grant date share price of $17.70 (except for Mr. Betori and Ms. Willis whose PSUs have a grant-date share price of $17.96), is $1,099,701 for Ms. Owen, $3,029,497 for Mr. Cooper, $476,077 for Mr. Schweihs, $785,508 for Mr. Gafford, $535,602 for Mr. Ferencz, $343,952 for Mr. Betori, and $343,952 for Ms. Willis.
TrueBlue, Inc. 2024 Proxy Statement  P. 51

TABLE OF CONTENTS

EXECUTIVE COMPENSATION TABLES
(2)
The amounts set forth in this column for the respective fiscal year were earned during such fiscal year and paid in the early part of the following fiscal year to each of the NEOs under our STI Plan. For additional information on the determination of the amounts related to Non-Equity Incentive Plan Compensation, see the discussion in the Compensation Discussion and Analysis section entitled “Short-Term Incentive Plan.”
(3)
Ms. Owen was promoted to President and Chief Executive Officer of the Company on September 12, 2023.
(4)
Mr. Schweihs was promoted to Executive Vice President and Chief Financial Officer of the Company on October 30, 2023.
(5)
Mr. Betori was promoted to Executive Vice President of the Company, and President of PeopleScout on March 20, 2023.
(6)
Ms. Willis was promoted to Executive Vice President of the Company, and President of PeopleReady on March 20, 2023.
(7)
This amount represents $11,250 for matching funds paid by the Company to participants in the Nonqualified Deferred Compensation Plan.
(8)
This amount includes, as a result of Mr. Cooper’s retirement, approximately $72,882 for group health plan coverage for Mr. Cooper and his spouse, calculated based on Mr. Cooper reaching 65 years of age, and a tax gross-up provided in respect to corporate gift cards which may be received by all corporate employees through our recognition and rewards program, TrueGratitude.
(9)
This amount includes, as a result of Mr. Gafford’s separation from the Company, $907,500 for 18 months’ of his base salary, and $11,250 for matching funds paid by the Company to participants in the Nonqualified Deferred Compensation Plan.
(10)
This amount includes $9,883 for matching funds paid by the Company to participants in the Nonqualified Deferred Compensation Plan and a tax gross-up provided in respect to corporate gift cards which may be received by all corporate employees through our recognition and rewards program, TrueGratitude.
(11)
This amount includes $11,250 for matching funds paid by the Company to participants in the Nonqualified Deferred Compensation Plan and a tax gross-up provided in respect to corporate gift cards which may be received by all corporate employees through our recognition and rewards program, TrueGratitude.
Grants of Plan-Based Awards
Estimated Possible Payouts Under
Non-Equity Incentive Plan Awards(3)
Estimated Future
Payouts Under Equity Incentive
Plan Awards(4)
All other
stock
awards:
number of
shares of
stock or
units
(#)(5)
Grant Date
Fair Value
of Equity
Based
Awards(6)
Name/Type of Award
Grant
Date
Action
Date(1)
Threshold
($)(2)
Target
($)
Maximum
($)
Threshold
(#)
Target
(#)
Maximum
(#)
Taryn R. Owen
Cash Incentive
 
3/8/2023
$560,949
$897,518
$1,436,028
Restricted Stock Units
2/3/2023
12/2/2022
31,719
$595,048
Restricted Stock Units
10/2/2023
8/10/2023
22,290
$332,567
Performance Share Units
3/10/2023
3/8/2023
20,710
41,420
62,130
$733,134
Steven C. Cooper
Cash Incentive
 
3/8/2023
$937,500
$1,500,000
$2,400,000
Restricted Stock Units
2/3/2023
12/2/2022
87,380
$1,639,249
Performance Share Units
3/10/2023
3/8/2023
57,053
114,105
171,158
$2,019,659
Carl R. Schweihs
Cash Incentive
 
3/8/2023
$238,356
$381,370
$610,192
Restricted Stock Units
2/3/2023
12/2/2022
13,732
$257,612
Restricted Stock Units
11/1/2023
10/9/2023
15,421
$171,173
Performance Share Units
3/10/2023
3/8/2023
8,966
17,931
26,897
$317,379
Derrek L. Gafford
Cash Incentive
 
3/8/2023
$283,594
$453,750
$726,000
Restricted Stock Units
2/3/2023
12/2/2022
22,657
$425,045
Performance Share Units
3/10/2023
3/8/2023
14,793
29,586
44,379
$523,672
Garrett R. Ferencz
Cash Incentive
 
3/8/2023
$232,031
$371,250
$594,000
Restricted Stock Units
2/3/2023
12/2/2022
15,448
$289,804
Performance Share Units
3/10/2023
3/8/2023
10,087
20,173
30,260
$357,062
Richard P. Betori
Cash Incentive
 
3/19/2023
$182,450
$291,920
$454,066
Restricted Stock Units
2/3/2023
12/2/2022
6,946
$130,307
Restricted Stock Units
4/3/2023
3/19/2023
9,285
$166,759
Restricted Stock Units
4/3/2023
3/19/2023
5,293
$95,062
Performance Share Units
4/3/2023
3/19/2023
6,384
12,767
19,151
$229,295
Kristy A. Willis
Cash Incentive
 
3/19/2023
$183,770
$294,033
$456,707
Restricted Stock Units
2/3/2023
12/2/2022
7,341
$137,717
Restricted Stock Units
4/3/2023
3/19/2023
9,285
$166,759
Restricted Stock Units
4/3/2023
3/19/2023
4,868
$87,429
Performance Share Units
4/3/2023
3/19/2023
6,384
12,767
19,151
$229,295
(1)
This column reflects the date that the Compensation Committee approved the Company performance targets (Adjusted EBITDA and relative revenue growth), business unit performance targets (Adjusted EBITDA), and individual performance targets and awards pursuant to the STI plan, and also approved the RSU awards and set the Company performance targets for the PSU awards under the LTI plan.
TrueBlue, Inc. 2024 Proxy Statement  P. 52

TABLE OF CONTENTS

EXECUTIVE COMPENSATION TABLES
(2)
These amounts include the individual performance (at target because there is no threshold for this component), Company Adjusted EBITDA (at threshold, if applicable), business unit Adjusted EBITDA (at threshold, if applicable), and Company relative revenue growth portions (at threshold) of the STI plan opportunity as discussed in the Compensation Discussion and Analysis section.
(3)
These columns show what the potential payout for each NEO would have been under the STI plan in 2023, if the threshold, target, or maximum goals were satisfied for all Company performance measures. The amount also reflects the individual performance goals component of the STI plan. The potential payouts were performance-driven and therefore completely at risk. For actual payouts under the STI plan for 2023, please see the Summary Compensation Table. The business measurements, performance goals, and salary multipliers for determining the payout are described in the Compensation Discussion and Analysis section.
(4)
These columns show the number of PSUs granted in 2023 to the NEOs under the LTI plan. The target number of PSUs granted was calculated using the target value for the award which is based on a percentage of the NEO’s salary. The 2023 PSUs vest, if at all, on or about the second day after the release of our annual earnings following the performance period, according to predetermined targets. The amounts shown reflect the potential payout for PSUs for each NEO under the LTI plan if the threshold, target, or maximum Company performance goals are satisfied. The performance goals and award multipliers for determining the potential vesting amounts are described in the Compensation Discussion and Analysis section. The number of PSUs granted was calculated using the target value for the award (a percentage of the NEO’s salary) divided by 80% of the average closing price of the Common Stock during the 60 trading days preceding and including the grant date, which was approximately $15.34, except for the PSUs awarded to Mr. Betori and Ms. Willis, which were divided by the average closing price of the Common Stock during the 60 trading days preceding and including the grant date, which was approximately $18.61.
(5)
This column shows the number of RSUs granted in 2023 to the NEOs under the LTI plan. The number of RSUs granted on February 3, 2023 was calculated using the target value for the award which is based on a percentage of the NEO’s salary and was calculated using the average closing price of the Common Stock during the 60 trading days preceding and including the grant date, which was $20.03. Except as noted below, 33.33% of each award vests annually over a three-year period. Mr. Betori and Ms. Willis’ RSU grants on February 3, 2023 will vest in equal annual installments over four years. This column also shows the number of RSUs granted to Mr. Betori and Ms. Willis on April 3, 2023, which was calculated using the average closing price of the Common Stock during the 60 trading days preceding and including the grant date, which was $18.61. Mr. Betori and Ms. Willis’ April 3, 2023 grant of 9,285 RSUs each will vest in equal annual installments over four years. Mr. Betori and Ms. Willis’ April 3, 2023 grants of 5,293 RSUs and 4,868 RSUs, respectively, will vest in equal annual installments over three years. This column also shows the number of RSUs granted in 2023 to Ms. Owen on October 2, 2023, which was calculated using the average closing price of the Common Stock during the 60 trading days preceding and including the grant date, which was $15.43. Ms. Owen’s October 2, 2023 grant will vest in equal annual installments over four years. This column also shows the number of RSUs granted in 2023 to Mr. Schweihs on November 1, 2023, which was calculated using the average closing price of the Common Stock during the 60 trading days preceding and including the grant date, which was $14.27. Mr. Schweihs’s November 1, 2023 grant will vest in equal annual installments over four years.
(6)
This column shows the grant date fair value of equity awards calculated in accordance with FASB ASC Topic 718. For RSUs, grant date fair value was calculated using the closing price of the Common Stock on the date of grant. The closing price of the Common Stock on February 3, 2023, was $18.76. For PSUs, the March 10, 2023 and April 3, 2023 grant date fair values were calculated using the closing price of the Common Stock on the date of grant and the target number of PSUs. The closing price of the Common Stock on March 10, 2023, April 3, 2023, October 2, 2023, and November 1, 2023, was $17.70, $17.96, $14.92, and $11.10, respectively. The performance goals and award multipliers for determining the potential vesting amounts are described in the Compensation Discussion and Analysis section. The amounts shown are consistent with the estimate of aggregate compensation cost to be recognized over the performance period determined as of the grant date under FASB ASC Topic 718, excluding the effect of forfeitures. For additional information on the calculation and valuation of equity awards, refer to the Compensation Discussion and Analysis section and refer to Note 10 to the Consolidated Financial Statements found in Item 8 of Part II of our 2023 Form 10-K (listed under Stock-Based Compensation).
TrueBlue, Inc. 2024 Proxy Statement  P. 53

TABLE OF CONTENTS

EXECUTIVE COMPENSATION TABLES
Outstanding Equity Awards at Fiscal Year-End
The following table provides information on the holdings of stock options, restricted shares, RSU, and PSU awards of the NEOs as of December 31, 2023. This table includes unvested shares of restricted stock, RSUs, and PSUs. The market value of the restricted shares, RSUs, and PSUs is based on the closing market price of the Common Stock on December 31, 2023, which was $15.34. For additional information about these awards, see the description of our LTI plan in the Compensation Discussion and Analysis section. Grants that are not listed in the vesting schedule were 100% vested as of December 31, 2023.
Stock Awards
Name
Grant
Date
Number of
Shares or Units of
Stock That Have
Not Vested (#)(1)
Market Value of
Shares or Units of
Stock That Have
Not Vested ($)
Equity Incentive Plan
Awards: Number of
Unearned Shares, Units
or Other Rights That
Have Not Vested (#)(2)
Equity Incentive Plan:
Market Value of
Unearned Shares, Units
or Other Rights That
Have Not Vested ($)
Taryn R. Owen
2/5/2021
27,405(3)
$420,393
2/4/2022
14,132
$216,785
26,497
$406,464
10/3/2022
9,708
$148,921
2/3/2023
31,719
$486,569
3/10/2023
41,420
$635,383
10/2/2023
22,290
$341,929
Steven C. Cooper
3/10/2023
$
95,296
$1,461,841
Carl R. Schweihs
2/5/2021
19,072(4)
$292,564
2/4/2022
6,729
$103,223
12,618
$193,560
2/3/2023
13,732
$210,649
3/10/2023
17,931
$275,062
11/1/2023
15,421
$236,558
Derrek L. Gafford
2/5/2021
12,483(5)
$191,489
2/4/2022
18,926
$290,325
3/10/2023
24,709
$379,036
Garrett R. Ferencz
1/2/2020
1,372
$21,046
2/7/2020
1,366
$20,954
8/3/2020
2,703
$41,464
2/5/2021
3,468
$53,199
2/4/2022
6,882
$105,570
12,905
$197,963
2/3/2023
15,448
$236,972
3/10/2023
20,173
$309,454
Richard P. Betori
2/7/2020
776
$11,904
7/1/2020
1,833
$28,118
2/5/2021
3,121
$47,876
12/1/2021
2,452
$37,614
2/4/2022
3,830
$58,752
2/3/2023
6,946
$106,552
4/3/2023
9,285
$142,432
4/3/2023
5,293
$81,195
4/3/2023
12,767
$195,846
Kristy A. Willis
2/7/2020
1,280
$19,635
2/5/2021
3,069
$47,078
12/1/2021
2,591
$39,746
2/4/2022
4,048
$62,096
2/3/2023
7,341
$112,611
4/3/2023
9,285
$142,432
4/3/2023
4,868
$74,675
4/3/2023
12,767
$195,846
(1)
This column includes unvested restricted shares and RSU awards as of December 31, 2023, PSUs that were granted in 2021 and that became determinable as of December 31, 2023, but which had not yet vested, and PSUs awarded based on individual performance (“Retention PSUs” or “PSUs”) that were granted in 2021 of which the remainder became determinable as of December 31, 2023, but which had not yet vested. As described in more detail in the Compensation Discussion and Analysis section above, the 2021 PSU grant resulted in 0% of the target number of PSUs being earned. For restricted shares and RSU awards, 33.33% of each NEO’s award vests every year for three years on each anniversary of the date of the grant, except for promotional awards and awards received by the NEOs prior to becoming an NEO which vest at a rate of 25% each year for four years on each anniversary of the date of the grant. The awards vesting over four years include Ms. Owen’s October 2022 and October 2023 award, Mr. Schweihs’s November 2023 award, all 2020 awards, and all awards to Ms. Willis and Mr. Betori prior to their promotions effective March 20, 2023, as well as their promotional grants on April 3, 2023, for 9,285 shares each.
TrueBlue, Inc. 2024 Proxy Statement  P. 54

TABLE OF CONTENTS

EXECUTIVE COMPENSATION TABLES
(2)
This column includes PSU awards. The PSU awards vest, if at all, on or about the second day after the release of our annual earnings following the performance period, according to predetermined targets. For additional information on the vesting schedule and Company performance goals for PSUs granted in 2023, please see the Compensation Discussion and Analysis section. For PSU awards granted in 2022, additional information on performance goals can be found in our prior proxy statement. The February 4, 2022, March 10, 2023 and April 3, 2023 PSU grants each assume a 100% payout of the award, or the target number of shares, will be earned. The February 5, 2021 PSU grant and the remainder of the February 5, 2021 Retention PSU grants became determinable as of December 31, 2023 and are not included in this column.
(3)
This amount includes 5,559 restricted shares and 21,846 shares under the Retention PSU award that vested on February 5, 2024.
(4)
This amount includes 3,468 restricted shares and 15,604 shares under the Retention PSU award that vested on February 5, 2024.
(5)
This amount represents 12,483 shares under the Retention PSU award that vested on February 5, 2024.
Stock Vested
The following table provides information for the NEOs regarding: (i) stock option exercises during 2023, to the extent any occurred, including the number of shares acquired upon exercise and the value realized; and (ii) the number of shares acquired upon the vesting of restricted shares, RSU, and PSU awards during 2023 and the value realized before payment of applicable withholding tax and broker commissions. The value realized represents long-term gain over several years, which is not part of the compensation awarded in 2023 as reported in the Summary Compensation Table.
Stock Awards
Name
Number of Shares
Acquired on Vesting (#)(1)
Value Realized
on Vesting ($)(2)
Taryn R. Owen
48,404
$894,822
Steven C. Cooper(3)
230,248
$3,277,452
Carl R. Schweihs
36,321
$678,996
Derrek L. Gafford(4)
72,602
$1,252,946
Garrett R. Ferencz
12,878
$233,074
Richard P. Betori
7,405
$131,440
Kristy A. Willis
6,706
$119,696
(1)
This column includes the vesting of PSUs for the 2020 PSU grant which resulted in 76.8% of the target shares being earned. This column also includes the vesting of the first tranche of the 2021 Retention PSU grants for Ms. Owen, Mr. Schweihs and Mr. Gafford. For additional information on the vesting of the 2020 PSUs and the 2021 Retention PSUs, please see our prior proxy statement. This column does not include the vesting of the 2021 PSUs or the second tranche of the 2021 Retention PSUs which vested in February 2024. For additional information on the vesting of the 2021 PSUs, please see the Outstanding Equity Awards at Fiscal Year-End section above.
(2)
The dollar amount realized upon vesting was calculated by multiplying the number of shares of stock by the market value of the Common Stock on the vesting date.
(3)
These amounts reflect the 171,995 shares Mr. Cooper received as of September 12, 2023 as a result of the CEO transition and 58,253 shares he received on December 31, 2023 as a result of his retirement.
(4)
These amounts include 31,701 shares Mr. Gafford received on December 31, 2023 as a result of his separation from the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 55

TABLE OF CONTENTS

EXECUTIVE COMPENSATION TABLES
Nonqualified Deferred Compensation
The Company maintains a Nonqualified Deferred Compensation Plan that allows certain highly compensated employees, including the NEOs, to defer portions of their base salary and annual non-equity incentive and thereby defer taxes. The Company also maintains the Director Equity Plan that allows directors to defer receipt of cash retainers and settlement of equity awards, in which Mr. Cooper participated prior to becoming CEO in June 2022. The following table provides additional information about the amounts deferred by our NEOs:
Name
Executive
Contributions
in Last FY ($)(1)
Company
Contributions
in Last FY ($)(2)
Aggregate
Earnings (Loss)
in Last FY ($)(3)
Aggregate
Withdrawals/
Distributions ($)
Aggregate
Balance at Last
FYE ($)
Taryn R. Owen
$34,898
$11,250
$49,856
$358,346
Steven C. Cooper(4)
$(92,358)
$296,924
Carl R. Schweihs
$103,979
$11,250
$58,588
$46,409
$526,070
Derrek L. Gafford
$217,773
$11,250
$159,513
$1,220,329
Garrett R. Ferencz
$30,340
$9,883
$52,970
$326,075
Richard P. Betori
$225,409
$11,250
$25,881
$444,538
Kristy A. Willis
$53,354
$11,250
$29,476
$233,254
(1)
For the Company’s NEOs, amounts in this column are included in the amounts shown as “Salary” in the Summary Compensation Table above.
(2)
These amounts were earned as a match to contributions made by the NEO to the Company Nonqualified Deferred Compensation Plan in 2023 but were paid in early 2024. The Company’s contribution is included in the columns “Registrant Contributions in Last FY” and “Aggregate Balance at Last FYE.” These amounts are included in the amounts shown as “All Other Compensation” in the Summary Compensation Table above.
(3)
These amounts were earned, or lost, by the NEO according to investment gains and losses based on the performance of certain investment choices selected by the participants in the Nonqualified Deferred Compensation Plan or Director Equity Plan, as applicable. Participants in the Nonqualified Deferred Compensation Plan may change their investment elections at any time under the same rules that apply under the 401(k) plan.
(4)
On December 11, 2023, Mr. Cooper received 20,254 shares that he had previously deferred under the Equity Retainer and Deferred Compensation Plan for Non-Employee Directors discussed in the Compensation of Directors section.
The participants in the Nonqualified Deferred Compensation Plan may annually elect to defer up to 75% of their salary and up to 100% of their annual non-equity incentive. Participants are always 100% vested in the elective deferral contributions to the plan. The amounts deferred into this plan and all earnings remain subject to the claims of the Company’s general creditors until distributed to the participant. Participants may receive their funds after the termination of their employment or during employment in the case of an unforeseen emergency, the disability of the participant, or a change in control. Participants also have the option to receive a distribution of deferred funds during employment if such a distribution was established prior to the deferral. Any Company matching contributions are discretionary. Whether a matching contribution will be made for a plan year and the amount of any such match is determined each year by the Company. Matching funds are immediately vested.
The deemed rates of return for the earnings options may be positive or negative and thus may result in gains or losses to a participant’s plan balance. No assets are required to actually be invested in such funds. The deemed investment options may be changed by the participant periodically throughout the year. For certain key employees, the distribution election must be made at least six months before the actual payment of the participant’s account balance.
Please refer to the description of the Director Equity Plan under the Compensation of Directors section in this proxy statement.
TrueBlue, Inc. 2024 Proxy Statement  P. 56

TABLE OF CONTENTS

Post-Employment Payments
Post-Employment Payments
The Company has entered into employment agreements and change-in-control agreements with each of the NEOs pursuant to which each NEO may be entitled to payments upon termination of employment under the circumstances described below. The payments are subject to the fulfillment of certain conditions, including compliance with a non-competition agreement, which are also described below. The information below is a summary of certain material provisions of these agreements and does not attempt to describe all aspects of the agreements. The rights of the parties are governed by the actual agreements and are in no way modified by the abbreviated summary set forth in this proxy statement.
Following the description of the agreements, there is a table showing the potential payments the NEOs could have received under these agreements, except for Messrs. Cooper and Gafford, assuming their employment with the Company was terminated without cause by the Company or for good reason by the NEO on December 31, 2023. The post-employment payments to Messrs. Cooper and Gafford are described below.
Retirement Payment for Steven C. Cooper
Mr. Cooper resigned from his position as Chief Executive Officer (“CEO”) effective September 12, 2023, and remained employed in an advisory role until he retired as an executive of the Company as of December 31, 2023. Mr. Cooper successfully completed a transition period during which, among other things, he developed a transition plan for the CEO position, assisted the Company in identifying and recruiting a successor CEO, transitioned his duties and responsibilities to the named successor, and provided additional assistance as requested by the Board to effect an orderly transition. As a result, Mr. Cooper received the following benefits upon his retirement from the Company:
payment of Mr. Cooper’s 2023 short-term incentive (“STI”) plan award subject to performance conditions set by the Board;
immediate vesting in all previously awarded but unvested restricted share units (“RSUs”) for the portion that would have vested in the 18-month period immediately following his retirement date;
continued vesting of outstanding performance share units (“PSUs”) at the end of the applicable performance period, prorated for the length of time Mr. Cooper served during the performance period, plus 18 months, and subject to each grant’s performance criteria; and
continued group health plan coverage for Mr. Cooper and his spouse until the later of: (i) Mr. Cooper and his spouse both reaching age sixty-five (65); or (ii) the date Mr. Cooper and his spouse are both eligible for Medicare, so long as Mr. Cooper remits to the Company the same premiums for coverage as an active employee under the Company’s group health plan.
As of December 31, 2023, Mr. Cooper’s total retirement benefits were approximately $3,515,824. This included: (i) $1,087,500 for his 2023 STI plan award; (ii) $893,601 for the RSUs that vested immediately upon his termination, which was calculated by using the closing price of a share of common stock on the date of vesting, which on December 31, 2023, was $15.34; (iii) $1,461,841 for the prorated PSUs, assuming each award vests at target, which was calculated by using the closing price of a share of common stock on the date of
Mr. Cooper’s retirement, which on December 31, 2023, was $15.34; and (iv) approximately $72,882 for the group health plan coverage for Mr. Cooper and his spouse, calculated based on Mr. Cooper reaching 65 years of age.
Separation Payment for Derrek L. Gafford
Mr. Gafford served as our Chief Financial Officer (“CFO”) until October 30, 2023, and remained employed in an advisory role until December 31, 2023. Mr. Gafford successfully completed a transition period during which, among other things, he developed a transition plan for the CFO position, assisted the Company in identifying and recruiting a successor CFO, transitioned his duties and responsibilities to the named successor, and provided additional assistance as requested by the CEO to effect an orderly transition. Pursuant to the terms of his employment agreement, as amended, Mr. Gafford received the following benefits upon his separation from the Company:
continued payments of Mr. Gafford’s base salary for 18 months following his termination date;
payment of Mr. Gafford’s 2023 STI plan award subject to performance conditions set by the Board;
immediate vesting in all previously awarded but unvested RSUs for the portion that would have vested in the 18-month period immediately following his termination date; and
continued vesting of outstanding PSUs at the end of the applicable performance period, prorated for the length of time Mr. Gafford served during the performance period, plus 18 months, and subject to each grant’s performance criteria.
As of December 31, 2023, Mr. Gafford’s total payments upon separation benefits were approximately $2,583,612. This included: (i) $907,500 for 18 months’ of his base salary; (ii) $328,969 for his 2023 STI plan award; (iii) $486,293 for the RSUs that vested immediately upon his termination, which was calculated by using the closing price of a share of common stock on the date of vesting, which on December 31, 2023, was $15.34; and (iv) $860,850 for the prorated PSUs, assuming each award vests at target, which was calculated by using the closing price of a share of common stock on the date of Mr. Gafford’s separation, which on December 31, 2023, was $15.34.
Employment Agreements for Ms. Owen
Ms. Owen’s employment agreement provides that if the Company terminates her employment without cause, or if Ms. Owen terminates her employment with good reason (subject to notice and cure provisions allowing the Company to remedy the condition constituting good reason), then she will be entitled to the following:
separation payments at a rate equal to her base salary at the time of termination for a period of 18 months;
payment of Ms. Owen’s then applicable short-term incentive award subject to performance conditions set by the Board and prorated for the portion of the period Ms. Owen is actually employed by the Company; and
additional equity vesting as follows: (a) to the extent that Ms. Owen’s unvested equity awards are scheduled to vest based solely on her continued employment within 18 months following such termination such portion of the awards will become fully vested on the termination date; and (b) Ms. Owen’s unvested equity awards scheduled to vest based upon
TrueBlue, Inc. 2024 Proxy Statement  P. 57

TABLE OF CONTENTS

Post-Employment Payments
attainment of specified performance goals shall vest after the end of the applicable performance period based on actual performance results, prorated for the portion of the performance period employed (for which purpose Ms. Owen will be deemed to have continued employment for a period of 18 months following termination but not beyond the end of the applicable performance period(s)).
The foregoing separation benefits are conditioned upon the execution by Ms. Owen of a release of claims against the Company and continued compliance by Ms. Owen with all covenants with the Company. Pursuant to her employment and non-compete agreements, Ms. Owen’s covenants with the Company include, without limitation, covenants requiring a duty of loyalty, non-disclosure of confidential information, assignment of inventions, non-competition for 18 months following her termination, and non-solicitation for 24 months following her termination. Ms. Owen is also party to a non-competition agreement with the Company.
Ms. Owen’s employment agreement, through reference to Ms. Owen’s change-in-control agreement, also provides that if she is deemed to receive an “excess parachute payment” as defined in Section 280G of the Internal Revenue Code (the “Code”) by reason of the accelerated vesting of the equity awards (taking into account any other compensation paid or deemed paid to her), the amount of such payments or deemed payments shall be reduced or, alternatively, the provisions of the employment agreement shall not act to vest unvested equity incentive awards to Ms. Owen, so that no such payments or deemed payments shall constitute excess parachute payments. The determination of whether a payment or deemed payment constitutes an excess parachute payment shall be in the sole discretion of the Board.
Employment Agreements for Messrs. Schweihs, Ferencz, and Betori and Ms. Willis
Messrs. Schweihs, Ferencz, and Betori and Ms. Willis are parties to employment agreements and incentive plan terms, which provide that if the Company terminates the NEO’s employment without cause, or if the NEO terminates his or her employment with good reason other than for death or disability, then the NEO will be entitled to the following:
separation payments at a rate equal to the NEO’s base salary at the time of termination for a period of 12 months;
payment of the NEO’s then applicable short-term incentive award subject to performance conditions set by the Board and prorated for the portion of the period the NEO is actually employed by the Company; and
additional equity vesting as follows: (a) to the extent that the NEO’s unvested equity awards are scheduled to vest based solely on his or her continued employment within 12 months following such termination, such portion of the awards will become fully vested; and (b) all of the NEO’s unvested equity awards scheduled to vest based on attainment of specified performance goals shall vest after the end of the applicable performance period based on actual performance results, prorated for the portion of the performance period employed (for which purpose such NEO will be deemed to have continued employment for a period of 12 months following termination but not beyond the end of the applicable performance period(s)).
As a condition precedent to being entitled to receive the benefits set forth above, the NEO must sign and deliver, and thereafter not revoke a release of claims against the Company, remain in full compliance with all provisions of the sections of the employment and non-compete agreement(s) relating to non-disclosure of confidential information and assignment of inventions, and be and remain in full compliance with the non-competition agreement and any other covenants with the Company entered into by the NEO. Each NEO is also party to a non-competition agreement with the Company.
In addition to the provisions described above, the employment agreement for each NEO also provides that, if at the time of termination of employment the NEO is considered a “specified employee” subject to the required six-month delay in benefit payments under Section 409A(a)(2)(B)(i) of the Code, then any separation payments that would otherwise have been paid within the first six months after termination of employment shall instead be paid in a single lump sum on (or within 15 days after) the six-month anniversary of such termination of employment and any remaining severance payments shall be made monthly after such six-month anniversary.
Change-in-Control Agreements
The Company has entered into change-in-control agreements with various executive officers, including each of the NEOs. Each change-in-control agreement by its terms expires each year on December 31st, provided that beginning on January 1st of each subsequent year, the change-in-control agreements will automatically extend for an additional year, unless either party gives notice of termination not later than September 30th of the immediately preceding year. Because no such notices of termination were provided, the change-in-control agreements were in effect through December 31, 2023, and were extended through December 31, 2024. If a change in control occurs during the term, the term will expire on the earlier of the third anniversary of the change in control or the date of the executive’s death (such period is referred to as the “Severance Period”).
Change in control means that during the term of the agreements any of the following events occur:
any individual, entity, or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) is or becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 33.33% of the combined voting power of the then-outstanding voting stock of the Company;
a majority of the Board ceases to be comprised of incumbent directors; or
the consummation of a reorganization, merger, consolidation, plan of liquidation or dissolution, recapitalization or sale, or other disposition of all or substantially all of the assets of the Company or the acquisition of the stock or assets of another corporation, or other transaction (each, a “Business Transaction”), and as a result of which less than 50% of the outstanding voting interests or securities of the surviving or resulting entity immediately after the Business Transaction are owned in the aggregate by the former shareholders of the Company, as the same shall have existed immediately prior to such Business Transaction, in substantially the same proportions as their ownership before such Business Transaction.
TrueBlue, Inc. 2024 Proxy Statement  P. 58

TABLE OF CONTENTS

Post-Employment Payments
The Company will be required to pay the amounts described in the table below, if following the occurrence of a change in control and during the Severance Period (or within 90 days prior to the date of a change in control, if at the request of a third party who has taken steps reasonably calculated to effect a change in control): (i) the Company terminates the NEO’s employment other than for cause, or as a result of the NEO’s death or permanent disability; or (ii) the NEO terminates the NEO’s employment for good reason. Each of (i) and (ii) is referred to in the change-in-control agreement as a “Triggering Termination.” As a condition precedent to receiving any payments and benefits under the change-in-control agreement, the NEO must execute and not later revoke a waiver and release agreement and be in compliance with the restrictive covenants and terms of the change-in-control agreement. The material covenants of each NEO in the change-in-control agreements include a duty of loyalty, non-disclosure, non-use, and protection of confidential information, non-disparagement, non-competition, and non-solicitation of employees and clients. The non-competition and non-solicitation provisions apply during the term of the change-in-control agreement and for a period of two years following the termination of employment.
In the event of a Triggering Termination, subject to the terms of the agreement, the Company is required to pay to the NEOs (A) an amount equal to two times the sum of (i) the NEO’s annual base salary rate in effect for the year in which the termination date occurs, plus (ii) the NEO’s target non-equity incentive (in an amount equal to the target non-equity incentive immediately prior to the change in control or, if such target shall not have been established or shall be reduced after a change in control, the highest aggregate incentive pay earned in any of the three fiscal years immediately preceding the year in which the change in control occurred), and (B) provide 18 months of health and welfare benefits. Such amounts shall be payable as follows: 50% shall be payable within five business days after the termination date and 50% shall be payable in equal monthly installments over the 24 months following the termination date. The agreement provides that the timing of payments may be adjusted if necessary to comply with Section 409A of the Code. The Company will also provide employee benefits to the NEO comparable to the benefits that the NEO was receiving or entitled to receive immediately prior to the termination date or will pay a lump sum payment in lieu of the continuation of such benefits, as described in the change-in-control agreement.
In addition to the amounts described above, if there is a Triggering Termination, the Company will pay in cash to the NEO a lump sum amount equal to the sum of (i) any unpaid incentive compensation that has been earned, accrued, allocated, or awarded to the NEO for any performance period ending prior to a Triggering Termination, plus (ii) the value of any annual non-equity incentive or long-term incentive pay earned, accrued, allocated, or awarded with respect to the NEO’s service during the performance period or periods that include the date on which the change in control occurred. Furthermore, if there is a Triggering Termination, all stock options, restricted shares, RSUs, PSUs, and any other equity award shall become fully vested as of the date of termination.
Notwithstanding any provision of the change-in-control agreement or any other agreement between the NEO and the Company to the contrary, if any amount or benefit to be paid or provided under the change-in-control agreement or any other agreement would be a payment that creates an obligation for the NEO to pay excise taxes under Section 280G of the Code (an “excess parachute payment”), then the payments and benefits to be paid or provided under the
change-in-control agreement and any other agreement will be reduced to the minimum extent necessary (but in no event to less than zero) so that no portion of any such payment or benefit, as so reduced, constitutes an excess parachute payment; provided that the foregoing reduction will not be made if such reduction would result in the NEO receiving an after-tax amount less than 90% of the after-tax amount of the severance payments the NEO would have received under the change-in-control agreement or under any other agreement. In the event that any payment or benefit intended to be provided is required to be reduced pursuant to this provision, the NEO will be entitled to designate the payments and/or benefits to be so reduced.
In addition to the foregoing limitation, the change-in-control agreements provide that to the extent that the NEO receives payments by reason of the NEO’s termination of employment pursuant to any other employment or severance agreement or employee plan (collectively, “Other Employment Agreements”), the amounts otherwise receivable under the change-in-control agreement will be reduced by the amounts actually paid pursuant to the Other Employment Agreements, but not below zero, to avoid duplication of payments so that the total amount payable or value of benefits receivable under the change-in-control agreement, and under the Other Employment Agreements, is not less than the amounts payable or value of benefits receivable had such benefits been paid in full under the change-in-control agreement.
Restricted Shares, Restricted Stock Units, and Performance Share Unit Agreements
The award agreements that govern the restricted shares, RSU, and PSU grants to the NEOs also provide that the restricted shares, RSU, and PSU, as applicable, will become fully vested if after a change of control, the NEO is terminated without cause or terminates employment for good reason. PSUs vest in such an event at the target level, provided that the Compensation Committee shall have the discretion to determine whether the performance goals shall be deemed to have been performed at the maximum level. For purposes of the restricted shares, RSU, and PSU agreements, “change of control” means the first day that any one or more of the following conditions shall have been satisfied:
the sale, liquidation, or other disposition of all or substantially all of the Company’s assets in one or a series of related transactions;
an acquisition (other than directly from the Company) of any outstanding voting securities by any person, after which such person has beneficial ownership of 25% or more of the then outstanding voting securities of the Company, other than a Board approved transaction;
during any consecutive 24-month period, the individuals who, at the beginning of such period, constitute the Board cease for any reason other than death to constitute at least a majority of the members of the Board, subject to certain exceptions; or
a merger, consolidation, or reorganization of the Company, as a result of which the shareholders of the Company immediately prior to such merger, consolidation, or reorganization own, directly or indirectly, immediately following such merger, consolidation, or reorganization less than 50% of the combined voting power of the outstanding voting securities of the entity resulting from such merger, consolidation, or reorganization.
TrueBlue, Inc. 2024 Proxy Statement  P. 59

TABLE OF CONTENTS

Post-Employment Payments
Potential Payout Upon an Involuntary Termination Without Cause or for Good Reason
The table below quantifies the potential payouts to each of the NEOs (other than Messrs. Cooper and Gafford) assuming his or her employment with the Company was terminated on December 31, 2023. The table shows two alternative scenarios: (i) termination before a change in control; and (ii) termination after a change in control. Actual payouts for Messrs. Cooper and Gafford in connection with their retirement and separation from the Company, respectively, effective December 31, 2023, are described above at the beginning of this Post-Employment Payments section.
Potential Payouts upon Involuntary Termination
by Company without Cause or by NEO for Good
Reason after a Change in Control(1)
Potential Payouts upon Involuntary Termination
by Company without Cause or by NEO for Good
Reason before a Change in Control(2)
Name(3)
Cash
Payment(4)
Restricted Shares,
Restricted Stock Unit
& Performance
Share Unit
Vesting(5)(6)
Continuation
of Health &
Welfare Benefits
Cash
Payment(7)
Restricted Shares,
Restricted Stock Unit
& Performance
Share Unit
Vesting(8)(9)
Continuation
of Health &
Welfare Benefits
Taryn R. Owen
$3,515,036
$2,656,443
$51,306
$1,979,931
$2,034,069
Carl R. Schweihs
$1,862,740
$1,311,616
$833,500
$851,217
Garrett R. Ferencz
$1,732,500
$986,623
$45,917
$792,000
$673,564
Richard P. Betori
$1,447,840
$710,288
$44,966
$629,442
$322,769
Kristy A. Willis
$1,452,066
$694,120
$51,065
$624,576
$303,487
(1)
Assumes that (a) the change-in-control agreement was effective as of December 31, 2023, (b) a change in control occurred on or before such date, and (c) the NEO was terminated by the Company without cause on such date or the NEO terminated NEO’s employment for good reason on such date.
(2)
Assumes that (a) the employment agreement was effective as of December 31, 2023, (b) no change in control occurred on or before such date, and (c) the NEO was terminated by the Company without cause on such date or the NEO terminated NEO’s employment for good reason on such date. These amounts reflect actual 2023 STI plan payments.
(3)
As discussed above, the amounts actually payable to the NEOs pursuant to the change-in-control agreement may be subject to reduction if any amount or benefit to be paid under such agreement or any other agreement would be a payment that creates an obligation for the NEO to pay excise taxes under Section 280G of the Code. For purposes of Section 280G, the value of the acceleration of stock options, restricted shares, RSUs, and PSUs is based on a time-based formula.
(4)
These amounts are based on the NEOs’ salary as of 2023 fiscal year-end and the target STI plan award for 2023.
(5)
The employment agreements for the NEOs provide for the accelerated vesting of all equity awards upon termination of employment under the conditions noted in footnote (1) above.
(6)
The amounts shown are calculated by multiplying the number of unvested restricted shares and RSU awards and unvested Retention PSU and annual PSU awards (which are shown at 0% of target for the 2021 PSU award) for such NEO with respect to which the vesting would accelerate as a result of termination under the conditions noted in footnote (1) above by the closing price of the Common Stock on December 31, 2023, which was $15.34. Unvested restricted shares, RSUs, and PSUs are set forth in the Outstanding Equity Awards at Fiscal Year-End table.
(7)
As of December 31, 2023, the NEOs’ employment agreements provide for cash payments of 12 months’ salary (18 months’ salary for Ms. Owen) and the amount earned under the 2023 STI plan up until the date of termination following a termination of employment under the conditions noted in footnote (2) above. These amounts are based on the NEO’s salary as of 2023 fiscal year-end and the amount earned under the 2023 STI plan.
(8)
The NEOs’ employment agreements provide for the accelerated vesting of those equity awards which would have vested in the 12-month period (18-month period for Ms. Owen) following a termination of employment under the conditions noted in footnote (2) above.
(9)
The PSU award agreements provide that, upon termination of employment under the conditions noted in footnote (2) above, a pro-rata portion of the PSUs vest and are paid out at the end of the performance period based on actual performance. The amounts shown reflect the 2021 PSU award at 0% of target, the amount actually earned. The amounts shown also reflect the Retention PSU awards based on the amount earned as of December 31, 2023.
TrueBlue, Inc. 2024 Proxy Statement  P. 60

TABLE OF CONTENTS

Post-Employment Payments
Retirement Benefits
We expect our NEOs to supplement their retirement income through our short- and long-term incentive (“STI” and “LTI,” respectively) plans. Retirement treatment will apply if the NEO has achieved: (a) at least 10 years of service; and (b) at least 55 years of age. In the event of termination of employment due to a qualified retirement, the NEOs’ STI and LTI awards will be prorated and paid as follows:
STI: the current year’s award will be prorated based on the days worked during the fiscal year and will be paid after the end of the year based on actual performance results;
Restricted Shares and RSUs: at the time of retirement, a prorated number of shares that would normally vest at the next scheduled vesting date will be vested based on days worked since the last vesting date; and
PSUs: awards will be prorated based on the number of days worked during the performance period and vest after the end of the performance period based on actual performance results.
As of December 31, 2023, except for Messrs. Cooper and Betori, our NEOs were all under the age of 55, and were not eligible for these
retirement benefits. Mr. Cooper’s retirement benefits in connection with his retirement as of December 31, 2023, are discussed at the beginning of this Post-Employment Payments section. Mr. Betori’s retirement benefits as of December 31, 2023 would have been $399,792.
Death and Disability Benefits
If any of the NEOs’ employment with the Company terminates due to death or disability, their PSU awards will be prorated based on the portion of the applicable performance period they were employed at the end of the performance period. Assuming a December 31, 2023 termination of employment due to death or disability, the total value of each NEO’s (other than Messrs. Cooper and Gafford) PSU awards was: Ms. Owen, $820,951; Mr. Schweihs, $461,458; Mr. Ferencz, $236,620; Mr. Betori, $66,008; and Ms. Willis, $66,008. These values are based on the closing price of the Common Stock as of December 31, 2023 ($15.34) and the target number of PSUs for each award, except for the 2021 PSU awards which paid out at 0%.
TrueBlue, Inc. 2024 Proxy Statement  P. 61

TABLE OF CONTENTS

PROPOSAL 3.
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S
2016 OMNIBUS INCENTIVE PLAN
Introduction and Summary of Proposed Amendment and Restatement
The Company currently maintains the TrueBlue, Inc. 2016 Omnibus Incentive Plan (the “2016 Plan”), which our shareholders originally approved on May 11, 2016 and later approved amendments and restatements on May 9, 2018 and May 11, 2023. Under the 2016 Plan, the Company has reserved a number of shares of the Company’s common stock (“Common Stock”) for issuance in the form of stock options, shares of restricted Common Stock (including other stock-based awards for non-employee directors under the director compensation program), restricted stock units (“RSUs”), performance share units (“PSUs”) and stock appreciation rights (“SARs”) and cash awards to employees, officers, consultants, and advisors of the Company and its subsidiaries and to non-employee directors of the Company. The purpose of the 2016 Plan is to (i) attract and retain talented employees, officers, directors, and consultants; and (ii) promote the growth and success of our business by aligning the long-term interests of employees, officers, directors, and consultants with those of our shareholders by providing an opportunity to acquire an interest in our business, rewards for exceptional performance, and long-term incentives for future contributions to our success.
In order to provide a sufficient pool of equity for the Company to continue to attract and retain talent and to provide a uniform provision in the event of a Change in Control (as defined below) for purposes of new awards, the Board has adopted, subject to shareholder approval, an amendment and restatement of the 2016 Plan (the “Amended 2016 Plan”) primarily to:
(i)
increase the number of authorized shares of Common Stock available for awards by 840,000;
(ii)
to provide that an award will become vested, exercisable, and non-forfeitable, including a performance award which will be deemed earned and vested at the target performance level, immediately prior to a Change in Control if the entity effecting a Change in Control does not assume the award;
(iii)
provide that in the event the entity effecting a Change in Control assumes the award, and the grantee either is terminated without Cause (as defined below) or terminates for Good Reason (as defined below) within one year after the Change in Control, then the awards will become fully vested, exercisable, and non-forfeitable, including a performance award which will vest as laid out in item (ii) above; and
(iv)
provide for the accelerated full vesting of an award, with a performance award vesting at target, upon the grantee’s death or disability.
Increase in Shares Available for Awards
The aggregate number of shares of Common Stock authorized to be awarded under the 2016 Plan after the amendment and restatement on May 11, 2023, is (i) 1,542,944 shares carried over from, and previously registered for offer or sale under, the Company’s Amended and Restated 2005 Long-Term Equity Incentive Plan (the “2005 Plan”); plus (ii) 1,800,000 shares; plus (iii) shares underlying any outstanding award granted under the 2005 Plan that, following the original adoption of the 2016 Plan, expired, or were terminated, surrendered, or forfeited for any reason without issuance of such shares (the “Rollover Shares”); (iv) plus 695,000 shares approved at the 2023 Annual Meeting of Shareholders. As of March 11, 2024, 306,124 shares of Common Stock remained available for issuance under the 2016 Plan. Pursuant to the proposed Amended 2016 Plan, there would be added an additional 840,000 shares of Common Stock, such that the total number of shares available to be awarded after the Amended 2016 Plan is approved will be 1,146,124. The maximum aggregate number of shares of Common Stock authorized to be awarded over the life of the Amended 2016 Plan is 8,614,975, including an aggregate total of 3,737,031 Rollover Shares that as of March 11, 2024, have become or may still become available for awards under the 2016 Plan.
Under the 2016 Plan, as of March 11, 2024, there were 2,448,097 shares subject to granted and outstanding awards, consisting of: 30,289 restricted shares; 1,589,522 RSUs; and 828,286 PSUs (at the maximum payout level). As of March 11, 2024, the closing price of a share of Common Stock on the New York Stock Exchange was $11.81.
Additional Equity Plan Information
As of the Record Date, there were 31,389,141 shares of Common Stock outstanding. The following table provides certain additional information as of March 11, 2024, regarding our equity compensation plans, excluding the 2010 Employee Stock Purchase Plan:
Total Restricted Stock Units (including maximum Performance Share Units) Outstanding
2,448,097
Total Shares Available for Grant Under the 2016 Plan
306,124
The following table provides a detailed break out of the number of restricted shares, RSUs, and PSUs at target granted under the 2016 Plan in a calendar year and also provides the number of PSUs earned in such calendar year, for the past three fiscal years:
Fiscal
Year
Total Full-Value
Awards Granted
Granted Restricted
Shares and RSUs
Granted Performance
Share Units
Earned Performance
Share Units
2023
1,012,300
763,551
248,749
80,196
2022
839,389
688,151
151,238
85,881
2021
822,859
562,574
260,285
113,579
TrueBlue, Inc. 2024 Proxy Statement  P. 62

TABLE OF CONTENTS

PROPOSAL 3.
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S
2016 OMNIBUS INCENTIVE PLAN
Plan Features and Grant Practices That Protect Shareholder Interests
The Amended 2016 Plan and our grant practices include features that protect the interests of our shareholders:
Independent oversight. The Amended 2016 Plan is administered by the Compensation Committee, a committee composed entirely of independent directors.
No evergreen feature. The Amended 2016 Plan includes a number of shares available for grant that will not automatically increase because of an “evergreen” feature.
No liberal share counting. The Amended 2016 Plan prohibits the Company from reusing shares that are tendered or withheld to pay the exercise cost or tax obligation of grants. Stock settled SARs are counted at the gross number of shares for which the SAR is granted. The only shares that are re-used in the Amended 2016 Plan are shares covered by awards that have been canceled, forfeited, or expired or for awards settled in cash.
Stock option/SAR limits. The exercise price of stock options and SARs awarded must be at least 100% of the fair market value on the date of the award. The maximum term of each stock option and SAR is 10 years.
No repricing. The Amended 2016 Plan does not permit the repricing of stock options or SARs without prior approval of the Company’s shareholders.
Clawback. Awards granted under the Amended 2016 Plan are subject to any compensation recovery or clawback policy as may be adopted by the Company from time to time.
Dividends. The Amended 2016 Plan requires any dividends or dividend equivalents applicable to an award to accrue and be paid only to the extent the award becomes vested or payable.
Reasonable run rate. The Compensation Committee continues to control the dilutive effect of equity issued under the Company’s plans by controlling the number of shares issued on an annual basis (run rate).
Use of performance-based awards. Named executive officers receive 50% of their annual equity awards as performance share units which will only vest if certain Company performance measures are achieved (see the Compensation Discussion and Analysis section above for further information).
Stock ownership requirements. The Company has adopted stock ownership guidelines for directors and executive officers that require them to retain a certain amount of shares of Common Stock (see the Compensation of Directors and Compensation Discussion and Analysis sections in this proxy statement for further information).
Minimum vesting requirements. Subject to a five percent carveout, the Amended 2016 Plan generally requires that equity-based awards do not vest until the first anniversary of the date the award is granted. Exceptions
are allowed for: (i) substitute awards, (ii) shares delivered in lieu of fully vested cash awards, and (iii) other stock-based awards to non-employee directors (including any such awards that are deferred under the Company’s deferred compensation plan for non-employee directors); (iv) other awards to non-employee directors that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders; (v) death or disability, as further detailed within the Plan; and (vi) Change in Control, as further detailed within the Plan.
Summary of the Amended 2016 Plan
The principal features of the Amended 2016 Plan are summarized below. The following summary of the Amended 2016 Plan does not purport to be a complete description of all of the provisions of the Amended 2016 Plan. It is qualified in its entirety by reference to the complete text of the Amended 2016 Plan, which is attached to this proxy statement as Appendix B.
Eligibility
Awards may be granted under the Amended 2016 Plan to officers, employees, consultants, and advisors of the Company and its subsidiaries and to non-employee directors of the Company. Incentive stock options may be granted only to employees of the Company or its subsidiaries. As of March 11, 2024, approximately 200 individuals were eligible to receive awards under the Amended 2016 Plan, including six executive officers and eight non-employee directors.
Administration
The Amended 2016 Plan may be administered by the Board or the Compensation Committee. The Compensation Committee, in its discretion, selects the individuals to whom awards may be granted, the time or times at which such awards are granted, and the terms of such awards.
Number of Authorized Shares
The number of shares of Common Stock authorized for issuance under the Amended 2016 Plan is the sum of (i) 1,542,944, the number of shares of Common Stock that were available for the grant of awards under the 2005 Plan as of the date the 2016 Plan was initially approved by the Company’s shareholders, (ii) the Rollover Shares, (iii) 1,800,000, (iv) 695,000 shares, and (v) upon approval of this proposal by our shareholders, 840,000 shares.
If any shares of Common Stock related to an award are canceled, terminated, expired, or lapse for any reason prior to the issuance of shares or are forfeited to the Company, the shares subject to such awards and the forfeited shares will not count against the aggregate number of shares of Common Stock available for grant under the Amended 2016 Plan. In addition, the following items will not count against the aggregate number of shares of Common Stock available for grant under the Amended 2016 Plan: (i) the payment in cash of dividends or dividend equivalents under any outstanding award, (ii) any award that is settled in cash rather than by issuance of shares of Common Stock, (iii) awards granted in assumption of, or in substitution for, awards previously granted by an acquired company, or (iv) dividends or dividend equivalents that are reinvested into additional shares of Common Stock or credited as additional shares
TrueBlue, Inc. 2024 Proxy Statement  P. 63

TABLE OF CONTENTS

PROPOSAL 3.
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S
2016 OMNIBUS INCENTIVE PLAN
of Common Stock subject or paid with respect to an award. Shares tendered or withheld to pay the exercise price or satisfy tax withholding for any award will continue to count against the aggregate number of shares of Common Stock available for grant under the Amended 2016 Plan. Share settled SARs are counted based on the gross number of shares covered by the award, not the net shares settled at exercise.
Awards to Non-Employee Directors
No more than $500,000 may be granted in equity-based awards during any one (1) year to a non-employee member of the Board, based on the grant date fair value for accounting purposes in the case of stock options or SARs and based on the fair market value of the Common Stock underlying the award on the grant date for other equity-based awards. This limit does not apply to shares received by a non-employee director at his or her election in lieu of all or a portion of the director’s retainer for serving on the Board or any Board committee.
Adjustments
If certain changes in the Common Stock occur by reason of any recapitalization, reclassification, stock split, reverse split, combination of shares, exchange of shares, stock dividend, or other distribution payable in stock, or other increase or decrease in the Common Stock without receipt of consideration by the Company, or if there occurs any spin-off, split-up, extraordinary cash dividend, or other distribution of assets by the Company, (i) the number and kind of securities for which awards may be made under the Amended 2016 Plan (including individual and incentive stock option limits) will be equitably adjusted by the Company; and (ii) the number and kind of securities subject to any outstanding awards and the exercise price of any outstanding stock options or SARs will be equitably adjusted by the Company.
Types of Awards
The Amended 2016 Plan permits the granting of any or all of the following types of awards:
Stock Options. Stock options entitle the holder to purchase a specified number of shares of Common Stock at a specified price (the exercise price), subject to the terms and conditions of the stock option grant. The Compensation Committee may grant either incentive stock options, which must comply with Code Section 422, or nonqualified stock options. The Compensation Committee sets exercise prices and terms, except that stock options must be granted with an exercise price not less than 100% of the fair market value of the Common Stock on the date of grant (excluding stock options granted in connection with assuming or substituting stock options in acquisition transactions). At the time of grant, the Compensation Committee determines the terms and conditions of stock options, including the quantity, exercise price, vesting periods, term (which cannot exceed 10 years) and other conditions on exercise.
Stock Appreciation Rights. The Compensation Committee may grant SARs, as a right in tandem with the number of shares underlying stock options granted under the Amended 2016 Plan or as a freestanding award. Upon exercise, SARs entitle the holder to receive payment per share in stock or cash equal to the excess of the share’s
fair market value on the date of exercise over the grant price of the SAR. The grant price of a tandem SAR is equal to the exercise price of the related stock option and the grant price for a freestanding SAR is determined by the Compensation Committee in accordance with the procedures described above for stock options. The term of a SAR cannot exceed 10 years.
Restricted Shares, Restricted Stock Units, and Other Stock-Based Awards. The Compensation Committee may grant awards of restricted shares, which are shares of Common Stock subject to specified restrictions, and RSUs, which represent the right to receive shares of the Common Stock in the future. These awards may be made subject to repurchase, forfeiture, or vesting restrictions at the Compensation Committee’s discretion. The restrictions may be based on continuous service with the Company or the attainment of specified performance goals, as determined by the Compensation Committee. Stock units may be paid in stock or cash, as determined by the Compensation Committee. The Compensation Committee may also grant other types of equity or equity-based awards subject to the terms of the Amended 2016 Plan and any other stock-based awards to non-employee directors, which includes unrestricted shares of stock as part of the annual retainer under the non-employee director compensation program, as described under the Compensation of Directors section in this proxy statement.
Performance Awards. The Compensation Committee may grant performance awards, which entitle participants to receive a payment from the Company, the amount of which is based on the attainment of performance goals established by the Compensation Committee over a specified award period. Performance awards may be settled in shares of Common Stock, cash, or other awards or property, as determined by the Compensation Committee. The Compensation Committee may, in its discretion, adjust the amount of a settlement otherwise to be made in connection with a performance award.
No Repricing
Without shareholder approval, the Compensation Committee is not authorized to: (i) change the terms of a stock option or SAR after it is granted to lower the exercise or grant price; (ii) take any other action that is treated as a repricing under generally accepted accounting principles (“GAAP”); or (iii) cancel a stock option or SAR at a time when its exercise or grant price exceeds the fair market value of the underlying stock, in exchange for cash or another award, unless the cancellation and exchange occur in connection with a change in capitalization or other similar change.
Clawback
The Company may retain the right in an award agreement to cause a forfeiture of any gain realized on account of a violation or breach of or in conflict with any employment agreement, non-competition agreement, non-solicitation agreement, or any confidentiality obligation with respect to the Company, or otherwise in competition with the Company.
TrueBlue, Inc. 2024 Proxy Statement  P. 64

TABLE OF CONTENTS

PROPOSAL 3.
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S
2016 OMNIBUS INCENTIVE PLAN
All cash and equity awards granted under the Amended 2016 Plan will be subject to the requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act regarding the recovery of erroneously awarded compensation, any implementing rules and regulations under such act, similar rules under the laws of any other jurisdiction, any policies adopted by the Company to implement such requirements, and any other compensation recovery policies as may be adopted from time to time by the Company.
Limitations
Subject to certain adjustments for changes in our corporate or capital structure described above, participants may not be granted stock options or stock appreciation rights for more than 1,000,000 shares in any calendar year or more than 1,000,000 shares for all share-based awards that are performance awards in any calendar year. The maximum dollar value granted to any participant pursuant to that portion of a cash award granted under the Amended 2016 Plan for any calendar year to any employee may not exceed $5 million for an annual incentive award and $5 million for all other cash-based performance awards.
Transferability
Awards are not transferable other than by will or the laws of descent and distribution, except that in certain instances transfers may be made to or for the benefit of designated family members of the participant for no value.
Effect of Change in Control
A “Change in Control” is defined as: (i) any individual, entity or group is or becomes the beneficial owner of more than 33 1/3% of the combined voting power of the then-outstanding securities entitled to vote in the election of directors for the Company; (ii) a majority of the Board ceases to be comprised of incumbent directors; or (iii) the consummation of a reorganization, merger, consolidation, plan of liquidation or dissolution, recapitalization or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of the stock or assets of another corporation, or other transaction, and as a result of which less than fifty percent (50%) of the outstanding voting interests or securities of the surviving or resulting entity immediately after such transaction are owned in the aggregate by the former shareholders of the Company, as the same existed immediately prior to such transaction, in substantially the same proportions as their ownership before such transaction.
Upon a Change in Control, unless otherwise specified in an award agreement or an employee’s Change in Control Agreement:
Each outstanding award will be assumed by the entity effecting the Change in Control. If the outstanding awards are not assumed by the entity effecting the Change in Control, then (i) such awards (other than performance awards) will become fully vested, exercisable or non-forfeitable, as the case may be, immediately prior to the Change in Control and (ii) such awards that are performance awards will be deemed earned and vested at the target performance level immediately prior to the Change in Control.
If the awards are assumed by the entity effecting the Change in Control, then (i) such awards (other than performance awards) will continue to become vested, exercisable and non-forfeitable, as the case may be, pursuant to the terms of the applicable award
agreement, and (ii) such awards that are performance awards will be deemed earned at the target performance level as of the date of the Change in Control and the award will remain subject to time-based vesting until the end of the performance period set forth in the applicable award agreement.
Notwithstanding the foregoing, if a grantee’s employment is terminated during the one-year period beginning on the date of a Change in Control and such termination is due to (1) a termination by the Company without Cause or (2) a voluntary termination by the grantee for Good Reason, then the following will occur with respect to the awards that are assumed: (i) with respect to awards other than performance awards, such awards will become fully vested, exercisable, and non-forfeitable, as the case may be, as of the effective date of a grantee’s termination of employment; and (ii) with respect to performance awards , the fixed number deemed earned as determined above will become fully vested, exercisable, and non-forfeitable, as the case may be, as of the effective date of a grantee’s termination of employment.
“Cause “ means that, unless otherwise defined in an employee’s Change in Control Agreement, prior to any termination: (i) the employee is convicted of or takes a plea of nolo contendere to a crime involving dishonesty, fraud or moral turpitude; (ii) the employee has engaged in fraud, embezzlement, theft or other dishonest acts; (iii) the employee materially violates a significant Company policy, such as policies required by the Sarbanes-Oxley Act of 2002, the Company’s Drug Free Workplace Policy or the Company’s policy against harassment, and does not cure such violation (if curable) within 10 days after written notice from the Company; or (iv) the employee intentionally takes any action that materially damages the assets (including tangible and intangible assets, such as name or reputation) of the Company.
“Good Reason” means, unless otherwise defined in an employee’s Change in Control Agreement, the occurrence of one or more of the following events: (i) failure of the Company to remedy any of the following within 10 calendar days after receipt by the Company of written notice thereof from the employee: (A) a significant adverse change in the nature or scope of the authorities, powers or functions attached to the position with the Company which the employee held immediately prior to the Change in Control, (B) a reduction in the employee’s base pay, (C) a reduction in the employee’s incentive or bonus pay opportunity, assuming 100% achievement of the quantitatively measurable conditions to receipt of such incentive or bonus pay, and all such qualitative conditions, in each case as applicable to the employee immediately prior to the Change in Control, or (D) the termination or denial of the employee’s rights to employee benefits or a reduction in the scope or value thereof, unless such termination or reduction referred to in clauses (B), (C) or (D) applies on a substantially similar basis to all employees of the Company and its parent entities; or (ii) if the employee’s principal residence at the time in question is within 35 miles of the Company’s headquarters, the Company requires the employee to have employee’s principal location of work changed to any location that is in excess of 50 miles from such residence without employee’s prior written consent.
Death and Disability
Upon a grantee’s death or separation of service due to disability, as defined under the Company’s long-term disability plans, all awards other than performance awards will become vested, exercisable and non-forfeitable, as the case may be, in full; any performance awards
TrueBlue, Inc. 2024 Proxy Statement  P. 65

TABLE OF CONTENTS

PROPOSAL 3.
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S
2016 OMNIBUS INCENTIVE PLAN
will be deemed earned and vested at the target level of performance. Any awards that become payable after the grantee’s death will be distributed to the grantee’s beneficiary or beneficiaries if the grantee has designated one or more beneficiaries for this purpose by filing the prescribed form with the Company. If no beneficiary was designated or if no designated beneficiary survives the grantee, then any award that becomes payable after the grantee’s death will be distributed to the grantee’s estate.
Term, Termination, and Amendment of the Amended 2016 Plan
Unless earlier terminated by the Board, the Amended 2016 Plan will terminate, and no further awards may be granted, 10 years after the date on which it is approved by shareholders at the 2024 Annual Meeting of Shareholders. The Board may amend, suspend, or terminate the Amended 2016 Plan at any time, except that, if required by applicable law, regulation, or stock exchange rule, shareholder approval will be required for any amendment. The amendment, suspension, or termination of the Amended 2016 Plan or the amendment of an outstanding award generally may not, without a participant’s consent, materially impair the participant’s rights under an outstanding award.
Amended 2016 Plan Benefits
Awards made under the Amended 2016 Plan will be made at the Compensation Committee’s discretion, subject to the Amended 2016 Plan. Therefore, the benefits and amounts that will be received or allowed under the Amended 2016 Plan are generally not determinable at this time. The equity grant program for our non-employee directors is described under the Compensation of Directors section in this proxy statement. Awards granted to our named executive officers under the 2016 Plan in the last fiscal year are shown under the Grants of Plan-Based Awards section in this proxy statement. No stock options have been granted under the 2016 Plan.
U.S. Federal Income Tax Information
The following is a brief summary of the material U.S. federal income tax consequences of the Amended 2016 Plan generally applicable to the Company and to participants in the Amended 2016 Plan who are U.S. citizens or residents for U.S. federal income tax purposes. The summary is based on the Code, applicable Treasury Regulations and administrative and judicial interpretations thereof, each as in effect on the date of this proxy statement, and is, therefore, subject to future changes in the law, possibly with retroactive effect. The summary is general in nature and does not purport to be legal or tax advice. Furthermore, the summary does not address issues relating to any U.S. gift or estate tax consequences or the consequences of any state, local, or foreign tax laws.
Nonqualified Stock Options. A participant generally will not recognize taxable income upon the grant or vesting of a nonqualified stock option. Upon the exercise of a nonqualified stock option, a participant generally will recognize compensation taxable as ordinary income in an amount equal to the spread at exercise (i.e., the excess of the fair market value of the shares underlying the stock option on the date of exercise over the exercise price of the stock option). When a participant sells the shares received upon the exercise of a nonqualified stock option, the participant will recognize short-term or long-term capital gain or loss, as the case may be, equal to the difference between the amount realized on the sale
of the shares and the tax basis of the shares sold. The tax basis of the shares generally will be equal to the greater of the fair market value of the shares on the exercise date or the exercise price of the stock option.
Incentive Stock Options. A participant generally will not recognize taxable income upon the grant, vesting or exercise of an incentive stock option. If a participant exercises an incentive stock option during employment or within three months after employment ends (12 months in the case of permanent and total disability), the participant will not recognize taxable income at the time of exercise for regular U.S. federal income tax purposes (although the participant generally will recognize taxable income for alternative minimum tax purposes at that time as if the stock option were a nonqualified stock option). If a participant sells or otherwise disposes of the shares acquired upon exercise of an incentive stock option after the later of: (a) one year from the date the participant exercised the stock option, and (b) two years from the grant date of the stock option (i.e., the “required holding periods”), the participant generally will recognize long-term capital gain or loss equal to the difference between the amount the participant received in the sale or disposition and the exercise price of the stock option. If a participant sells or otherwise disposes of shares acquired upon exercise of an incentive stock option before the end of the required holding periods, the sale or disposition will constitute a “disqualifying disposition,” and the participant generally will recognize ordinary compensation income in the year of sale or disposition equal to the excess of the fair market value of the shares on the date of exercise over the exercise price of the stock option (or, if less, the excess of the amount realized on the sale or disposition of the shares over the exercise price of the stock option). The balance of the participant’s gain on a disqualifying disposition, if any, will be taxed as short-term or long-term capital gain, as the case may be.
Stock Appreciation Rights. A participant generally will not recognize taxable income upon the grant or vesting of a SAR. Upon the exercise of a SAR, a participant generally will recognize ordinary compensation income in an amount equal to the cash, or the fair market value of any shares, received in respect of the SAR. With respect to any shares received, upon a sale of the shares, a participant generally will recognize short-term or long-term capital gain or loss, as the case may be, equal to the difference between the amount realized on the sale of the shares and the tax basis of the shares. The tax basis of the shares generally will be equal to the value of the shares on the date received.
Restricted Share Awards. A participant generally will not recognize taxable income upon the grant of unvested restricted shares. Instead, the participant will recognize ordinary compensation income at the time the shares become vested equal to the difference between the fair market value of the shares and any amount paid by the participant for such shares, unless the participant made an election under Code Section 83(b) to be taxed at the time of grant. If a participant makes a Code Section 83(b) election with respect to restricted shares, the participant will recognize ordinary compensation income at the time of grant equal to the difference between the fair market value of the shares on that date and any amount paid by the participant for the shares. If the election is made, the participant will not be allowed a deduction for any income recognized with respect to shares that are subsequently required to be forfeited to the Company. Any dividends received with respect to an unvested restricted share award for which an election under Code Section 83(b) has not been made will be treated as ordinary compensation income, rather than dividend income, when received by the participant. If an election under Code Section 83(b) is made with respect to restricted shares, any dividends received generally will be treated as dividend income, which may be subject to tax at reduced rates.
TrueBlue, Inc. 2024 Proxy Statement  P. 66

TABLE OF CONTENTS

PROPOSAL 3.
APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S
2016 OMNIBUS INCENTIVE PLAN
Upon a sale of shares received, the participant generally will recognize short-term or long-term capital gain or loss, as the case may be, equal to the difference between the amount realized on the sale of the shares and the participant’s tax basis in the shares, which generally is equal to the amount paid for the shares, plus any ordinary compensation income recognized by the participant. A participant’s holding period for the shares generally begins at the time the participant recognizes income with respect thereto.
RSUs and Performance Awards. A participant will not be subject to tax upon the grant of an RSU award or performance award. Instead, upon the delivery of shares or cash pursuant to an RSU award or performance award, the participant will recognize taxable compensation income equal to the fair market value of the shares or the amount of cash received. Upon a sale of any shares received, the participant will recognize short-term or long-term capital gain or loss, as the case may be, equal to difference between the amount realized on the sale of shares and the participant’s tax basis in the shares, which generally is equal to the value of the shares on the date of transfer to the participant. Dividend equivalents, if any, received with respect to an RSU award or performance award will be treated as ordinary compensation income, rather than dividend income, when received by a participant.
Other Stock-Based Awards. The U.S. federal income tax consequences of other stock-based awards will depend upon the specific terms of each award. In general, a participant will recognize ordinary compensation income upon receipt of vested stock pursuant to a stock-based award. Upon a sale of the shares, the participant will
recognize short-term or long-term capital gain or loss, as the case may be, equal to the difference between the amount realized on the sale of the shares and the participant’s tax basis in the shares, which generally is equal to the value of the shares on the date received.
Tax Consequences to the Company. In the foregoing cases, we generally will be entitled to a deduction at the same time, and in the same amount, as a participant recognizes ordinary income, subject to certain limitations imposed under the Code (including Sections 280G and 162(m)).
Code Section 409A. Code Section 409A imposes election and payment timing requirements on “non-qualified deferred compensation.” If a non-qualified deferred compensation arrangement subject to Code Section 409A fails to meet, or is not operated in accordance with, the requirements of Code Section 409A, then compensation deferred under the arrangement may become immediately taxable and subject to a 20% additional tax. We intend that awards granted under the Amended 2016 Plan will comply with, or otherwise be exempt from, Code Section 409A, but make no representation or warranty to that effect.
Tax Withholding. We are authorized to deduct or withhold from any award granted or payment due under the Amended 2016 Plan, or require a participant to remit to us, the amount of any withholding taxes due in respect of the award or payment and to take such other action as may be necessary to satisfy all obligations for the payment of applicable withholding taxes. We are not required to issue any shares of common stock or otherwise settle an award under the Amended 2016 Plan until all tax withholding obligations are satisfied.
FOR
OUR BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY’S 2016 OMNIBUS INCENTIVE PLAN
TrueBlue, Inc. 2024 Proxy Statement  P. 67

TABLE OF CONTENTS

AUDIT COMMITTEE REPORT

AUDIT COMMITTEE REPORT
The Audit Committee is currently composed of Kim Harris Jones, who chairs the committee, R. Chris Kreidler, Sonita Lontoh, Paul G. Reitz, and Jeffrey B. Sakaguchi. The Audit Committee is composed solely of non-employee directors, all of whom the Board determined are independent pursuant to the New York Stock Exchange (“NYSE”) rules and the independence standards set forth in Rule 10A-3 of the Securities Exchange Act of 1934 (“Exchange Act”). The Board has affirmatively determined that each member of the Audit Committee is “financially literate” under the listing standards of the NYSE and that Ms. Harris Jones and Messrs. Kreidler, Reitz, and Sakaguchi are “audit committee financial experts” as such term is defined in Item 407 of Regulation S-K. The Board has adopted a charter for the Audit Committee, which is available at https://investor.trueblue.com/corporate-governance/
governance-documents. The charter is also available in print to any shareholder upon request.
The Audit Committee met 10 times during the 2023 fiscal year. These meetings included private, executive sessions between the Audit Committee and our independent auditors, Deloitte & Touche LLP (“Deloitte”), the Company’s chief financial officer, chief legal officer, and vice president of internal audit. During its meetings, the Audit Committee reviewed and discussed, among other things:
the status of any significant issues in connection with the quarterly reviews and annual audit of the Company’s financial statements;
the Audit Committee’s charter and any modifications thereto;
the Company’s annual external audit plans and the staffing resources available to carry out those audit plans;
the Company’s annual internal audit plans and the staffing resources available to carry out those audit plans;
the Company’s significant accounting policies and estimates;
the Company’s use of non-generally accepted accounting principles (“non-GAAP”) measures and related Company policies and disclosure controls;
the Company’s progress toward evaluating and documenting its internal controls pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 and Committee of Sponsoring Organizations (“COSO”) 2013;
the impact and implementation of new accounting standards;
the impact of recent developments in corporate governance;
current tax matters affecting the Company;
the Company’s investment guidelines;
the Company’s compliance initiatives;
the Company’s processes for responding to, and investigation of, employee complaints regarding internal controls, auditing issues, or questionable accounting matters; and
the Company’s enterprise risk management efforts.
In addition to the meetings discussed above, the Audit Committee reviewed, with management and Deloitte, the Company’s interim financial statements for each quarter of 2023 prior to the quarterly release of earnings.
The Audit Committee also reviewed and discussed with the Company’s chief executive officer, chief financial officer, chief legal officer, chief accounting officer, other senior members of the finance department, the vice president of internal audit, and Deloitte the Company’s audited financial statements as of and for the fiscal year ended December 31, 2023, prior to the release of earnings on Form 10-K. This discussion included, among other things:
critical accounting policies and practices used in the preparation of the Company’s financial statements;
significant items involving management’s estimates and judgments, including workers’ compensation reserves, tax matters, allowance for doubtful accounts, goodwill and intangible assets, business acquisition accounting, and legal and regulatory contingencies;
alternative treatments within GAAP of the Company’s annual financial information;
the effect of regulatory and accounting initiatives on the Company’s financial statements, including the adoption of significant accounting pronouncements;
any significant audit adjustments proposed by Deloitte and management’s response; and
confirmation that there were no matters of significant disagreement between management and Deloitte arising during the audit.
The Audit Committee has discussed with Deloitte the matters required to be discussed under the Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard No. 1301, Communications with Audit Committees (“AS 1301”). The Audit Committee has received and reviewed the written disclosures and the letter from Deloitte in accordance with the applicable requirements of the PCAOB regarding the independent auditor’s communications with the Audit Committee concerning independence and has discussed with Deloitte its independence.
The Audit Committee pre-approved all audit and non-audit services provided by Deloitte prior to any engagement with respect to such services. Deloitte may be engaged to provide non-audit services only after the Audit Committee has first considered the proposed engagement and has determined, in each instance, that the proposed services are not prohibited by applicable regulations and that Deloitte’s independence will not be materially impaired as a result of having provided such services. Based on the reviews and discussions referred to above, the Audit Committee believes that Deloitte has been independent, objective, and impartial in conducting the 2023 fiscal year audit.
TrueBlue, Inc. 2024 Proxy Statement  P. 68

TABLE OF CONTENTS

AUDIT COMMITTEE REPORT
In performing all of the functions described above, the Audit Committee acts in an oversight capacity. In that role, the Audit Committee relies primarily on the work and assurances of our management, which has the primary responsibility for our financial statements and reports, and of the independent auditors who, in their report, express an opinion on the conformity of our annual financial statements to accounting principles generally accepted in the United States of America.
Based on the reviews and discussions referred to above, the Audit Committee recommended to the Board, and the Board agreed, that the audited financial statements as of and for the year ended December 31, 2023, be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, for filing with the SEC.
Members of the Audit Committee
Kim Harris Jones, Chair
R. Chris Kreidler
Sonita Lontoh
Paul G. Reitz
Jeffrey B. Sakaguchi
TrueBlue, Inc. 2024 Proxy Statement  P. 69

TABLE OF CONTENTS

PROPOSAL 4.
RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As a matter of good corporate governance, the Audit Committee requests that shareholders ratify its selection of Deloitte & Touche LLP (“Deloitte”) to serve as our independent registered public accounting firm for fiscal year 2024. The Audit Committee of the board of directors (the “Board”) has appointed Deloitte as the independent registered public accounting firm to audit the Company’s consolidated financial statements for the fiscal year ending December 29, 2024. Representatives of Deloitte will be available during the 2024 Annual Meeting of Shareholders to make a statement, if they desire to do so, and respond to appropriate questions by shareholders.
Proxies will be voted “For” the ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2024 unless other instructions are indicated on your proxy card. In the event shareholders do not ratify the appointment, the Audit Committee will reconsider the appointment. The Audit Committee reserves the right to change its independent registered public accounting firm without seeking shareholder approval if it determines that such change is in the best interest of the Company.
Fees Paid to Independent Registered Public Accountant for Fiscal Years 2022 and 2023
Deloitte was the independent registered public accounting firm that audited the Company’s consolidated financial statements for the fiscal years ended December 25, 2022 and December 31, 2023. Services provided to the Company and its subsidiaries by Deloitte in fiscal years 2022 and 2023, are described in the following table:
2022
2023
Audit fees:(1)
$2,412,000
$2,411,000
Audit-related fees:(2)
15,000
Tax fees:(3)
All other fees:(4)
4,180
4,180
Total
$2,416,180
$2,430,180
(1)
Audit fees for the 2022 and 2023 fiscal years were for services rendered for the audits of the consolidated financial statements included in the Company’s Annual Reports on Form 10-K, quarterly reviews of the financial statements included in the Company’s Quarterly Reports on Form 10-Q, reviews of internal controls over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, and other assistance required to complete the year-end audit of the consolidated financial statements.
(2)
Audit-related fees are for other SEC filings, including consents, comfort letters, or shelf-registrations.
(3)
Tax fees could include consultation on tax compliance, tax advice, and tax planning. The Company paid no such fees to Deloitte in fiscal years 2022 or 2023.
(4)
All other fees for the 2022 and 2023 fiscal year were comprised of accounting research services subscription fees.
The services described in the table on the left were approved by the Audit Committee pursuant to the policy described below. The Audit Committee did not rely on any of the exceptions to pre-approval under Rule 2-01(c)(7)(i)(C) of Regulation S-X.
Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm
The Audit Committee pre-approves all audit and non-audit services provided by the independent registered public accounting firm prior to the engagement of the independent accountants with respect to such services. The Company’s independent accountants may be engaged to provide non-audit services only after the Audit Committee has first considered the proposed engagement and has determined in each instance that the proposed services are not prohibited by applicable regulations and that the accountants’ independence will not be materially impaired as a result of having provided such services. In making this determination, the Audit Committee shall take into consideration whether a reasonable investor, knowing all relevant facts and circumstances, would conclude that the accountants’ exercise of objective and impartial judgment on all issues encompassed within the accountants’ engagement would be materially impaired. The Audit Committee may delegate its approval authority to pre-approve services provided by the independent accountants to one or more of the members of the Audit Committee, provided that any such approvals are presented to the Audit Committee at its next scheduled meeting.
FOR
THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” THE RATIFICATION OF DELOITTE & TOUCHE LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 29, 2024.
TrueBlue, Inc. 2024 Proxy Statement  P. 70

TABLE OF CONTENTS

OTHER INFORMATION

CEO PAY RATIO
This section sets forth information concerning the ratio between the annual total compensation of the Company’s median employee and the annual total compensation of our Chief Executive Officer (“CEO”), Taryn R. Owen.
For the 2023 calendar year, the annual total compensation of the employee identified as our Company’s median employee was $8,862. Our CEO’s annualized total compensation in 2023 was $3,221,930. Accordingly, for 2023, the CEO pay ratio was estimated to be 364 to 1.
The CEO pay ratio identified for our Company reflects the fact that the significant majority of our employees are temporary employees who work at our clients’ job sites, generally on a short-term project basis, and are not typically employed for a full year. The wages of temporary employees cannot be annualized under the SEC rules for the calculation of this CEO pay ratio.
To identify the employee with the median annual total compensation, as well as to determine the annual total compensation of the median employee, we adopted a variety of methodologies, applied certain exclusions, and made reasonable estimates based on our payroll and employment records, in a manner consistent with SEC rules.
Our “Measurement Date” was the third Sunday of October, which was October 15, 2023. On the Measurement Date, our active U.S. and Canadian employees, excluding the CEO, consisted of 44,961 individuals. Our employee population was comprised primarily of temporary employees. For our temporary employees, the definition of who was an active employee on the Measurement Date was anyone who worked during the workweek ending on the Measurement Date. For our staff employees, anyone who was denoted as active within our human resources systems on the Measurement Date was included in our employee population.
To identify the “median employee” from our employee population, we used taxable wages for the full 2023 calendar year. We did not annualize the salary of any of our staff employees who were employed with the Company for part of the year, except for Ms. Owen’s salary as discussed above.
Our employee population, from which the median employee was identified, included our U.S. and Canadian employees, which make up the predominant number of employees in the Company. We did not include any of the employees outside the U.S. and Canada as those employees outside the U.S. and Canada were less than 5% of all employees.
The Company’s total U.S. employee count at the Measurement Date was 42,935 and the total Canada employee count was 2,027. The total number of employees outside the U.S. and Canada at the Measurement Date was 1,621. The combined total of all employees worldwide at the Measurement Date was 46,583.
The employees outside the U.S. and Canada at the Measurement Date were located in the following jurisdictions:
Country
Approximate Number of
Employees Excluded in 2023
India
1,185
United Kingdom
247
Australia
97
Poland
83
New Zealand
7
Singapore
1
Mexico
1
TrueBlue, Inc. 2024 Proxy Statement  P. 71

TABLE OF CONTENTS

OTHER INFORMATION
EQUITY COMPENSATION PLAN INFORMATION
Equity Compensation Plan Table
The following table presents information on the Company’s equity compensation plans as of December 31, 2023, all of which have been approved by shareholders:
Plan category
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights(1)
Weighted-average
exercise price of
outstanding options,
warrants and
rights(2)
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
the first column)
Equity compensation plans approved by security
holders(3)
1,614,731
$0
2,444,925
(1)
This amount reflects the total number of outstanding nonqualified and incentive stock options, restricted stock units (“RSUs”), and performance share units (“PSUs”) (vesting at the maximum amount) as of the fiscal year end.
(2)
This weighted-average exercise price excludes the price of full value awards such as restricted shares, RSUs, and PSUs.
(3)
Equity compensation plans approved by security holders include the following:
2016 TrueBlue Omnibus Incentive Plan (the “2016 Plan”). The 2016 Plan applies to directors, officers, employees, and consultants of the Company and permits the granting of nonqualified and incentive stock options, restricted shares, PSUs, RSUs, and stock appreciation rights. As of December 31, 2023, the total number of shares available for future issuance under the 2016 Plan was 1,385,762. Under this plan, there were an aggregate of 1,683,868 restricted shares, RSUs, PSUs (at the maximum amount), and deferred shares outstanding and zero stock options outstanding as of December 31, 2023. All future stock compensation awards will be awarded from this plan.
2010 TrueBlue Employee Stock Purchase Plan. This plan provides an opportunity for regular employees who have met certain service qualifications to purchase shares of Common Stock through payroll deductions of up to 10% of eligible after-tax compensation. These deductions are used to purchase shares of Common Stock at 85% of the fair market value of Common Stock as of either the first day or last day of each month, whichever is less. As of December 31, 2023, there were 1,059,163 shares available for future issuance under this plan.
TrueBlue, Inc. 2024 Proxy Statement  P. 72

TABLE OF CONTENTS

INFORMATION ABOUT THE MEETING
Background
What is the proxy statement?
This proxy statement is furnished in connection with the solicitation of proxies by the board of directors (the “Board”) of TrueBlue, Inc. (“TrueBlue,” “Company,” “we,” “us,” or “our” ) to be voted on at our 2024 Annual Meeting of Shareholders (the “Meeting”) to be held in a virtual format at 8:00 a.m., Pacific Daylight Time (“PDT”), on Wednesday, May 15, 2024, and at any adjournment thereof. This proxy statement contains the required information under the rules of the U.S. Securities and Exchange Commission (“SEC”) and is designed to assist you in voting your shares.
What is the purpose of the Meeting?
At the Meeting, shareholders as of the Record Date (defined below) will vote on the items of business outlined in the Notice of Annual Meeting of Shareholders (“Meeting Notice”). In addition, management will report on our business and respond to questions from shareholders.
When is the record date?
The Board has established March 11, 2024, as the record date for the Meeting (“Record Date”).
How do I participate in the Meeting?
You have the right to participate in the Meeting if you were a shareholder as of the Record Date. This year’s Meeting will be held in a virtual format through a live webcast on Wednesday, May 15, 2024, at 8:00 a.m., PDT. A recording of the Meeting will be available on the TrueBlue Investor Relations website after the Meeting.
You may submit questions in writing during the Meeting. To submit a question during the Meeting, you must first join the Meeting with your 16-digit control number (“Control Number”). Your Control Number can be found next to the label for postal mail recipients or within the body of the email sending you the proxy statement. We intend to answer questions pertinent to Company matters as time allows at the question and answer session following the formal portion of the Meeting. Questions that are substantially similar may be grouped and answered once to avoid repetition.
The Meeting webcast will begin promptly at 8:00 a.m. PDT. We encourage you to access the Meeting prior to the start time. Online check-in will begin at 7:30 a.m. PDT, and you should allow ample time for the check-in procedures. If you experience technical difficulties during the check-in process or during the Meeting, a technical assistance phone number will be made available on the Meeting’s registration page 15 minutes prior to the start time of the Meeting.
Why did I receive a Notice of Internet Availability of Proxy Materials or why did I receive this proxy statement and a proxy card?
You received a Notice of Internet Availability of Proxy Materials (“Proxy Notice”) or this proxy statement and a proxy card because you owned shares of TrueBlue common stock (“Common Stock”) as of the Record Date and are entitled to vote on the items of business at the Meeting. This proxy statement describes the items of business that will be voted on at the Meeting and provides information on these items so that you can make an informed decision.
Who may vote?
In order to vote at the Meeting, you must be a TrueBlue shareholder as of the Record Date. If, on the close of business on the Record Date, your shares were registered directly in your name with our transfer agent, then you are a shareholder of record. As a shareholder of record, you may vote virtually at the Meeting or by proxy.
If, on the close of business on the Record Date, your shares were held in an account at a brokerage firm, bank, or other agent (“Agent”) and not in your name, then you are the beneficial owner of shares held in “street name” and these proxy materials are being made available or being forwarded to you by your Agent. The Agent holding your account is considered to be the shareholder of record for purposes of voting at the Meeting. As a beneficial owner, you have the right to direct your Agent on how to vote the shares in your account. You are also invited to attend the Meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the Meeting unless you request and obtain a valid legal proxy issued in your name from your Agent.
How many shares of Common Stock are outstanding?
As of the Record Date, there were 31,389,141 shares of Common Stock outstanding. There are no other classes of capital stock outstanding.
Voting Procedure
How do I vote?
If you are a shareholder of record (your shares are owned in your name and not in “street name”), you may vote:
online at www.proxyvote.com;
by using your mobile device to scan the Quick Response (“QR”) Code provided in the proxy statement summary;
by telephone toll-free (within the U.S. or Canada) at 1-800-690-6903;
by requesting, signing, and returning a proxy card; or
by virtually attending the Meeting.
If you wish to vote online or by telephone, you must do so before 11:59 p.m., Eastern Daylight Time, on Tuesday, May 14, 2024. After that time, online or telephone voting will not be permitted, and a shareholder wishing to vote, or revoke an earlier proxy, must vote virtually during the Meeting. Shareholders can vote online during the Meeting. Shareholders of record that join the Meeting with their Control Number will be able to vote at the Meeting. “Street name” shareholders, also known as beneficial holders, must contact the institution that holds their shares for assistance with obtaining a Control Number that would permit them to vote at the Meeting. Shareholders voting online will need to follow the instructions at www.proxyvote.com. Voting online at the Meeting by a shareholder will revoke and replace any previous votes submitted by proxy.
In accordance with the SEC rules, we are providing all shareholders with their proxy materials online unless a shareholder has affirmatively elected to receive paper materials. You may elect to receive paper copies of proxy materials, at no cost to you, by following the instructions contained in the Proxy Notice.
TrueBlue, Inc. 2024 Proxy Statement  P. 73

TABLE OF CONTENTS

INFORMATION ABOUT THE MEETING
How are my voting instructions carried out and how does the Board recommend I vote?
When you vote via proxy, by properly executing and returning a proxy card, or by voting online or by telephone, you appoint the individuals named on the proxy card (the “Proxy”) as your representatives at the Meeting. The Proxy will vote your shares at the Meeting, or at any adjournment of the Meeting, as you have instructed them on the proxy card. We urge you to specify your choices by marking the appropriate boxes on the proxy card, or carefully following the instructions for voting online or by telephone.
The Board recommends that you vote:
(i)
FOR the election of the director nominees named in this proxy statement (Proposal 1);
(ii)
FOR the advisory approval of our executive compensation (Proposal 2);
(iii)
FOR approval of the Amended and Restated of the Company’s 2016 Omnibus Incentive Plan (Proposal 3);
(iv)
FOR the ratification of the selection of Deloitte & Touche LLP (“Deloitte”) as our independent registered public accounting firm for the fiscal year ending December 29, 2024 (Proposal 4).
With proxy voting, your shares will be voted regardless of whether you attend the Meeting. Even if you plan to attend the Meeting, it is advisable to vote your shares via Proxy in advance of the Meeting in case your plans change.
If any nominee for director is unable to serve, or for good cause will not serve, or if an item that is not described in the Meeting Notice properly comes up for vote at the Meeting, or at any postponement or adjournment of the Meeting, your Proxy will vote the shares as recommended by the Board pursuant to the discretionary authority granted in the proxy card. At the time this proxy statement was printed, we were not aware of any other matters to be voted on.
How long are directors elected for?
The Company’s directors are elected each year at the annual meeting of shareholders to serve until the next annual meeting when their successors are elected and qualified, or until they resign, are removed, or are otherwise disqualified to serve. The Company’s Board currently consists of nine directors.
How many votes do I have?
You have one vote for each share of Common Stock you own, and you can vote those shares for each director nominee and for each other item of business to be addressed at the Meeting.
How many shares must be present to hold a valid Meeting?
For us to hold a valid meeting, we must have a quorum, which means that a majority of the outstanding shares of Common Stock that are entitled to cast a vote are present in person, or by Proxy, at the Meeting. Proxy cards received but marked as abstentions and Broker Non-Votes (discussed below) will be treated as shares that are present and entitled to vote for purposes of determining a quorum. Your shares will be counted as present at the Meeting if you:
vote online or by telephone;
properly submit a proxy card by mail (even if you do not provide voting instructions); or
attend the Meeting and vote online at the Meeting.
How many votes are required to approve an item of business?
As described in more detail in the Corporate Governance section under “Majority Voting for Directors,” the Company has adopted majority voting procedures for the election of directors in uncontested elections. As this is an uncontested election, each of the nominees for directors will be elected by the vote of the majority of the votes cast. A “majority of the votes cast” means that the number of votes cast “For” a nominee’s election exceeds the number of votes cast “Against” that nominee’s election. There is no cumulative voting for the election of the Company’s directors. Abstentions and Broker Non-Votes are not considered “votes cast.” Likewise, a share otherwise present at the Meeting as to which a shareholder gives no authority or direction to vote is also not considered a “vote cast.”
The proposal to approve, by advisory vote, our executive compensation will be approved under Washington law and our Amended and Restated Bylaws (“Bylaws”) if the number of votes cast “For” the proposal exceeds the number of votes cast “Against” the proposal. Abstentions and Broker Non-Votes are not considered “votes cast.” Likewise, a share otherwise present at the Meeting as to which a shareholder gives no authority or direction to vote is also not considered a “vote cast.”
The proposal to approve the Amended and Restated Company 2016 Omnibus Incentive Plan will be approved under Washington law if the number of votes cast “For” the proposal exceeds the number of votes cast “Against” the proposal. Abstentions and Broker Non-Votes are not considered “votes cast.” Likewise, a share otherwise present at the Meeting as to which a shareholder gives no authority or direction to vote is also not considered a “vote cast.”
The proposal to ratify the appointment of Deloitte as the Company’s independent registered public accounting firm will be approved under Washington law and our Bylaws if the number of votes cast “For” the proposal exceeds the number of votes cast “Against” the proposal. Abstentions and Broker Non-Votes are not considered “votes cast.” Likewise, a share otherwise present at the Meeting as to which a shareholder gives no authority or direction to vote is also not considered a “vote cast.”
What if my shares are held by a brokerage firm?
If you are a beneficial owner whose shares are held on record by a broker, you should instruct the broker how to vote your shares. The rules of the New York Stock Exchange (“NYSE”) allow brokerage firms to vote their clients’ shares on routine matters if the clients do not provide voting instructions at least 10 days prior to an annual shareholder meeting. The ratification of the appointment of Deloitte as our independent registered public accounting firm is considered a routine matter under NYSE rules. However, all the other proposals in this proxy statement are not considered routine matters under NYSE rules. The NYSE rules do not allow brokerage firms to vote their clients’ shares on non-routine matters in the absence of affirmative voting instructions. Accordingly, it is particularly important that the beneficial owners instruct their brokers how they wish to vote their shares.
If your shares are represented at the Meeting but you do not provide voting instructions (a “Broker Non-Vote”), your shares will be
TrueBlue, Inc. 2024 Proxy Statement  P. 74

TABLE OF CONTENTS

INFORMATION ABOUT THE MEETING
counted for purposes of establishing a quorum to conduct business at the Meeting but will not be counted in determining the number of shares voted for or against the non-routine matter.
What if I change my mind after I submit my proxy?
You may revoke your proxy at any time before your shares are voted by:
submitting a later dated proxy prior to the Meeting (by mail, online, or telephone to be received before 11:59 p.m. Eastern Daylight Time, on May 14, 2024);
delivering a written request to return the executed proxy;
voting online at the Meeting; or
providing written notice of revocation to the Corporate Secretary of the Company at 1015 A Street, Tacoma, Washington 98402.
Where can I find the voting results of the Meeting?
We will announce preliminary voting results at the Meeting. We plan to publish the final voting results in a Current Report on Form 8-K (“Form 8-K”) filed with the SEC within four business days of the Meeting. If final voting results are not available within the four business day time frame, we plan to file a Form 8-K disclosing preliminary voting results within the required four business days, to be followed as soon as practicable by an amendment to the Form 8-K containing final voting results.
How can multiple shareholders sharing the same address request the receipt of only one set of proxy materials and other investor communications?
If you opt to continue to receive paper copies of our proxy materials, you may elect to receive future proxy materials, as well as other investor communications, in a single package per address. This practice, known as “householding,” is designed to reduce our paper use, printing, and postage costs. To make the election, please indicate on your proxy card under “Householding Election” your consent to receive such communications in a single package per address. Once we receive your consent, we will send a single package per household until you revoke your consent by notifying our Investor Relations Department at 1015 A Street, Tacoma, Washington 98402, by email at InvestorRelations@TrueBlue.com, or by phone at (253) 948-3258. We will start sending you individual copies of proxy materials and other investor communications within 30 days of your revocation. In addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of our 2023 Form 10-K, this proxy statement, proxy card, or the Proxy Notice to a stockholder at a shared address to which a single copy of the documents was delivered.
Can I receive the proxy materials electronically?
Yes. Shareholders who have not affirmatively opted to receive paper proxy materials through the mail will receive a Proxy Notice and may access our proxy materials online. On or about April 4, 2024, we mailed to our shareholders a Proxy Notice directing shareholders to the website where they can access our 2024 proxy statement, 2023 Annual Report, and instructions on how to vote online or by phone. If you received the Proxy Notice and would like to receive a paper copy of the proxy materials, please follow the instructions printed on the Proxy Notice to request that a paper copy be mailed to you.
We will arrange with brokerage firms, custodians, nominees, and fiduciaries to forward proxy materials to certain beneficial owners of Common Stock. We will reimburse such brokerage firms, custodians, nominees, and fiduciaries for reasonable out-of-pocket expenses that they incur as a result of forwarding the proxy materials.
Who may solicit proxies?
Proxies may be solicited by our officers, directors, and regular supervisory and executive employees, none of whom will receive any additional compensation for their services.
Who will count the votes?
Broadridge Investor Services will count the votes and will serve as the independent inspector of election.
Proposals by Shareholders
How can a shareholder submit a proposal to be voted on at the 2025 Annual Meeting of Shareholders?
If a shareholder wishes to submit a proposal for consideration at the 2025 Annual Meeting of Shareholders (“2025 Meeting”) pursuant to our Bylaws, the shareholder must submit the proposal in writing to our principal executive offices located at 1015 A Street, Tacoma, Washington 98402, Attn: Corporate Secretary, no earlier than the close of business on the 120th day and no later than the close of business on the 90th day prior to the first anniversary of the date of the Meeting (for the 2025 Meeting, proposals must be submitted between January 15, 2025, and February 14, 2025). In the event that the number of directors to be elected at a meeting is increased and we do not make a public announcement naming all of the nominees for director or specifying the size of the increased Board at least 100 days prior to the first anniversary of the preceding year’s annual meeting, a proposal will be considered timely, only with respect to nominees for any new positions created by such increase, if delivered to the Corporate Secretary no later than the tenth day following the day on which the public announcement of the increase is first made. Any such proposal must comply with the requirements set forth in our Bylaws. Copies of the Bylaws are available to shareholders upon request to the Company’s Corporate Secretary.
If a shareholder wishes to have a proposal considered for inclusion in our 2025 proxy statement pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, the proposal must comply with Rule 14a-8 and be received by the Company at InvestorRelations@TrueBlue.com or our principal executive offices located at 1015 A Street, Tacoma, Washington 98402, Attn: Corporate Secretary, by no later than 120 calendar days before the first anniversary of the date on which the Company is releasing this proxy statement to shareholders in connection with the Meeting (for the 2025 Meeting, proposals must be submitted by December 5, 2024).
A proposal for action to be presented by any shareholder at an annual meeting will be out of order and will not be acted upon unless it has been submitted in compliance with the requirements set forth in our Bylaws and is, under law, an appropriate subject for shareholder action.
TrueBlue, Inc. 2024 Proxy Statement  P. 75

TABLE OF CONTENTS

INFORMATION ABOUT THE MEETING
Nominations by Shareholders
In accordance with our Bylaws, shareholders wishing to nominate a candidate must deliver the name and address of the shareholder as they appear on the Company’s books (or if the shareholder holds shares for the benefit of another person, the name and address of such beneficial owner) in a letter addressed to the Chair of the Governance Committee in care of the Company’s Corporate Secretary and mailed to the Company’s principal executive offices located at 1015 A Street, Tacoma, WA 98402, not earlier than the close of business on the 120th day and not later than the close of business on the 90th day prior to the first anniversary of the Meeting (nominations for the 2025 Meeting must be submitted between January 15, 2025, and February 14, 2025). The notice must include the information with respect to the shareholder and the nominee specified by our Bylaws. In addition to satisfying the foregoing requirements under our Bylaws with respect to advance notice of any. nomination, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must comply with all the requirements of Rule 14a-19.
Additional Company Information
Where can I find more of TrueBlue’s corporate governance documents?
The following corporate governance materials are available and can be viewed and downloaded from the Governance Documents subsection of the Governance section of the Company’s Investor Relations website at https://investor.trueblue.com/corporate-governance/governance-documents.
The Company’s Amended and Restated Articles of Incorporation
The Company’s Amended and Restated Bylaws
The Company’s Corporate Governance Guidelines
The Audit Committee Charter
The Compensation Committee Charter
The Corporate Governance and Nominating Committee Charter
The Innovation and Technology Committee Charter
Additional relevant materials including the Company’s Anti-Bribery and Corruption Policy, Insider Trading Policy, and Code of Conduct and Business Ethics can be viewed and downloaded on our website at https://www.trueblue.com/corporate-reports.
Where can I find additional information about TrueBlue?
Our reports on Forms 10-K, 10-Q, 8-K, and other publicly available information should be consulted for other important information about TrueBlue. You can also find additional information about us on our website at www.TrueBlue.com. The mailing address of the principal executive offices of the Company is 1015 A Street, Tacoma, Washington 98402. The telephone number for the Company is (253) 383-9101.
TrueBlue, Inc. 2024 Proxy Statement  P. 76

TABLE OF CONTENTS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the beneficial ownership of Common Stock as of March 11, 2024, for (i) each person known to the Company to own beneficially five percent or more of Common Stock; (ii) each director of the Company; (iii) each individual identified as a Named Executive Officer (“NEO”) of the Company pursuant to Item 402 of Regulation S-K; and (iv) all executive officers and directors of the Company as a group. Except as otherwise noted, the named beneficial owner has sole voting and investment power. As of March 11, 2024, the Company had no other classes of outstanding equity securities.
Name & Address of Beneficial Owner**
Title of Class
Amount and Nature of
Beneficial Ownership
(Number of Shares)(1)
Percent of
Class
Taryn R. Owen
Common Stock
247,212
*
Carl R. Schweihs
Common Stock
100,691
*
Garrett R. Ferencz
Common Stock
90,901
*
Richard P. Betori
Common Stock
70,893
*
Kristy A. Willis
Common Stock
60,441
*
Steven C. Cooper
Common Stock
318,467
1%
Derrek L. Gafford
Common Stock
123,781
*
Colleen B. Brown
Common Stock
41,904
*
William C. Goings(2)
Common Stock
36,965
*
Kim Harris Jones(3)
Common Stock
52,025
*
R. Chris Kreidler(4)
Common Stock
40,657
*
Sonita Lontoh
Common Stock
30,195
*
Paul G. Reitz
Common Stock
13,588
*
Jeffrey B. Sakaguchi
Common Stock
66,469
*
Kristi A. Savacool(5)
Common Stock
43,859
*
All executive officers and directors as a group (15 individuals)
Common Stock
1,338,048
4%
BlackRock, Inc.(6)
Common Stock
5,270,012
17%
Pzena Investment Management, LLC(7)
Common Stock
3,092,337
10%
The Vanguard Group, Inc.(8)
Common Stock
2,589,679
8%
Dimensional Fund Advisors LP(9)
Common Stock
2,048,852
7%
Hotchkis and Wiley Capital Management, LLC(10)
Common Stock
810,650
3%
(1)
Beneficial ownership is calculated in accordance with Rule 13d-3(d)(1) of the Securities Exchange Act of 1934 (“Exchange Act”), and includes: (i) shares held outright, shares held under the Company’s employee stock purchase plan, restricted shares; and (ii) shares issuable upon exercise of options, warrants, and other securities convertible into or exchangeable for shares, which were exercisable on or within 60 days after March 11, 2024. These amounts also include RSUs and deferred shares which were not scheduled to vest within 60 days after March 11, 2024.
(2)
Includes 36,965 deferred shares.
(3)
Includes 5,341 shares held outright and 46,684 deferred shares.
(4)
Includes 13,717 shares held outright and 26,940 deferred shares.
(5)
Includes 6,596 shares held outright and 37,263 deferred shares.
(6)
Information provided is based solely on a Schedule 13G/A filed on January 22, 2024, on behalf of BlackRock, Inc. BlackRock, Inc. has sole voting power with respect to 5,202,112 shares and sole dispositive power with respect to 5,270,012 shares. The business address of BlackRock, Inc. is 50 Hudson Yards, New York, New York 10001.
(7)
Information provided is based solely on a Schedule 13G filed on February 7, 2024, on behalf of Pzena Investment Management, LLC. Pzena Investment Management, LLC has sole voting power with respect to 2,517,017 shares and sole dispositive power with respect to 3,092,337 shares. The business address of Pzena Investment Management, LLC. is 320 Park Avenue, 8th Floor, New York, NY 10022.
(8)
Information provided is based solely on a Schedule 13G/A filed on February 13, 2024, on behalf of The Vanguard Group, Inc. The Vanguard Group, Inc. has sole voting power with respect to zero (0) shares, shared voting power with respect to 23,593 shares, sole dispositive power with respect to 2,535,839 shares, and shared dispositive power with respect to 53,840 shares. The business address of The Vanguard Group, Inc. is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.
(9)
Information provided is based solely on a Schedule 13G/A filed on February 9, 2024, on behalf of Dimensional Fund Advisors LP. Dimensional Fund Advisors LP has sole voting power with respect to 2,006,947 shares and sole dispositive power with respect to 2,048,852 shares. The business address of Dimensional Fund Advisors LP is 6300 Bee Cave Road, Building One, Austin, Texas 78746. Dimensional Fund Advisors LP, an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, furnishes investment advice to four investment companies registered under the Investment Company Act of 1940, and serves as investment manager or sub-adviser to certain other commingled funds, group trusts, and separate accounts (such investment companies, trusts, and accounts, collectively referred to as the “Funds”). In certain cases, subsidiaries of Dimensional Fund Advisors LP may act as an adviser or sub-adviser to certain Funds. In its role as investment advisor, sub-adviser, and/or manager, Dimensional Fund Advisors LP or its subsidiaries (collectively, “Dimensional”) may possess voting and/or investment power over the securities of the Company that are owned by the Funds and may be deemed to be the beneficial owner of the shares of the Company held by the Funds. However, all securities reported in this line are owned by the Funds. Dimensional disclaims beneficial ownership of such securities.
(10)
Information provided is based solely on a Schedule 13G/A filed on February 13, 2024, on behalf of Hotchkis and Wiley Capital Management, LLC. Hotchkis and Wiley Capital Management, LLC has sole voting power with respect to 707,350 shares and sole dispositive power with respect to 810,650 shares. The business address of Hotchkis and Wiley Capital Management, LLC is 601 S. Figueroa Street 39th Fl, Los Angeles, CA 90017.
*
Less than 1%.
**
The address of the NEOs and directors is c/o TrueBlue, Inc., 1015 A Street, Tacoma, Washington.
TrueBlue, Inc. 2024 Proxy Statement  P. 77

TABLE OF CONTENTS

OTHER BUSINESS
We do not intend to bring any other business before the 2024 Annual Meeting of Shareholders (the “Meeting”), and, so far as we know, no matters are to be brought before the Meeting except as specified in the Notice of Annual Meeting of Shareholders. However, as to any other business which may properly come before the Meeting, it is intended that proxies, in the form enclosed, will be voted in respect thereof, in accordance with the discretion of the proxies.
TrueBlue, Inc. 2024 Proxy Statement  P. 78

TABLE OF CONTENTS

FORM 10-K REPORT AVAILABLE
A copy of the Company’s 2023 Annual Report on Form 10-K, as filed with the SEC, will be furnished without charge to shareholders upon request to the chief financial officer at TrueBlue, Inc., 1015 A Street, Tacoma, Washington 98402 or by telephone at (253) 383-9101.
TRUEBLUE, INC.
By Order of the Board of Directors,
Todd N. Gilman
Corporate Secretary
/s/ Todd N. Gilman
Tacoma, Washington
April 4, 2024
TrueBlue, Inc. 2024 Proxy Statement  P. 79

TABLE OF CONTENTS

APPENDIX A
TRUEBLUE, INC.
NON-GAAP FINANCIAL MEASURES AND NON-GAAP RECONCILIATIONS
In addition to financial measures presented in accordance with U.S. GAAP, we monitor certain non-GAAP key financial measures. The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with U.S. GAAP, and may not be comparable to similarly titled measures of other companies.
Non-GAAP measure
Definition
Purpose of adjusted measures
Adjusted net income and Adjusted net income per diluted share
Net income (loss) and net income (loss) per diluted share, excluding:
 – amortization of intangibles,
 – amortization of software as a service assets,
 – goodwill and intangible asset impairment  charge,
 – accelerated depreciation,
 – PeopleReady technology upgrade costs,
 – executive leadership transition,
 – COVID-19 government subsidies,
 – other adjustments, net, and
 – tax effect of each adjustment to U.S. GAAP.
 – Enhances comparability on a consistent basis  and provides investors with useful insight into  the underlying trends of the business.

 – Used by management to assess performance and effectiveness of our business strategies.

 – Provides a measure, among others, used in  the determination of incentive compensation  for management.
EBITDA and
Adjusted EBITDA
EBITDA excludes from net income (loss):
 – income tax expense (benefit),
 – interest and other (income) expense, net, and
 – depreciation and amortization.

 Adjusted EBITDA further excludes:
 – third-party processing fees for hiring tax  credits,
 – amortization of software as a service assets,
 – goodwill and intangible asset impairment  charge,
 – PeopleReady technology upgrade costs,
 – executive leadership transition,
 – gain on deferred compensation assets,
 – COVID-19 government subsidies, net, and
 – other adjustments, net.
 – Enhances comparability on a consistent basis  and provides investors with useful insight into  the underlying trends of the business.

 – Used by management to assess performance  and effectiveness of our business strategies.

 – Provides a measure, among others, used in  the determination of incentive compensation  for management.
TrueBlue, Inc. 2024 Proxy Statement  P. 80

TABLE OF CONTENTS

APPENDIX A
1.
RECONCILIATION OF U.S. GAAP NET INCOME (LOSS) TO ADJUSTED NET INCOME AND ADJUSTED NET INCOME PER DILUTED SHARE
(Unaudited)
(in thousands, except for per share data)
53 weeks ended
Dec 31, 2023(1)
52 weeks ended
Dec 25, 2022
52 weeks ended
Dec 26, 2021
Net income (loss)
$(14,173)
$62,273
$61,634
Amortization of intangible assets
5,175
5,746
6,704
Amortization of software as a service assets(2)
2,985
2,709
Goodwill and Intangible asset impairment charge
9,485
Accelerated depreciation(3)
1,658
PeopleReady technology upgrade costs(4)
1,342
7,935
1,300
Executive leadership transition costs(5)
5,788
(1,422)
232
COVID-19 government subsidies, net
(4,222)
Other adjustments, net(6)
6,028
5,449
4,172
Tax effect of adjustments to net income (loss)(7)
(4,920)
(5,811)
(2,832)
Adjusted net income
$8,725
$78,813
$69,697
Adjusted net income per diluted share
$0.28
$2.36
$1.97
Diluted weighted average shares outstanding
31,590
33,447
35,434
2.
RECONCILIATION OF U.S. GAAP NET INCOME (LOSS) TO EBITDA AND ADJUSTED EBITDA (Unaudited)
(in thousands)
53 weeks ended
Dec 31, 2023(1)
52 weeks ended
Dec 25, 2022
52 weeks ended
Dec 26, 2021
Net income (loss)
$(14,173)
$62,273
$61,634
Income tax expense (benefit)
(6,472)
11,143
12,216
Interest and other (income) expense, net
(3,205)
(1,231)
(5,408)
Depreciation and amortization
25,821
29,273
27,556
EBITDA
1,971
101,458
95,998
Third-party processing fees for hiring tax credits(8)
253
594
734
Amortization of software as a service assets(2)
4,117
2,985
2,709
Goodwill and intangible asset impairment charge
9,485
PeopleReady technology upgrade costs(4)
1,342
7,935
1,300
Executive leadership transition costs(5)
5,788
(1,422)
232
Gain on deferred compensation assets(9)
2,897
COVID-19 government subsidies, net
(4,222)
Other adjustments, net(6)
6,028
5,449
4,172
Adjusted EBITDA
$28,984
$116,999
$103,820
1.
Our fiscal period ends on the Sunday closest to the last day of December. In fiscal years consisting of 53 weeks, the final quarter consists of 14 weeks, while in fiscal years consisting of 52 weeks, all quarters consist of 13 weeks.
2.
Amortization of software as a service assets is reported in selling, general and administrative expense. Note, amortization of software as a service assets was included as an adjustment to net income during transitory periods ending with fiscal 2022 and is only considered an adjustment to EBITDA going forward to be consistent with the treatment of depreciation and amortization.
3.
Accelerated depreciation for the existing systems being replaced by the upgraded PeopleReady technology platform.
4.
Costs associated with upgrading legacy PeopleReady technology.
5.
Costs associated with our CEO and CFO transitions, including accelerated vesting of stock awards and other separation related payments.
6.
Other adjustments for 53 weeks ended December 31, 2023 primarily include workforce reduction costs of $5.1 million and adjustments to COVID-19 government subsidies of $0.5 million. Other adjustments for 52 weeks ended December 25, 2022 primarily include $4.2 million in accelerated software costs, as well as costs of $1.1 million incurred to transition to a new third-party claims administrator for workers’ compensation. Other adjustments for the 52 weeks ended December 26, 2021 primarily include workforce reduction costs of $2.0 million, costs incurred while transitioning into our new Chicago office of $1.8 million, as well as other technology implementation costs.
TrueBlue, Inc. 2024 Proxy Statement  P. 81

TABLE OF CONTENTS

APPENDIX A
7.
Total tax effect of the adjustments to U.S. GAAP net income (loss). The tax effect includes the application of our statutory rate of 26% to all taxable/deductible adjustments. Note, prior periods were reported using the effective rate for the respective period and have been recast to conform to the current presentation for comparability. Please refer to the reconciliations on the financial results page under the investor relations section of our website for additional information on comparable historical periods.
8.
These third-party processing fees are associated with generating hiring tax credits.
9.
Gain realized on sale of deferred compensation mutual funds to purchase corporate owned life insurance policies.
TrueBlue, Inc. 2024 Proxy Statement  P. 82

TABLE OF CONTENTS

APPENDIX B
TRUEBLUE, INC.

2016 OMNIBUS INCENTIVE PLAN
As Amended and Restated Effective    , 2024
TrueBlue, Inc., a Washington corporation, sets forth herein the terms of its 2016 Omnibus Incentive Plan, as amended and restated effective    , 2024, as follows:
1. PURPOSE
The Plan is intended to enhance the Company’s and its Affiliates’ ability to attract and retain highly compensated Employees, Consultants, and Non-Employee Directors, and to motivate such Employees, Consultants, and Non-Employee Directors to serve the Company and its Affiliates and to expend maximum effort to improve the business results and earnings of the Company, by providing to such persons an opportunity to acquire or increase a direct proprietary interest in the operations and future success of the Company. To this end, the Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, and cash awards. Any of these awards may, but need not, be made as performance incentives to reward attainment of performance goals in accordance with the terms hereof. Stock options granted under the Plan may be non-qualified stock options or incentive stock options, as provided herein. Upon originally becoming effective, the Plan replaced, and no further awards shall be made under, the Predecessor Plan.
2. DEFINITIONS
For purposes of interpreting the Plan and related documents (including Award Agreements), the following definitions shall apply:
2.1. “Affiliate” means any company or other trade or business that “controls,” is “controlled by” or is “under common control” with the Company within the meaning of Rule 405 of Regulation C under the Securities Act, including, without limitation, any Subsidiary.
2.2. “Annual Incentive Award” means a cash-based Performance Award with a performance period that is the Company’s fiscal year or other 12-month (or shorter) performance period as specified under the terms of the Award as approved by the Committee.
2.3. “Award” means a grant of an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, Other Stock-based Award, or cash award under the Plan.
2.4. “Award Agreement” means a written agreement between the Company and a Grantee or notice from the Company or an Affiliate to a Grantee that evidences and sets out the terms and conditions of an Award.
2.5. “Board” means the Board of Directors of the Company.
2.6. “Cause” means that, unless otherwise defined in an Employee’s Change in Control Agreement, prior to any termination:
(i)
The Employee is convicted of or takes a plea of nolo contendere to a crime involving dishonesty, fraud or moral turpitude;
(ii)
The Employee has engaged in fraud, embezzlement, theft or other dishonest acts;
(iii)
The Employee materially violates a significant Company policy, such as policies required by the Sarbanes-Oxley Act of 2002, the Company’s Drug Free Workplace Policy or Company’s policy against harassment, and does not cure such violation (if curable) within ten (10) days after written notice from the Company; or
(iv)
The Employee intentionally takes any action that materially damages the assets (including tangible and intangible assets, such as name or reputation) of the Company.
For purposes of Section 2.2.6.(iv), no act or failure to act on the part of the Employee will be deemed “intentional” if it was due primarily to an error in judgment or ordinary negligence but will be deemed “intentional” only if done or omitted to be done by the Employee not in good faith and without reasonable belief that the Employee’s action or omission was in the best interest of the Company.
2.7. “Change in Control” means that any of the following events occurs:
(i)
any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) is or becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 33 1/3% of the combined voting power of the then-outstanding securities entitled to vote in the election of directors for the Company;
(ii)
a majority of the Board ceases to be comprised of Incumbent Directors, defined below; or
(iii)
the consummation of a reorganization, merger, consolidation, plan of liquidation or dissolution, recapitalization or sale or other disposition of all or substantially all of the assets of the Company or the acquisition of the stock or assets of another corporation, or other transaction (each, a “Business Transaction”), and as a result of which less than fifty percent (50%) of the outstanding voting interests or securities of the surviving or resulting entity immediately after the Business Transaction are owned in the aggregate by the former shareholders of the Company, as the same shall have existed immediately prior to such Business Transaction, in substantially the same proportions as their ownership before such Business Transaction.
2.8. “Code” means the Internal Revenue Code of 1986, as now in effect or as hereafter amended. References to the Code shall include the valid and binding governmental regulations, court decisions, and other regulatory and judicial authority issued or rendered thereunder.
TrueBlue, Inc. 2024 Proxy Statement  P. 83

TABLE OF CONTENTS

APPENDIX B
2.9. “Committee” means the Compensation Committee of the Board or any committee or other person or persons designated by the Board to administer the Plan. The Board will cause the Committee to satisfy the applicable requirements of any stock exchange on which the Common Stock may then be listed. For purposes of Awards to Grantees who are subject to Section 16 of the Exchange Act, Committee means all of the members of the Committee who are “non-employee directors” within the meaning of Rule 16b-3 adopted under the Exchange Act. All references in the Plan to the Board shall mean such Committee or the Board.
2.10. “Company” means TrueBlue, Inc., a Washington corporation, or any successor corporation.
2.11. “Common Stock” or “Stock” means a share of common stock of the Company, no par value per share.
2.12. “Consultant” means any person, except an Employee or Non-Employee Director, engaged by the Company or any Subsidiary, to render personal services to such entity, including as an advisor, pursuant to the terms of a written agreement.
2.13. “Disability” means disability that would qualify as such under the Company’s long-term disability plan.
2.14. “Effective Date” means May 11, 2016, the date the Plan was approved by the Company’s stockholders. “Restatement Effective Date” means    , 2024, the date this amendment and restatement of the Plan was approved by the Company’s stockholders.
2.15. “Employee” means any person, including an officer, who is a common law employee of, receives remuneration for personal services to, is reflected on the official human resources database as an employee of, and is on the payroll of the Company or any Subsidiary. A person is on the payroll if he or she is paid from or at the direction of the payroll department of the Company or any Subsidiary. Persons providing services to the Company, or to any Subsidiary, pursuant to an agreement with a staff leasing organization, temporary workers engaged through or employed by temporary or leasing agencies and workers who hold themselves out to the Company, or a Subsidiary to which they are providing services as being independent contractors, or as being employed by or engaged through another company while providing the services, and persons covered by a collective bargaining agreement (unless the collective bargaining agreement applicable to the person specifically provides for participation in this Plan) are not Employees for purposes of this Plan and do not and cannot participate in this Plan, whether or not such persons are, or may be reclassified by the courts, the Internal Revenue Service, the U. S. Department of Labor, or other person or entity, as common law employees of the Company, or any Subsidiary, either solely or jointly with another person or entity.
2.16. “Exchange Act” means the Securities Exchange Act of 1934, as now in effect or as hereafter amended.
2.17. “Fair Market Value” of a share of Common Stock as of a particular date shall mean (i) if the Common Stock is listed on a national securities exchange, the closing or last price of the Common Stock on the composite tape or other comparable reporting system for the applicable date, or if the applicable date is not a trading day, the trading day immediately preceding the applicable date, or (ii) if the shares of Common Stock are not then listed on a national securities exchange, the closing or last price of the Common Stock quoted by an established quotation service for over-the-counter securities, or (iii) if the shares of Common Stock are not then listed on a national securities exchange or quoted by an established quotation service for over-the-counter securities, or the value of such shares is not otherwise determinable, such value as determined by the Board in good faith in its sole discretion.
2.18. “Family Member” means a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother, sister, brother-in-law, or sister-in-law, including adoptive relationships, of the applicable individual, any person sharing the applicable individual’s household (other than a tenant or employee), a trust in which any one or more of these persons have more than fifty percent of the beneficial interest, a foundation in which any one or more of these persons (or the applicable individual) control the management of assets, and any other entity in which one or more of these persons (or the applicable individual) own more than fifty percent of the voting interests.
2.19. “Good Reason” means, unless otherwise defined in an Employee’s Change in Control Agreement, the occurrence of one or more of the following events:
(i)
Failure of the Company to remedy any of the following within 10 calendar days after receipt by the Company of written notice thereof from the Employee: (A) a significant adverse change in the nature or scope of the authorities, powers or functions attached to the position with the Company which the Employee held immediately prior to the Change in Control, (B) a reduction in the Employee’s base pay, (C) a reduction in the Employee’s incentive or bonus pay opportunity, assuming 100% achievement of the quantitatively measurable conditions to receipt of such incentive or bonus pay, and all such qualitative conditions, in each case as applicable to the Employee immediately prior to the Change in Control, or (D) the termination or denial of the Employee’s rights to Employee Benefits or a reduction in the scope or value thereof, unless such termination or reduction referred to in clauses (B), (C) or (D) applies on a substantially similar basis to all executive officers of the Company and its parent entities; or
(ii)
If the Employee’s principal residence at the time in question is within 35 miles of the Company’s headquarters, the Company requires the Employee to have Employee’s principal location of work changed to any location that is in excess of 50 miles from such residence without Employee’s prior written consent.
A termination of employment by the Employee for one of the reasons set forth in clauses (i) - (ii) above will not constitute “Good Reason” unless, within the 60-day period immediately following the occurrence of such Good Reason event, the Employee has given written notice to the Company specifying in reasonable detail the event or events relied upon for such termination and the Company has not remedied such event or events within 10 days of the receipt of such notice. The Company and the Employee may mutually waive in writing any of the foregoing provisions with respect to an event or events that otherwise would constitute Good Reason
2.20. “Grant Date” means, as determined by the Board, the latest to occur of (i) the date as of which the Board approves an Award, (ii) the date on which the recipient of an Award first becomes eligible to receive an Award under Section 6 hereof, or (iii) such other date as may be specified by the Board in the Award Agreement.
2.21. “Grantee” means a person who receives or holds an Award under the Plan.
2.22. “Incentive Stock Option” means an “incentive stock option” within the meaning of Section 422 of the Code, or the corresponding provision of any subsequently enacted tax statute, as amended from time to time.
2.23. “Incumbent Directors” means the individuals who, as of the date hereof, are Directors of the Company and any individual becoming a Director subsequent to the date hereof whose election, nomination for election by the Company’s shareholders, or appointment, was approved by a vote of at least two-thirds of the then Incumbent Directors (either by a specific vote or by approval of the proxy statement of the Company in
TrueBlue, Inc. 2024 Proxy Statement  P. 84

TABLE OF CONTENTS

APPENDIX B
which such person is named as a nominee for director, without objection to such nomination); provided, however, that an individual shall not be an Incumbent Director if such individual’s election or appointment to the Board occurs as a result of an actual or threatened election contest (as described in Rule 14a-12(c) of the Exchange Act) with respect to the election or removal of Directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board.
2.24. “Non-Employee Director” means a member of the Board who is not an Employee.
2.25. “Non-qualified Stock Option” means an Option that is not an Incentive Stock Option.
2.26. “Option” means an option to purchase one or more shares of Stock pursuant to the Plan.
2.27. “Option Price” means the exercise price for each share of Stock subject to an Option.
2.28. “Other Stock-based Award” means an award of non-restricted Stock to a Non-Employee Director as part of the annual retainer under the Non-Employee Director compensation program.
2.29. “Performance Award” means an Award made subject to the attainment of performance goals (as described in Section 12) over a performance period established by the Committee and includes an Annual Incentive Award.
2.30. “Plan” means this TrueBlue, Inc. 2016 Omnibus Incentive Plan, as amended from time to time.
2.31. “Predecessor Plan” means the TrueBlue, Inc. 2005 Long-Term Equity Incentive Plan.
2.32. “Purchase Price” means the purchase price for each share of Stock pursuant to a grant of Restricted Stock.
2.33. “Restricted Period” shall have the meaning set forth in Section 10.1.
2.34. “Restricted Stock” means shares of Stock, awarded to a Grantee pursuant to Section 10 hereof.
2.35. “Restricted Stock Unit” means a bookkeeping entry representing the equivalent of shares of Stock, awarded to a Grantee pursuant to Section 10 hereof. The Award of a Restricted Stock Unit represents the mere promise of the Company to deliver a share of Stock or the appropriate amount of cash, as applicable, upon satisfaction of all applicable vesting conditions (or such later date as provided by the Award Agreement) in accordance with and subject to the terms and conditions of the applicable Award Agreement and is not intended to constitute a transfer of “property” within the meaning of Section 83 of the Code.
2.36. “SAR Exercise Price” means the per share exercise price of a SAR granted to a Grantee under Section 9 hereof.
2.37. “SEC” means the United States Securities and Exchange Commission.
2.38. “Section 409A” means Section 409A of the Code.
2.39. “Securities Act” means the Securities Act of 1933, as now in effect or as hereafter amended.
2.40. “Separation from Service” means a termination of Service by a Service Provider, as determined by the Board, which determination shall be final, binding, and conclusive; provided if any Award governed by Section 409A is to be distributed on a Separation from Service, then the definition of Separation from Service for such purposes shall comply with the definition provided in Section 409A.
2.41. “Service” means service as a Service Provider to the Company or an Affiliate. Unless otherwise stated in the applicable Award Agreement, a Grantee’s change in position or duties shall not result in interrupted or terminated Service, so long as such Grantee continues to be a Service Provider to the Company or an Affiliate.
2.42. “Service Provider” means an Employee, Non-Employee Director, or Consultant.
2.43. “Stock Appreciation Right” or “SAR” means a right granted to a Grantee under Section 9 hereof.
2.44. “Subsidiary” means any “subsidiary corporation” of the Company within the meaning of Section 424(f) of the Code.
2.45. “Substitute Award” means any Award granted in assumption of or in substitution for an award of a company or business acquired by the Company or a Subsidiary or with which the Company or an Affiliate combines.
2.46. “Ten Percent Stockholder” means an individual who owns more than ten percent (10%) of the total combined voting power of all classes of outstanding stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Section 424(d) of the Code shall be applied.
2.47. “Termination Date” means the date that is ten (10) years after the Restatement Effective Date, unless the Plan is earlier terminated by the Board under Section 5.2 hereof.
TrueBlue, Inc. 2024 Proxy Statement  P. 85

TABLE OF CONTENTS

APPENDIX B
3. ADMINISTRATION OF THE PLAN
3.1. General.
The Board shall have such powers and authorities related to the administration of the Plan as are consistent with the Company’s articles of incorporation and bylaws and applicable law. The Board shall have the power and authority to delegate its powers and responsibilities hereunder to the Committee, which shall have full authority to act in accordance with its charter, and with respect to the authority of the Board to act hereunder, all references to the Board shall be deemed to include a reference to the Committee, to the extent such power or responsibilities have been delegated. Except as specifically provided in Section 13 or as otherwise may be required by applicable law, regulatory requirement or the certificate of incorporation or the bylaws of the Company, the Board shall have full power and authority to take all actions and to make all determinations required or provided for under the Plan, any Award or any Award Agreement, and shall have full power and authority to take all such other actions and make all such other determinations not inconsistent with the specific terms and provisions of the Plan that the Board deems to be necessary or appropriate to the administration of the Plan. The Committee shall administer the Plan; provided that, the Board shall retain the right to exercise the authority of the Committee to the extent consistent with applicable law and the applicable requirements of any securities exchange on which the Common Stock may then be listed. The interpretation and construction by the Board of any provision of the Plan, any Award or any Award Agreement shall be final, binding, and conclusive. Without limitation, the Board shall have full and final authority, subject to the other terms and conditions of the Plan, to:
1.
designate Grantees;
2.
determine the type or types of Awards to be made to a Grantee;
3.
determine the number of shares of Stock to be subject to an Award;
4.
establish the terms and conditions of each Award (including, but not limited to, the Option Price of any Option, the nature and duration of any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer, or forfeiture of an Award or the shares of Stock subject thereto, and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options);
5.
prescribe the form of each Award Agreement; and
6.
amend, modify, or supplement the terms of any outstanding Award including the authority, in order to effectuate the purposes of the Plan, to modify Awards to foreign nationals or individuals who are employed outside the United States to recognize differences in local law, tax policy, or custom.
To the extent permitted by applicable law, the Board may delegate its authority as identified herein to any individual or committee of individuals (who need not be directors), including without limitation the authority to make Awards to Grantees who are not subject to Section 16 of the Exchange Act or who are not Covered Employees. To the extent that the Board delegates its authority to make Awards as provided by this Section 3.1, all references in the Plan to the Board’s authority to make Awards and determinations with respect thereto shall be deemed to include the Board’s delegate. Any such delegate shall serve at the pleasure of, and may be removed at any time by, the Board.
3.2. No Repricing.
Notwithstanding any provision herein to the contrary, the repricing of Options or SARs is prohibited without prior approval of the Company’s stockholders. For this purpose, a “repricing” means any of the following (or any other action that has the same effect as any of the following): (i) changing the terms of an Option or SAR to lower its Option Price or SAR Exercise Price; (ii) any other action that is treated as a “repricing” under generally accepted accounting principles; and (iii) repurchasing for cash or canceling an Option or SAR at a time when its Option Price or SAR Exercise Price is greater than the Fair Market Value of the underlying shares in exchange for another Award, unless the cancellation and exchange occurs in connection with a change in capitalization or similar change under Section 14. A cancellation and exchange under clause (iii) would be considered a “repricing” regardless of whether it is treated as a “repricing” under generally accepted accounting principles and regardless of whether it is voluntary on the part of the Grantee.
3.3. Award Agreements; Clawbacks.
The grant of any Award may be contingent upon the Grantee executing the appropriate Award Agreement. The Company may retain the right in an Award Agreement to cause a forfeiture of the gain realized by a Grantee on account of actions taken by the Grantee in violation or breach of or in conflict with any employment agreement, non-competition agreement, any agreement prohibiting solicitation of employees or clients of the Company or any Affiliate thereof, or any confidentiality obligation with respect to the Company or any Affiliate thereof, or otherwise in competition with the Company or any Affiliate thereof. Furthermore, the Company may annul an Award if the Grantee is terminated for “Cause.”
Awards shall be subject to the requirements of (i) Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act (regarding recovery of erroneously awarded compensation) and any implementing rules and regulations thereunder; (ii) similar rules under the laws of any other jurisdiction; (iii) any compensation recovery policies adopted by the Company to implement any such requirements; or (iv) any other compensation recovery policies as may be adopted from time to time by the Company, all to the extent determined by the Committee in its discretion to be applicable to a Grantee.
3.4. Deferral Arrangement.
The Board may permit or require the deferral of any Award payment into a deferred compensation arrangement, subject to such rules and procedures as it may establish and in accordance with Section 409A, which may include provisions for the payment or crediting of interest or dividend equivalents, including converting such credits into deferred Stock units.
3.5. No Liability.
No member of the Board or of the Committee shall be liable for any action or determination made in good faith with respect to the Plan, any Award, or Award Agreement.
3.6. Minimum Vesting Requirements.
Notwithstanding any other provision of the Plan to the contrary, except as provided in Sections 14.2 and 16.13 of this Plan or in the event of a Grantee’s qualified retirement under the Company’s Retirement Policy as approved by the Committee, equity-based Awards granted under the Plan shall vest no earlier than the first anniversary of the date the Award is granted (excluding, for this purpose, any (i) Substitute Awards,
TrueBlue, Inc. 2024 Proxy Statement  P. 86

TABLE OF CONTENTS

APPENDIX B
(ii) shares delivered in lieu of fully vested cash Awards, (iii) Other Stock-based Awards to Non-Employee Directors (including any such Awards that are deferred under the Company’s deferred compensation plan for Non-Employee Directors); and (iv) other Awards to Non-employee Directors that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders); provided, that, the Board may grant equity-based Awards without regard to the foregoing minimum vesting requirement with respect to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 4.1 (subject to adjustment under Section 14).
3.7. Book Entry.
Notwithstanding any other provision of this Plan to the contrary, the Company may elect to satisfy any requirement under this Plan for the delivery of stock certificates through the use of book-entry.
4. STOCK SUBJECT TO THE PLAN
4.1. Authorized Number of Shares
Subject to adjustment under Section 14, the total number of shares of Common Stock authorized to be awarded under the Plan shall not exceed the sum of (A) 1,542,944, the number of shares of Common Stock available for the grant of awards as of the Effective Date under the Predecessor Plan; (B) effective upon approval of the Company’s stockholders at the 2018 annual meeting of stockholders 1,800,000 shares; (C) effective upon approval of the Company’s stockholders at the 2023 annual meeting of stockholders 695,000 shares; and (D) effective upon approval of the Company’s stockholders at the 2024 annual meeting of stockholders 840,000 shares. In addition, shares of Common Stock underlying any outstanding award granted under the Predecessor Plan that, following the Effective Date, expires, or is terminated, surrendered, or forfeited for any reason without issuance of such shares shall be available for the grant of new Awards under this Plan. As provided in Section 1, no new awards shall be granted under the Predecessor Plan following the Effective Date. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares, treasury shares, or shares purchased on the open market or otherwise, all as determined by the Company from time to time.
4.2. Share Counting
4.2.1. General
Each share of Common Stock granted in connection with an Award shall be counted as one share against the limit in Section 4.1, subject to the provisions of this Section 4.2. Share-based Performance Awards shall be counted assuming maximum performance results (if applicable) until such time as actual performance results can be determined.
4.2.2. Cash-Settled Awards
Any Award settled in cash shall not be counted as shares of Common Stock for any purpose under this Plan.
4.2.3. Expired or Terminated Awards
If any Award under the Plan expires, or is terminated, surrendered, or forfeited, in whole or in part, the unissued Common Stock covered by such Award shall again be available for the grant of Awards under the Plan.
4.2.4. Payment of Option Price or Tax Withholding in Shares
The full number of shares of Common Stock with respect to which an Option or SAR is granted shall count against the aggregate number of shares available for grant under the Plan. Accordingly, (i) if in accordance with the terms of the Plan, a Grantee pays the Option Price for an Option by either tendering previously owned shares or having the Company withhold shares, then such shares surrendered to pay the Option Price shall continue to count against the aggregate number of shares available for grant under the Plan set forth in Section 4.1 above; and (ii) for a share-settled SAR, the gross number of shares with respect to which the SAR is granted shall be counted against the limit in Section 4.1 (i.e., not just the net shares actually issued upon exercise of the SAR). In addition, if in accordance with the terms of the Plan, a Grantee satisfies any tax withholding requirement with respect to any taxable event arising as a result of this Plan by either tendering previously owned shares or having the Company withhold shares, then such shares surrendered to satisfy such tax withholding requirements shall continue to count against the aggregate number of shares available for grant under the Plan set forth in Section 4.1 above.
4.2.5. Substitute Awards
In the case of any Substitute Award, such Substitute Award shall not be counted against the number of shares reserved under the Plan.
4.3. Award Limits
4.3.1. Incentive Stock Options.
Subject to adjustment under Section 14, 4 million shares of Common Stock available for issuance under the Plan shall be available for issuance under Incentive Stock Options.
4.3.2. Individual Award Limits - Share-Based Awards.
Subject to adjustment under Section 14, the maximum number of each type of Award (other than cash-based Performance Awards) granted to any Grantee in any calendar year shall not exceed the following number of shares of Common Stock: (i) Options and SARs: 1 million shares; and (ii) all share-based Performance Awards (including Restricted Stock and Restricted Stock Units that are Performance Awards): 1 million shares.
4.3.3. Individual Award Limits - Cash-Based Awards.
The maximum amount of cash-based Performance Awards granted to any Grantee in any calendar year shall not exceed the following: (i) Annual Incentive Award: $5 million; and (ii) all other cash-based Performance Awards: $5 million.
4.3.4. Limits on Awards to Non-Employee Directors.
No more than $500,000 may be granted in share-based Awards under the Plan during any one year to a Grantee who is a Non-Employee Director (based on the Fair Market Value of the shares of Common Stock underlying the Award as of the applicable Grant
TrueBlue, Inc. 2024 Proxy Statement  P. 87

TABLE OF CONTENTS

APPENDIX B
Date in the case of Restricted Stock, Restricted Stock Units, or Other Stock-based Awards, and based on the applicable grant date fair value for accounting purposes in the case of Options or SARs); provided, however, that share-based Awards made to a Grantee who is a Non-Employee Director at such Grantee’s election in lieu of all or a portion of his or her cash retainer or fees for service on the Board and any Board committee shall not be counted towards the limit under this Section 4.3.4.
5. EFFECTIVE DATE, DURATION AND AMENDMENTS
5.1.  Term.
The Plan shall be effective as of the Effective Date, provided that it has been approved by the Company’s stockholders. The Plan shall terminate automatically on the ten (10) year anniversary of the Restatement Effective Date and may be terminated on any earlier date as provided in Section 5.2.
5.2. Amendment and Termination of the Plan.
The Board may, at any time and from time to time, amend, suspend, or terminate the Plan as to any Awards which have not been made. An amendment shall be contingent on approval of the Company’s stockholders to the extent stated by the Board, required by applicable law, or required by applicable stock exchange listing requirements. Notwithstanding the foregoing, any amendment to Section 3.2 shall be contingent upon the approval of the Company’s stockholders. No Awards shall be made after the Termination Date. The applicable terms of the Plan, and any terms and conditions applicable to Awards granted prior to the Termination Date shall survive the termination of the Plan and continue to apply to such Awards. No amendment, suspension, or termination of the Plan shall, without the consent of the Grantee, materially impair rights or obligations under any Award theretofore awarded.
6. AWARD ELIGIBILITY AND LIMITATIONS
6.1. Service Providers.
Subject to this Section 6.1, Awards may be made to any Service Provider as the Board shall determine and designate from time to time in its discretion.
6.2 Successive Awards.
An eligible person may receive more than one Award, subject to such restrictions as are provided herein.
6.3. Stand-Alone, Additional, Tandem, and Substitute Awards.
Awards may, in the discretion of the Board, be granted either alone or in addition to, in tandem with, or in substitution or exchange for, any other Award or any award granted under another plan of the Company, any Affiliate, or any business entity to be acquired by the Company or an Affiliate, or any other right of a Grantee to receive payment from the Company or any Affiliate. Such additional, tandem, and substitute or exchange Awards may be granted at any time. If an Award is granted in substitution or exchange for another Award, the Board shall have the right to require the surrender of such other Award in consideration for the grant of the new Award. Subject to Section 3.2, the Board shall have the right, in its discretion, to make Awards in substitution or exchange for any other award under another plan of the Company, any Affiliate, or any business entity to be acquired by the Company or an Affiliate. In addition, Awards may be granted in lieu of cash compensation, including in lieu of cash amounts payable under other plans of the Company or any Affiliate, in which the value of Stock subject to the Award is equivalent in value to the cash compensation (for example, Restricted Stock Units or Restricted Stock).
7. AWARD AGREEMENT
Each Award shall be evidenced by an Award Agreement, in such form or forms as the Board shall from time to time determine. Without limiting the foregoing, an Award Agreement may be provided in the form of a notice which provides that acceptance of the Award constitutes acceptance of all terms of the Plan and the notice. Award Agreements granted from time to time or at the same time need not contain similar provisions but shall be consistent with the terms of the Plan. Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended to be Non-qualified Stock Options or Incentive Stock Options, and in the absence of such specification such options shall be deemed Non-qualified Stock Options.
8. TERMS AND CONDITIONS OF OPTIONS
8.1. Option Price.
The Option Price of each Option shall be fixed by the Board and stated in the related Award Agreement. The Option Price of each Option (except those that constitute Substitute Awards) shall be at least the Fair Market Value on the Grant Date of a share of Stock; provided, however, that in the event that a Grantee is a Ten Percent Stockholder as of the Grant Date, the Option Price of an Option granted to such Grantee that is intended to be an Incentive Stock Option shall be not less than 110 percent of the Fair Market Value of a share of Stock on the Grant Date. In no case shall the Option Price of any Option be less than the par value of a share of Stock.
8.2. Vesting.
Subject to Section 8.3 hereof, each Option shall become exercisable at such times and under such conditions (including, without limitation, performance requirements) as shall be determined by the Board and stated in the Award Agreement.
8.3. Term.
Each Option shall terminate, and all rights to purchase shares of Stock thereunder shall cease, upon the expiration of a period not to exceed ten (10) years from the Grant Date, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Board and stated in the related Award Agreement; provided, however, that in the event that the Grantee is a Ten Percent Stockholder, an Option granted to such Grantee that is intended to be an Incentive Stock Option at the Grant Date shall not be exercisable after the expiration of five (5) years from its Grant Date.
TrueBlue, Inc. 2024 Proxy Statement  P. 88

TABLE OF CONTENTS

APPENDIX B
8.4. Limitations on Exercise of Option.
Notwithstanding any other provision of the Plan, in no event may any Option be exercised, in whole or in part, (i) prior to the date the Plan is approved by the stockholders of the Company as provided herein or (ii) after the occurrence of an event which results in termination of the Option.
8.5. Method of Exercise.
An Option that is exercisable may be exercised by the Grantee’s delivery of a notice of exercise to the Company, setting forth the number of shares of Stock with respect to which the Option is to be exercised, accompanied by full payment for the shares. To be effective, notice of exercise must be made in accordance with procedures established by the Company from time to time.
8.6. Rights of Holders of Options.
Unless otherwise stated in the related Award Agreement, an individual holding or exercising an Option shall have none of the rights of a stockholder (for example, the right to receive cash or dividend payments or distributions attributable to the subject shares of Stock or to direct the voting of the subject shares of Stock) until the shares of Stock covered thereby are fully paid and issued to him. Except as provided in Section 14 hereof or the related Award Agreement, no adjustment shall be made for dividends, distributions, or other rights for which the record date is prior to the date of such issuance.
8.7. Limitations on Incentive Stock Options.
An Option shall constitute an Incentive Stock Option only (i) if the Grantee of such Option is an employee of the Company or any Subsidiary of the Company; (ii) to the extent specifically provided in the related Award Agreement; and (iii) to the extent that the aggregate Fair Market Value (determined at the time the Option is granted) of the shares of Stock with respect to which all Incentive Stock Options held by such Grantee become exercisable for the first time during any calendar year (under the Plan and all other plans of the Grantee’s employer and its Affiliates) does not exceed $100,000. This limitation shall be applied by taking Options into account in the order in which they were granted.
9. TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS
9.1. Right to Payment.
A SAR shall confer on the Grantee a right to receive, upon exercise thereof, the excess of (i) the Fair Market Value of one share of Stock on the date of exercise over (ii) the SAR Exercise Price, as determined by the Board. The Award Agreement for a SAR (except those that constitute Substitute Awards) shall specify the SAR Exercise Price, which shall be fixed on the Grant Date as not less than the Fair Market Value of a share of Stock on that date. SARs may be granted alone or in conjunction with all or part of an Option or at any subsequent time during the term of such Option or in conjunction with all or part of any other Award. A SAR granted in tandem with an outstanding Option following the Grant Date of such Option shall have a SAR Exercise Price that is equal to the Option Price; provided, however, that the SAR Exercise Price may not be less than the Fair Market Value of a share of Stock on the Grant Date of the SAR to the extent required by Section 409A.
9.2. Other Terms.
The Board shall determine at the Grant Date, the time or times at which and the circumstances under which a SAR may be exercised in whole or in part (including based on achievement of performance goals and/or future service requirements), the time or times at which SARs shall cease to be or become exercisable following Separation from Service or upon other conditions, the method of exercise, whether or not a SAR shall be in tandem or in combination with any other Award, and any other terms and conditions of any SAR.
9.3. Term of SARs.
The term of a SAR granted under the Plan shall be determined by the Board, in its sole discretion; provided, however, that such term shall not exceed ten (10) years.
9.4. Payment of SAR Amount.
Upon exercise of a SAR, a Grantee shall be entitled to receive payment from the Company (in cash or Stock, as determined by the Board) in an amount determined by multiplying:
(1)
the difference between the Fair Market Value of a share of Stock on the date of exercise over the SAR Exercise Price; by
(2)
the number of shares of Stock with respect to which the SAR is exercised.
10. TERMS AND CONDITIONS OF RESTRICTED STOCK, RESTRICTED STOCK UNITS, AND OTHER STOCK-BASED AWARDS
10.1 Restrictions.
At the time of grant, the Board may, in its sole discretion, establish a period of time (a “Restricted Period”) and any additional restrictions including the satisfaction of corporate or individual performance objectives applicable to an Award of Restricted Stock or Restricted Stock Units in accordance with Section 12. Each Award of Restricted Stock or Restricted Stock Units may be subject to a different Restricted Period and additional restrictions. Neither Restricted Stock nor Restricted Stock Units may be sold, transferred, assigned, pledged, or otherwise encumbered or disposed of during the Restricted Period or prior to the satisfaction of any other applicable restrictions. The Board may also grant Other Stock-based Awards to Non-Employee Directors, which Awards may be subject to deferral under the terms of the Company’s deferred compensation plan for Non-Employee Directors (as in effect from time to time), in which case such Other Stock-Based Awards shall be considered to be fully vested Restricted Stock Units.
10.2. Restricted Stock Certificates.
The Company shall issue stock, in the name of each Grantee to whom Restricted Stock has been granted, stock certificates or other evidence of ownership representing the total number of shares of Restricted Stock granted to the Grantee, as soon as reasonably practicable after the Grant Date.
TrueBlue, Inc. 2024 Proxy Statement  P. 89

TABLE OF CONTENTS

APPENDIX B
10.3. Rights of Holders of Restricted Stock.
Unless the Board otherwise provides in an Award Agreement and subject to Section 16.12, holders of Restricted Stock shall have rights as stockholders of the Company, including voting and dividend rights.
10.4. Rights of Holders of Restricted Stock Units.
10.4.1. Settlement of Restricted Stock Units.
Restricted Stock Units may be settled in cash or Stock, as determined by the Board, and set forth in the Award Agreement. The Award Agreement shall also set forth whether the Restricted Stock Units shall be settled (i) within the time period specified for “short term deferrals” under Section 409A or (ii) otherwise within the requirements of Section 409A, in which case the Award Agreement shall specify upon which events such Restricted Stock Units shall be settled.
10.4.2. Voting and Dividend Rights.
Unless otherwise stated in the applicable Award Agreement and subject to Section 16.12, holders of Restricted Stock Units shall not have rights as stockholders of the Company, including no voting or dividend or dividend equivalents rights.
10.4.3. Creditor’s Rights.
A holder of Restricted Stock Units shall have no rights other than those of a general creditor of the Company. Restricted Stock Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Award Agreement.
10.5. Purchase of Restricted Stock.
The Grantee shall be required, to the extent required by applicable law, to purchase the Restricted Stock from the Company at a Purchase Price equal to the greater of (i) the aggregate par value of the shares of Stock represented by such Restricted Stock or (ii) the Purchase Price, if any, specified in the related Award Agreement. If specified in the Award Agreement, the Purchase Price may be deemed paid by Services already rendered. The Purchase Price shall be payable in a form described in Section 11 or, in the discretion of the Board, in consideration for past Services rendered.
10.6. Delivery of Stock.
Upon the expiration or termination of any Restricted Period and the satisfaction of any other conditions prescribed by the Board, the restrictions applicable to shares of Restricted Stock or Restricted Stock Units settled in Stock shall lapse, and, unless otherwise provided in the Award Agreement, a stock certificate for such shares shall be delivered, free of all such restrictions, to the Grantee or the Grantee’s beneficiary or estate, as the case may be.
11. FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK
11.1. General Rule.
Payment of the Option Price for the shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock shall be made in cash or in cash equivalents acceptable to the Company, except as provided in this Section 11.
11.2. Surrender of Stock.
To the extent the Award Agreement so provides, payment of the Option Price for shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock may be made all or in part through the tender to the Company of shares of Stock, which shares shall be valued, for purposes of determining the extent to which the Option Price or Purchase Price for Restricted Stock has been paid thereby, at their Fair Market Value on the date of exercise or surrender. Notwithstanding the foregoing, in the case of an Incentive Stock Option, the right to make payment in the form of already owned shares of Stock may be authorized only at the time of grant.
11.3. Cashless Exercise.
With respect to an Option only (and not with respect to Restricted Stock), to the extent permitted by law and to the extent the Award Agreement so provides, payment of the Option Price may be made all or in part by delivery (on a form acceptable to the Company) of an irrevocable direction to a licensed securities broker acceptable to the Company to sell shares of Stock and to deliver all or part of the sales proceeds to the Company in payment of the Option Price and any withholding taxes described in Section 16.3.
11.4. Other Forms of Payment.
To the extent the Award Agreement so provides, payment of the Option Price or the Purchase Price for Restricted Stock may be made in any other form that is consistent with applicable laws, regulations, and rules, including, but not limited to, the Company’s withholding of shares of Stock otherwise due to the exercising Grantee.
12. TERMS AND CONDITIONS OF PERFORMANCE AWARDS
12.1 Performance Conditions.
The Committee may grant Performance Awards subject to such performance conditions as may be specified by the Committee. The Committee may use such business criteria, other measures of performance, or other terms and conditions as it may deem appropriate in establishing any performance goals. Performance goals may differ for Performance Awards granted to any one Grantee or to different Grantees.
12.2 Settlement of Performance Awards.
Settlement of Performance Awards shall be in cash, Stock, other Awards, or other property, in the discretion of the Committee. The Committee may, in its discretion, adjust the amount of a settlement otherwise to be made in connection with Performance Awards.
TrueBlue, Inc. 2024 Proxy Statement  P. 90

TABLE OF CONTENTS

APPENDIX B
13. REQUIREMENTS OF LAW
13.1. General.
The Company shall not be required to sell or issue any shares of Stock under any Award if the sale or issuance of such shares would constitute a violation by the Grantee, any other individual exercising an Option, or the Company of any provision of any law or regulation of any governmental authority, including without limitation any federal or state securities laws or regulations. If at any time the Company shall determine, in its discretion, that the listing, registration or qualification of any shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the issuance or purchase of shares hereunder, no shares of Stock may be issued or sold to the Grantee or any other individual exercising an Option pursuant to such Award unless such listing, registration, qualification, consent, or approval shall have been effected or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act, upon the exercise of any Option or the delivery of any shares of Stock underlying an Award, unless a registration statement under such Act is in effect with respect to the shares of Stock covered by such Award, the Company shall not be required to sell or issue such shares unless the Board has received evidence satisfactory to it that the Grantee or any other individual exercising an Option may acquire such shares pursuant to an exemption from registration under the Securities Act. Any determination in this connection by the Board shall be final, binding, and conclusive. The Company may, but shall in no event be obligated to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative action in order to cause the exercise of an Option or the issuance of shares of Stock pursuant to the Plan to comply with any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option shall not be exercisable until the shares of Stock covered by such Option are registered or are exempt from registration, the exercise of such Option (when the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability of such an exemption.
13.2 Rule 16b-3.
During any time when the Company has a class of equity security registered under Section 12 of the Exchange Act, it is the intent of the Company that Awards and the exercise of Options granted to officers and directors hereunder will qualify for the exemption provided by Rule 16b-3 under the Exchange Act. To the extent that any provision of the Plan or action by the Board or Committee does not comply with the requirements of Rule 16b-3, it shall be deemed inoperative to the extent permitted by law and deemed advisable by the Board and shall not affect the validity of the Plan. In the event that Rule 16b-3 is revised or replaced, the Board may exercise its discretion to modify this Plan in any respect necessary to satisfy the requirements of, or to take advantage of any features of, the revised exemption or its replacement.
14. EFFECT OF CHANGES IN CAPITALIZATION
14.1 Changes in Stock.
If (i) the number of outstanding shares of Stock is increased or decreased or the shares of Stock are changed into or exchanged for a different number or kind of shares or other securities of the Company on account of any recapitalization, reclassification, stock split, reverse split, combination of shares, exchange of shares, stock dividend, or other distribution payable in capital stock, or other increase or decrease in such shares effected without receipt of consideration by the Company occurring after the Effective Date, or (ii) there occurs any spin-off, split-up, extraordinary cash dividend, or other distribution of assets by the Company, the number and kinds of shares for which grants of Awards may be made under the Plan (including the maximums set forth in Section 4.3) shall be equitably adjusted by the Company; provided that any such adjustment shall comply with Section 409A. In addition, in the event of any such increase or decrease in the number of outstanding shares or other transaction described in clause (ii) above, the number and kind of shares for which Awards are outstanding and the Option Price per share of outstanding Options and SAR Exercise Price per share of outstanding SARs shall be equitably adjusted, provided that any such adjustment shall comply with Section 409A. Adjustments under this Section 14.1 related to shares of Stock or securities of the Company shall be made by the Board, whose determination in that respect shall be final, binding, and conclusive. No fractional shares or other securities shall be issued pursuant to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the nearest whole share.
14.2. Change in Control.
Upon a Change in Control, unless otherwise specified in the Award Agreement or in an Employee’s Change in Control Agreement:
Each outstanding Award will be Assumed (as defined below) by the entity effecting the Change in Control (or a successor or parent corporation). If the outstanding Awards are not Assumed by the entity effecting the Change in Control (or a successor or parent corporation), then (i) such Awards (other than Performance Awards) will become fully vested, exercisable or non-forfeitable, as the case may be, immediately prior to the Change in Control and (ii) such Awards that are Performance Awards will be deemed earned and vested at the target performance level immediately prior to the Change in Control.
If the Awards are Assumed by the entity effecting the Change in Control (or a successor or parent corporation), then (i) such Awards (other than Performance Awards) shall continue to become vested, exercisable and non-forfeitable, as the case may be, pursuant to the terms of the applicable Award Agreement, and (ii) such Awards that are Performance Awards will be deemed earned at the target performance level as of the date of the Change in Control and the Award shall remain subject to time-based vesting until the end of the performance period set forth in the applicable Award Agreement. Notwithstanding the foregoing, if a Grantee’s employment is terminated during the one-year period beginning on the date of a Change in Control and such termination is due to (1) a termination by the Company without Cause or (2) a voluntary termination by the Grantee due to the existence of Good Reason, then the following shall occur with respect to the Awards that are Assumed:
(i)
With respect to Awards other than Performance Awards, such awards shall become fully vested, exercisable, and non-forfeitable, as the case may be, as of the effective date of a Grantee’s termination of employment; and
(ii)
With respect to Performance Awards, the fixed number deemed earned as determined above shall become fully vested, exercisable, and non-forfeitable, as the case may be, as of the effective date of a Grantee’s termination of employment.
Awards will be considered assumed (“Assumed”) if the following conditions are met (1) the Awards are converted into replacement awards in a manner that complies with Section 409A of the Code; (2) the replacement award contains provisions for scheduled vesting and treatment on termination of employment that are no less favorable to the Grantee than those in this Plan or the applicable Award Agreement, and all other terms of the replacement award (other than the security, the number of shares represented by the replacement award, and the exercise price of the replacement award, if applicable) are substantially similar to those in this Plan and the applicable Award Agreement; and (3) the security represented by the replacement award is of a class that is publicly held and widely traded on an established stock exchange.
TrueBlue, Inc. 2024 Proxy Statement  P. 91

TABLE OF CONTENTS

APPENDIX B
15. NO LIMITATION ON COMPANY
The making of Awards pursuant to the Plan shall not affect or limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure or to merge, consolidate, dissolve, or liquidate, or to sell or transfer all or any part of its business or assets.
16. TERMS APPLICABLE GENERALLY TO AWARDS GRANTED UNDER THE PLAN
16.1. Disclaimer of Rights.
No provision in the Plan or in any Award Agreement shall be construed to confer upon any individual the right to remain in the employ or service of the Company or any Affiliate, or to interfere in any way with any contractual or other right or authority of the Company either to increase or decrease the compensation or other payments to any individual at any time, or to terminate any employment or other relationship between any individual and the Company. In addition, notwithstanding anything contained in the Plan to the contrary, unless otherwise stated in the applicable Award Agreement, no Award granted under the Plan shall be affected by any change of duties or position of the Grantee, so long as such Grantee continues to be a Service Provider. The obligation of the Company to pay any benefits pursuant to this Plan shall be interpreted as a contractual obligation to pay only those amounts described herein, in the manner and under the conditions prescribed herein. The Plan shall in no way be interpreted to require the Company to transfer any amounts to a third-party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee or beneficiary under the terms of the Plan.
16.2. Nonexclusivity of the Plan.
Neither the adoption of the Plan nor the submission of the Plan to the stockholders of the Company for approval shall be construed as creating any limitations upon the right and authority of the Board to adopt such other incentive compensation arrangements (which arrangements may be applicable either generally to a class or classes of individuals or specifically to a particular individual or particular individuals), including, without limitation, the granting of stock options as the Board in its discretion determines desirable.
16.3. Withholding Taxes.
The Company or an Affiliate, as the case may be, shall have the right to deduct from payments of any kind otherwise due to a Grantee any federal, state, or local taxes of any kind required by law to be withheld (i) with respect to the vesting of or other lapse of restrictions applicable to an Award; (ii) upon the issuance of any shares of Stock upon the exercise of an Option or SAR; or (iii) otherwise due in connection with an Award. At the time of such vesting, lapse, or exercise, the Grantee shall pay to the Company or the Affiliate, as the case may be, any amount that the Company or the Affiliate may reasonably determine to be necessary to satisfy such withholding obligation. The Company or the Affiliate, as the case may be, may in its sole discretion, require or permit the Grantee to satisfy such obligations, in whole or in part, (i) by causing the Company or the Affiliate to withhold the minimum required number of shares of Stock otherwise issuable to the Grantee as may be necessary to satisfy such withholding obligation, or (ii) by delivering to the Company or the Affiliate shares of Stock already owned by the Grantee. The shares of Stock so delivered or withheld shall have an aggregate Fair Market Value equal to such withholding obligations, provided it does not exceed the employer’s applicable minimum required tax withholding rate or such other applicable rate as is deemed necessary or advisable to avoid adverse treatment for financial accounting purposes, as determined by the Committee in its sole discretion. The Fair Market Value of the shares of Stock used to satisfy such withholding obligation shall be determined by the Company or the Affiliate as of the date that the amount of tax to be withheld is to be determined. To the extent applicable, a Grantee may satisfy his or her withholding obligation only with shares of Stock that are not subject to any repurchase, forfeiture, unfulfilled vesting, or other similar requirements.
16.4. Captions.
The use of captions in this Plan or any Award Agreement is for the convenience of reference only and shall not affect the meaning of any provision of the Plan or any Award Agreement.
16.5. Other Provisions.
Each Award Agreement may contain such other terms and conditions not inconsistent with the Plan as may be determined by the Board, in its sole discretion. In the event of any conflict between the terms of an employment agreement, an Award Agreement, and the Plan, the documents shall govern in the order listed herein, to the extent permitted by the terms of the Plan.
16.6. Number and Gender.
With respect to words used in this Plan, the singular form shall include the plural form, the masculine gender shall include the feminine gender, etc., as the context requires.
16.7. Severability.
If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.
16.8. Governing Law.
The Plan shall be governed by and construed in accordance with the laws of the State of Washington without giving effect to the principles of conflicts of law, and applicable Federal law.
16.9. Section 409A.
The Plan is intended to comply with Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to comply therewith. Any payments described in the Plan that are due within the “short-term deferral period” as defined in Section 409A shall not be treated as deferred compensation unless applicable laws require otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six (6) month period immediately following the Grantee’s Separation from Service shall instead be paid on the first payroll date after the six-month anniversary of the Grantee’s Separation
TrueBlue, Inc. 2024 Proxy Statement  P. 92

TABLE OF CONTENTS

APPENDIX B
from Service (or the Grantee’s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any obligation to take any action to prevent the assessment of any excise tax or penalty on any Grantee under Section 409A and neither the Company nor the Committee will have any liability to any Grantee for such tax or penalty.
16.10. Separation from Service.
The Board shall determine the effect of a Separation from Service upon Awards, and such effect shall be set forth in the appropriate Award Agreement. Without limiting the foregoing, the Board may provide in the Award Agreements at the time of grant, or any time thereafter with the consent of the Grantee, the actions that will be taken upon the occurrence of a Separation from Service, including, but not limited to, accelerated vesting or termination, depending upon the circumstances surrounding the Separation from Service.
16.11. Transferability of Awards.
16.11.1. Transfers in General.
Except as provided in Section 16.11.2, no Award shall be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and distribution, and, during the lifetime of the Grantee, only the Grantee personally (or the Grantee’s personal representative) may exercise rights under the Plan. However, this Subsection shall not preclude a Grantee from designating a beneficiary who will receive any outstanding Award in the event of the Grantee’s death.
16.11.2. Family Transfers.
If authorized in the applicable Award Agreement, a Grantee may transfer, not for value, all or part of an Award (other than Incentive Stock Options) to any Family Member. For the purpose of this Section 16.11.2, a “not for value” transfer is a transfer which is (i) a gift, (ii) a transfer under a domestic relations order in settlement of marital property rights; or (iii) a transfer to an entity in which more than fifty percent of the voting interests are owned by Family Members (or the Grantee) in exchange for an interest in that entity. Following a transfer under this Section 16.11.2, any such Award shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer. Subsequent transfers of transferred Awards are prohibited except to Family Members of the original Grantee in accordance with this Section 16.11.2 or by will or the laws of descent and distribution.
16.12. Dividends and Dividend Equivalent Rights.
If specified in the Award Agreement, the recipient of an Award other than Options or SARs under this Plan may be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents with respect to the Common Stock or other securities covered by an Award. The terms and conditions of a dividend equivalent right may be set forth in the Award Agreement. Dividend equivalents credited to a Grantee may be paid currently or may be deemed to be reinvested in additional shares of Stock or other securities of the Company at a price per unit equal to the Fair Market Value of a share of Stock on the date that such dividend was paid to stockholders, as determined in the sole discretion of the Committee. Notwithstanding the foregoing, the dividends or dividend equivalents shall accrue and be paid only to the extent the Award becomes vested or payable. The number of shares of Common Stock available for issuance under the Plan shall not be reduced to reflect any dividends or dividend equivalents that are reinvested into additional shares of Common Stock or credited as additional shares of Common Stock subject or paid with respect to an Award.
16.13. Death; Disability.
All Awards other than Performance Awards shall become vested, exercisable and non-forfeitable, as the case may be, in full upon a Grantee’s death or Separation from Service due to Disability; any Performance Awards shall be deemed earned and vested at the target level of performance. Any Awards that become payable after the Grantee’s death shall be distributed to the Grantee’s beneficiary or beneficiaries if the Grantee has designated one or more beneficiaries for this purpose by filing the prescribed form with the Company. If no beneficiary was designated or if no designated beneficiary survives the Grantee, then any Award that becomes payable after the Grantee’s death shall be distributed to the Grantee’s estate.
The Plan was originally approved by the stockholders of the Company on May 11, 2016.

The first amendment and restatement of the Plan was approved by the stockholders of the Company on May 9, 2018.

The second amendment and restatement of the Plan was approved by the stockholders of the Company on May 11, 2023.

This third amendment and restatement of the Plan was approved by the stockholders of the Company on    , 2024.
TrueBlue, Inc. 2024 Proxy Statement  P. 93

TABLE OF CONTENTS



TABLE OF CONTENTS


false DEF 14A 0000768899 0000768899 2022-12-26 2023-12-31 0000768899 tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:MrBeharelleMember 2022-12-26 2023-12-31 0000768899 tbi:MsOwenMember 2021-12-27 2022-12-25 0000768899 tbi:MrCooperMember 2021-12-27 2022-12-25 0000768899 tbi:MrBeharelleMember 2021-12-27 2022-12-25 0000768899 2021-12-27 2022-12-25 0000768899 tbi:MsOwenMember 2020-12-28 2021-12-26 0000768899 tbi:MrCooperMember 2020-12-28 2021-12-26 0000768899 tbi:MrBeharelleMember 2020-12-28 2021-12-26 0000768899 2020-12-28 2021-12-26 0000768899 tbi:MsOwenMember 2019-12-30 2020-12-27 0000768899 tbi:MrCooperMember 2019-12-30 2020-12-27 0000768899 tbi:MrBeharelleMember 2019-12-30 2020-12-27 0000768899 2019-12-30 2020-12-27 0000768899 2023-09-13 2023-12-31 0000768899 2022-12-26 2023-09-12 0000768899 2022-06-15 2022-12-25 0000768899 2021-12-27 2022-06-14 0000768899 1 2022-12-26 2023-12-31 0000768899 tbi:StockAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:YearEndFairValueOfCurrentYearRSAndRSUAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:YearEndFairValueOfCurrentYearPSUAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorRSAndRSUAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorPSUAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfCurrentYearVestedEquityAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorVestedEquityAwardsMember ecd:PeoMember tbi:MsOwenMember 2022-12-26 2023-12-31 0000768899 tbi:StockAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:YearEndFairValueOfCurrentYearRSAndRSUAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:YearEndFairValueOfCurrentYearPSUAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorRSAndRSUAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorPSUAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfCurrentYearVestedEquityAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorVestedEquityAwardsMember ecd:PeoMember tbi:MrCooperMember 2022-12-26 2023-12-31 0000768899 tbi:StockAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:YearEndFairValueOfCurrentYearRSAndRSUAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:YearEndFairValueOfCurrentYearPSUAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorRSAndRSUAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorPSUAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfCurrentYearVestedEquityAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:ChangeInFairValueOfPriorVestedEquityAwardsMember ecd:NonPeoNeoMember 2022-12-26 2023-12-31 0000768899 tbi:MrGaffordMember 2022-12-26 2023-12-31 0000768899 tbi:MrSchweihsMember 2022-12-26 2023-12-31 0000768899 2 2022-12-26 2023-12-31 0000768899 3 2022-12-26 2023-12-31 0000768899 4 2022-12-26 2023-12-31 iso4217:USD xbrli:pure xbrli:shares